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2ABSTRACT
The relationship between cancer and psychological distress is widely 
recognised and reflected by the large and growing body of psycho-oncology 
research. Oesophageal cancer is an aggressive malignant disease which is 
most frequently diagnosed once too advanced for curative treatment. For a 
small proportion of patients, a risky and invasive oesophagectomy operation 
can attempt to remove the cancer. The treatment process is physically and 
emotionally gruelling, yet little research has focused on the experience for 
patients. The majority of existing research has used quantitative methods. 
This study aimed to increase understanding of how people with oesophageal 
cancer experience the pre-operative treatment process and the approaching, 
yet uncertain, surgery. Qualitative semi-structured interviews were carried out 
with seven patients and eight members of their cancer centre’s multidisciplinary 
team. This intended to increase insight into patients’ personal experiences and 
staff’s accounts of diverse patients with whom they have worked. Analysis was 
conducted using a critical realist epistemology and thematic analysis. 
Three overarching patient themes were identified of ‘fear and the unknown’, 
‘treatment brings hope and uncertainty’ and ‘committing to getting through 
treatment’. Patient participants described determinedly following medical advice 
whilst feeling fearful about surgery and its aftermath. Staff spoke more directly 
about the risks, dilemmas and often harrowing effects of treatment, as well as 
their efforts to support patients with this. Two main staff themes were developed 
of ‘between the devil and the deep blue sea’ and ‘predicting the unpredictable’. 
The findings suggest a need to consider decision-making in this particular 
context. In clinical practice, healthcare professionals must facilitate careful 
consideration of the subjective complexity central to treatment decisions. 
Further research should examine the transmission of information about the risks 
and potential consequences of surgery, the psychological processes involved in 
patients’ decisions and methods for improving psychological preparation for 
surgery. 
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1. INTRODUCTION 
1.1 Background
This research focuses on exploring patients’1 experiences of pre-operative 
treatment for oesophageal cancer (O.C.) from the perspective of both patients 
and staff. I2 begin the introduction by describing the context of cancer drawing 
on relevant literature, policy and practice guidelines, considering implications for 
clinical practice. The specific features of potentially curative treatment for O.C.
will then be described, highlighting the characteristics and challenges of this
disease and treatment pathway. Finally, I will outline the findings of a systematic 
literature review which gave rise to the study’s aims and research questions.   
Both those who encourage and critique qualitative approaches acknowledge the 
influence of researchers’ assumptions and interpretations on the process and 
analysis (Harper, 2012). I have therefore aimed to become aware of 
assumptions influencing my decisions throughout this thesis. During my first 
experience of working in oncology and palliative care in 2010, I became 
interested in the idiosyncratic responses of individuals with varied sociocultural 
contexts who encounter the challenges of cancer and its treatment. I believe 
that a life-threatening cancer diagnosis interacts with other challenges and 
social inequalities and developing a contextualised understanding is therefore 
necessary, in order to consider how staff and systems can help.
My belief is that it is crucial to question taken-for-granted ‘truths’. In line with
this, my aim is that this thesis can create the possibility for further insight into 
patients’ experiences of pre-operative treatment for O.C. I hope that hearing 
directly from staff and patients during the challenging pre-operative period will
                                                            
1 This term will be used to refer to people with cancer in line with conventions, but with the 
acknowledgement of its problematic hierarchical connotations.
2 I have written this thesis in the first person to reflect that this is one interpretation, inextricably 
influenced by my own position and experiences, rather than a reflection of a reality.
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enable us to learn how patients themselves conceptualise their experiences
(which may differ from the dominant narratives about generic cancer 
experiences), with the opportunity to focus on this very specific treatment 
context. 
1.2 Cancer 
1.2.1 Prevalence and policy 
Unprecedented numbers of people receive cancer diagnoses each year and it is 
anticipated that by the end of 2016 more than one thousand people will be 
diagnosed with cancer daily in the United Kingdom (UK; Macmillan, 2015). 
Improved diagnostics, public health initiatives, screening and awareness are 
key contributors to this. In addition, work is being done to change cultural 
attitudes about cancer, particularly by organisations like Macmillan. This aims to
reduce negative and hopeless ideas about the disease, increasing awareness 
and consequently improving access to screening (Macmillan, 2013).
Over the past 15 years, medical advances have led not only to more curative 
outcomes, but also to significantly higher numbers of people surviving and living 
with cancer (Cancer Research UK; CRUK, 2014). Increases in cancer 
‘survivorship’ have primarily been linked with the aging population in the UK and 
more successful treatments, as well as earlier diagnoses (Macmillan, 2013).
Maddams, Utley and Møller (2012) projected that numbers of cancer survivors
in the UK will continue to grow by approximately one million every decade, 
doubling from two million in 2010 to four million in 2030. In 2015, this figure was 
reportedly two and a half million (Macmillan, 2015). This reflects great changes 
in outlook for many people with cancer, which is a disease that has historically 
been perceived as a ‘death sentence’ (Macmillan, 2012).
Increases in cancer survivorship, whilst providing hope, also create concern 
about the challenges this presents to the National Health Service’s (NHS)
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resources. Vast developments in medical science are increasing the chances of 
cure and survival and the resource-stretched NHS is therefore caring for and 
monitoring the growing numbers of people living with cancer and the effects of 
treatment (Macmillan, 2013). Although many people who have cancer will return 
to their pre-diagnostic levels of wellbeing and functioning, a significant number 
will continue to experience long-term distressing difficulties (Macmillan, 2013). 
The National Cancer Survivorship Initiative (NCSI, 2013) report ‘Living with and 
Beyond Cancer: Taking Action to Improve Outcomes’ asked commissioners and 
service providers to develop and commission care pathways that would work to 
minimise the consequences of cancer and its treatments. Macmillan argues that 
self-management (which has been emphasised in recent policy initiatives; 
Macmillan, 2009) is not sufficient without the health service taking responsibility 
for supporting the significant proportion of cancer patients managing long-term 
effects of the disease and treatment. From a health economic perspective, the 
NCSI report (2013; chapter 4) highlights the cost to the NHS and wider 
economy of failing to meet the needs of these people, due to the high costs 
following the end of treatment when needs are not met. For example, patients 
and carers’ ability to work is commonly impacted by cancer. 
The UK government have identified cancer as a national priority and Improving 
Outcomes: A Strategy for Cancer (Department of Health; DoH, 2014) outlined 
the challenges for the NHS of meeting the growing number of patients’ needs, 
coupled with current requirements for services to make savings. In the 
accompanying document to this, the government reported considerable 
progress in survival rates and patient experiences of cancer care in the UK
since the Cancer plan (DoH, 2000) and Cancer Reform Strategy (DoH, 2007). 
However, these rates remain lower than in comparable countries (De Angelis et 
al., 2014). 
Wilkinson and Pickett’s (2009) The Spirit Level provides powerful evidence for a
relationship between inequalities and health, where areas with the largest 
income gaps (including the UK and United States of America; U.S.A.) report 
greatest health problems. Cancer Research UK (2004) found a cancer
14
‘socioeconomic gradient’ with wealthier people more likely to have greater 
knowledge of cancer risks, leading to widespread inequalities. Evidence also 
suggests that there are higher rates of some cancers in people from minority 
ethnic groups (e.g. prostate cancer and black men; Ben-Shlomo et al., 2008) 
which is likely to relate to inter-group differences in lifestyle-based risk factors, 
diagnosis and access to treatment including lower income, educational 
opportunity and racism, as well as genetics. People from subjugated groups are 
also less likely to attend health screening (e.g. Baker & Middlerton; Rankow & 
Tessaro, 1998). Alongside this, people who described themselves as from an 
ethnic or sexual minority or as having a disability reported less positive 
experiences of cancer care in the patient experience survey  (DOH, 2010).  The 
Department of Health (2011) also highlight the continuing impact of social 
inequalities in cancer services. This evidence demonstrates that as with many 
health conditions, intersectional inequalities have a bidirectional relationship 
with cancer (Rowlingson, 2011). Therefore, I would suggest increasing 
understanding of cancer embedded in the complicated realities of people’s 
dynamic and intersecting contexts, is central to the pursuit of patient-centred 
care at all levels. 
1.2.2 Emotional effects of cancer 
Cancer continues to cause immense suffering for patients and carers, eliciting a 
diverse range of emotional responses and social consequences (Han et al.,
2014). Although progress in medical oncology has provided increased hope, 
pervasive ideas about cancer as a ‘death sentence’ remain influential. In 1978, 
Susan Sontag’s classic work Illness as Metaphor powerfully illuminated the 
ways in which societal ideas about cancer influence individuals’ experiences, 
with the argument that in order to make sense of our experiences, we draw on 
the ideas available within society. 
People’s experiences of cancer and the emotions it evokes are unique and
individual, shaped by these societal narratives, multiple intersecting contexts
and wide variation in the disease itself. A large and growing body of 
psychosocial literature reflects the increasing focus in western cancer care on 
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emotional and holistic support, in which HCPs work to enhance all aspects of 
wellbeing and health related-quality of life (HR-QOL). In comparison, 
historically, the focus was almost entirely on the physical consequences of 
illness. The effects of cancer and its treatments are at best unpleasant and at 
worst devastating. For a considerable proportion of people this leads to far-
reaching changes in every area of life and identity. That said, the changes that 
cancer provokes are not always negative, as the large body of literature on the 
concept of ‘post-traumatic growth’ suggests (Parkes, 1971). 
Distress and fear for cancer patients has been described as the ‘sixth vital sign’3
by Bultz and Carlson (2005) and studies using systematic screening tools have 
found that 33%-45% of cancer patients reported ‘significant distress’ (Carlson & 
Bultz, 2003; p.403). The appropriate and understandable response of fear and 
distress when facing cancer is eloquently articulated by Brennan (2001; p. 2): 
‘It4 seems highly arguable whether psychological turmoil provoked by a severe 
life event should be regarded as morbid or part of an adaptive process’. 
However, as the literature review for this study later exemplifies, a considerable 
proportion of psychosocial research in cancer has viewed distress through the 
lens of psychiatric diagnosis, portraying psychological distress in isolation rather 
than in context (Brennan, 2004). This is despite the well-established relationship 
between context and wellbeing, extensively supported by research evidence 
and included in national and international policies (DOH, 2003; World Health 
Organisation, 2009). The ethos of supportive and palliative care is also based 
upon principles of ‘person-centred care’ which aim to understand the person 
and the meaning of their experiences in the context of their individual history, 
current circumstances and values (Jeffrey, 2003).
The uncertainty associated with cancer often makes it particularly 
psychologically challenging. The construct of locus of control developed by 
Rotter (1954) can be applied to make sense of why unpredictability is so
                                                            
3 A reference to the five vital signs of nursing usually considered to be: pain, respiratory rate, 
temperature, heart rate and blood pressure (Berry et al., 2001).
4 Single quotation marks will be used to indicate quotations from academic texts and reports, 
double quotation marks will be used for direct quotes from interiews.
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difficult. This theory has been highly influential across health research and 
practice, and suggests that when people believe that what happens to them is
related to their own actions (internal reinforcement) or rather due to powerful 
outside forces (external reinforcement), it impacts on their capacity to adapt to 
illness. Internal health locus of control has consistently been associated with 
better health outcomes, when focused on having control in the future, but is 
related to more distress if this is focused on perceptions of control in the past 
(Mystakidou et al., 2015). However, Christensen, Howren and Rosenthal (2010) 
found that strong internal locus of control is related to positive adjustment to 
illness solely where control is ‘realistic’. They suggest that it may conversely be 
harmful where there are insurmountable barriers to utilising personal control. In 
a cancer context, this is particularly complicated, as overall personal control 
may be limited, for example despite adhering to medical advice, the 
effectiveness of treatment itself may be outside of patients’ control. Oppressive 
social circumstances may exacerbate this.
Understanding how people adapt to such threatening events and how to 
support them with this, is central to clinical practice with people with cancer.
Brennan’s (2001) influential social-cognitive transition model of adjustment 
proposes that the highly shocking demands of cancer require a fundamental re-
adjustment of the mental maps through which we predict and make sense of 
our experiences and the world. The experience of violation of our expectations 
of safety by a cancer diagnosis leads the world to feel uncertain and unsafe 
until more coherent mental maps can be developed. These processes of 
adjustment through re-organising our beliefs often lead to distress (Brennan, 
2004).
Much research has investigated variables that influence patients’ experiences of 
cancer. This has included factors such as speed of diagnosis (Thomas et al., 
2001), age (Brennan, 2004), gender (Moynihan, 2002) and attitudes of ‘fighting 
spirit’ or optimism which have been proposed as associated with better coping 
(Watson, Greer & Rowden et al., 1991; Carver et al., 1993). Brennan (2004), 
however, highlights that research on attitudes is individualising and implies
universality, rather than acknowledging that a variety of styles are likely to be 
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helpful at different time points or in combination, depending on circumstances.
He proposes that the strongest evidence suggests that ‘active’ styles of coping, 
where patients participate and engage with their circumstances and healthcare, 
are associated with positive adjustment (e.g. Rodrigue, Behen & Tumlin, 1994). 
1.2.3 Health-Related Quality of Life
The concept of HR-QOL, a dominant construct in the cancer literature (Abitbol, 
2014), can be defined as a subjective sense of satisfaction with life and 
wellbeing (Schumacher, Olschewski & Schulgen, 1991). Cancer and its 
treatment affects people’s HR-QOL in individual and varied ways depending on 
individual circumstances (Macmillan, 2014a). Götze et al.’s (2014) multi-site 
longitudinal survey study of heterogeneous cancer patients post-treatment 
found that emotional, role and social domains of HR-QOL were most negatively 
affected by cancer, above physical symptoms. 
Macmillan (2013; p.3) highlight that it is important to note that ‘not dying’ is not 
the same as ‘being well’. Similarly the idea of HR-QOL not being about how 
long you live, but rather a subjective sense of wellbeing is often used in 
definitions of supportive and palliative care (Payne, Seymour & Ingleton, 2008). 
Calman’s classic paper (1984; p. 124) emphasised that HR-QOL ‘…can only be 
described by the individual, and must take into account many aspects of life’. 
However, Rapley (2003) highlighted the problematic use of this construct in 
measures which attempt to quantify HR-QOL. The effects of this can be seen in 
the literature review presented later in this chapter. 
1.3 Oesophageal Cancer
While cancers share a basic biological process of the uncontrolled replication of 
cells, there is much variation in unique presentation and the impact it has on an 
individual’s experiences in a particular context (Vickery, Latchford, Bellew & 
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Feber, 2003). I think it is therefore important to put the challenges faced by 
specific patient groups in context (Clarke, McCorry & Dempster, 2011). 
Oesophageal cancer (O.C.) is an aggressive malignant disease, most often 
diagnosed at an advanced stage (Hodgson, 2006). It is internationally the eighth 
most common form of cancer for males and thirteenth most common for 
females (CRUK, 2016c). In 2012 it was found by Cancer Research UK to be the 
fourth most common cause of cancer death for men in the UK and the sixth 
most common cause of cancer death overall. Since the late 1970s rates of O.C. 
diagnoses have increased by 43% in the UK (CRUK, 2016c). The UK’s 
incidence rates for O.C. are the highest in Europe for females and second 
highest for males, although the reasons are unclear (CRUK, 2016c). There are 
differences in O.C. mortality rates across the UK with higher rates in the north
and lowest rates in the south and east (CRUK, 2012). O.C. is most common in 
socioeconomically deprived areas (Price, Sikora & Illidge, 2008). 
Patients with O.C. usually experience symptoms of dysphagia (difficulty 
swallowing), weight loss and pain. Due to the oesophagus’ expandable nature, 
there is often a delay before these symptoms are noticed and in most cases the 
cancer is only identified once too advanced for curative treatment (Andreassen 
& Randers et al., 2006). Lagergren’s (2010) review found that up to 75% of 
patients with O.C. are not treated with curative intent, usually due to advanced 
cancer stage or insufficient fitness for surgery. As with most other major 
resections for cancer, the number of patients for whom surgery is deemed 
plausible declines as age increases (National Cancer Intelligence Network, 
2014).
Overall most people with advanced O.C. live on average for 3-12 months post-
diagnosis (CRUK, 2016b). Where potentially curative treatment is feasible, 
there is a good chance of survival (Lagergren, 2010) and the National 
Oesophago–Gastric Cancer Audit (2014) found a reduction in deaths within 90 
days of surgery from 5.7% in 2010 to 4.4% in 2014. Approximately 14% of 
people underwent major resection surgery between 2006 and 2010 in England 
(CRUK, 2016c) which intends to remove the cancer surgically with the aim of
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cure. This ‘oesophagectomy’ surgery is an invasive and complicated procedure 
which offers potentially curative treatment, with a long and arduous recovery 
process. However, this is only viable when the disease is identified at an early 
and localised stage. Cancer Research UK (2016b) reports that 30-40% of 
people with localised O.C. would be eligible for this treatment. 
However, even after curatively intended oesophagectomy, five-year survival 
figures have been reported as 30% (Rouvelas, Zeng, Lindblad et al., 2005). In 
contrast, five-year survival rates for breast and prostate cancers in the UK have 
been reported as 78% and 84% respectively, with testicular cancer’s 10-year 
survival rate of 98% (CRUK, 2016a). Oesophagectomy provides hope of a cure, 
but has the highest mortality rates of any planned surgery. It has been 
described as ‘perhaps the most traumatic general surgical procedure’ 
(Tatematsu, Hasegawa, Tanaka, Sakai & Tsuboyama, 2013; p. 309) and long-
term effects include nutritional and gastrointestinal difficulties. At the point of 
diagnosis patients deemed suitable begin intensive treatment in preparation for 
surgery, often including chemotherapy (Lagergren, 2010).
The emotional demands of O.C. in particular have been acknowledged in the 
literature as posing a significant threat to HR-QOL (Verschuur et. al., 2006). The 
pre-operative treatment process can be especially gruelling, as treatment and 
physical optimisation begin soon after diagnosis and are crucial preparation for 
the operation (Djarv & Lagergren, 2012). It is widely acknowledged that patients 
who have oesophagectomy operations face great challenges physically and 
psychologically and so it is perhaps unsurprising that the process is usually
associated with a negative impact on HR-QOL and daily living, persisting during 
the long recovery period (e.g. Malmstrom, Klefsgård, Ivarsson et al., 2015). 
Malmstrom, Ivarsson, Johansson & Klefsgård (2013a) highlight that outcome of 
oesophagectomy has mainly been reported through quantitative measures such 
as survival, hospital stays and medical complications (e.g. Blazeby et al., 2000; 
Viklund et al., 2006a). Although important, this fails to capture patients’ lived 
experiences or to acknowledge other aspects of a successful outcome. 
While much has been written about the impact of cancer on HR-QOL, little 
research has focused on this unique treatment context. I would argue that the 
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experience of this type of treatment is likely to differ significantly from the 
experience of the more common types of treatment for O.C. (e.g. palliative 
symptom control). The below figure depicts typical care pathways for patients 
with O.C. (adapted from Viklund & Lagergren, 2007).
Figure 1: Typical oesophageal cancer care pathway
In addition to the widely-accepted sequence of treatments (Lagergren, 2010) 
the importance of a well-co-ordinated pathway for patients having this treatment 
has been documented extensively in the literature (Viklund, Wengstrom &
Lagergren, 2006b; Viklund & Lagergren, 2007). 
1.3.1 Multidisciplinary treatment pathway
Some treatment centres have developed specialist treatment pathways to 
support patients during this process. 
Referral:
• Computed tomography
• Gastroscopy 
• Outpatient clinic 
Disease  is potentially curable Disease is not curable 
Palliative care 
• Detailed diagnostic procedures
• Optimization of general condition
• Chemotherapy where appropriate
• Oesophagectomy
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Intensive pre-operative pathways known as ‘pre-habilitation care pathways’ 
have been shown to improve physical and emotional outcomes (Silver & Baima, 
2013). It is common for pre-habilitation care pathways to involve intensive
multidisciplinary support alongside direct medical treatment. At the London 
cancer centre where this study was carried out, there is a specific pre-
habilitation care pathway for those patients with O.C. who are medically suitable 
for treatment with curative intent. This pathway was introduced in 2014 to 
prepare patients for oesophagectomy surgery. The pathway which is this 
study’s focus entails additional medical and dietetic consultations, intensive 
exercise therapy and specialist nurse support throughout the pre-operative 
process where patients frequently also have chemotherapy. It has a holistic 
approach, emphasising both personalised care and standardisation, aiming to 
offer equity and efficiency to all patients. This new pathway is showing promise
and is likely to be expanded to other cancers in the near future. The following
figure depicts the pre-habilitation pathway for patients at this cancer centre.
Figure 2: oesophagectomy pre-habilitation pathway
Diagnosis of 
O.C. – tests 
suggest it is 
treatable. Patient 
and team agree 
to proceed with 
potentially 
curative 
treatment.
Chemotherapy:
8-10 weeks of 
chemotherapy with 
moderately toxic  
chemotherapy drug. Likely 
to experience fatigue, 
nausea, loss of appetite. 
Preparation for operation:
intensive exercise therapy, 
dietetics, scans, 
psychological screening
and regular meetings with 
clinical nurse specialist. 
Oesophagectomy 
operation 
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During the pre-operative treatment period, patients usually receive 
multidisciplinary pre-operative support through specialist nurses, doctors, 
dieticians, physiothererapists and psychologists whose interventions aim to 
physically and psychologically prepare patients for surgery, whilst supporting 
them during pre-operative treatment. There is much variation in patients’ 
physical symptoms and responses to treatment, meaning that there is a wide 
range of treatment pathways and experiences. For example, at the point of 
diagnosis and during the pre-operative treatment process some patients have 
very few physical symptoms while others experience extreme dysphagia 
obstructing eating and drinking, which may lead to rapid weight loss and 
necessitate a feeding tube.
The recommended medical treatment typically includes patients undergoing
approximately nine weeks of neoadjuvant chemotherapy, followed by a scan to 
check the response to chemotherapy and confirm eligibility for surgery. When 
patients are eligible, after a break of four to six weeks following chemotherapy, 
potentially curative surgery can take place. Where patients experience adverse 
effects to chemotherapy (particularly toxicity), chemotherapy will be 
discontinued and the timing of surgery will at times be accelerated. However 
where the scan indicates tumour progression, surgery would not be possible
and would be removed as a treatment option.
1.4 Systematic literature searches 
Systematic literature searches were carried out in November 2014-March 2016
to set the empirical context for the study. 
1.4.1 Search strategy
The following questions guided the literature review: 
 How is the relationship between oesophagectomy and HR-QOL
conceptualised? 
 How do patients describe their experiences of the process leading up to 
and following potentially curative oesophagectomy surgery? 
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The following databases were searched: Psychinfo, PsychArticles, CINAHL 
Plus and Science Direct, with no limits on date or country. 
The search terminology used in varied combinations was: (*esophagectomy OR 
*esophageal cancer) AND (experience* OR health related-quality of life OR 
mood OR distress). 
1.4.2 Inclusion criteria
Qualitative and quantitative articles published in the English language in a peer-
reviewed journal, describing research where a significant focus was the
experience or HR-QOL of patients who were having or had surgery for O.C.
with curative intent. 
1.4.3 Exclusion criteria
Papers not written in English, where the focus was not on the psychological 
experience for patients who were due to have or have had oesophagectomy. 
Papers where HR-QOL was mentioned but where the focus was on surgical or 
treatment techniques were excluded.
1.4.4 Search results
The search strategy initially identified a total of 2243 publications (170 from 
PsychInfo, 3 from PsychArticles, 1367 from CINAHL Plus, 703 from Science 
Direct). These searches, along with a search of the Cochrane library of 
systematic reviews using the search terms ‘oesophageal cancer’ and 
‘experience’ and ‘HR-QOL’ revealed that no similar systematic reviews had 
been published under these terms. The below figure depicts the process of 
initial searches, followed by manually reviewing the titles, abstracts and then full 
texts. In the case of uncertainty over the inclusion of a paper, the methodology 
and results section were also reviewed and on occasion, decisions were 
discussed with my supervisory team. Manual searching of the reference lists of 
relevant publications revealed a further five publications for screening. The final 
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step of retrieving and reviewing these 62 papers in full identified a total of 33
publications which fulfilled the inclusion criteria for review. A narrative review of 
the identified articles follows, with further details in Appendices A-E.
Figure 3: overview of search process
1.5 Critical appraisal of core papers
The quality of all papers meeting inclusion criteria was assessed. Most of the 
articles found were quantitative studies with a proportion of qualitative, as well 
as review articles. The review papers will be discussed first. Papers focusing on 
HR-QOL and oesophagectomy will then be considered, followed by papers 
which attend to elements of patients’ experiences of oesophagectomy. 
1.5.1 Review papers 
Wikman, Smedfors and Lagergren’s (2013) review suggested that there has 
been limited investigation of emotional distress and O.C., despite available 
Total articles = 2243
Titles and abstracts reviewed: 
2186 articles did not meet 
inclusion criteria. 
57 articles included at this stage. 
57 articles read in full
33 core articles included 
and critically reviewed. 
29 articles 
excluded as focus 
not patient’s 
experience 
5 new relevant 
articles found 
from reference 
lists
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evidence demonstrating that these patients tend to experience significant
distress in the short- and long-term. They state that it is difficult to draw 
conclusions from the current literature, as studies are mainly cross-sectional 
and have inconsistent assessment points with small and heterogeneous 
samples of patients with different treatment pathways and stages. The authors 
suggest further research is essential to look at the prevalence of distress and 
risk factors for this, and to further consider carers’ roles in emotional distress.
Whilst I agree that further research is important, I would argue that research 
that contextualises distress, rather than considering it detached from meaning 
and social context, is crucial. 
In a meta-analysis of 15 papers, Jacobs et al. (2014) found that deterioration on
social (role functioning) domains of HR-QOL questionnaires was particularly 
striking and correlated with physical symptoms. They concluded that 
participants experienced a long-lasting deterioration in HR-QOL following 
oesophagectomy, although this frequently improved 9-12 months post-surgery. 
The authors invite further qualitative research to explore in more detail how 
patients conceptualise their experiences and HR-QOL.
A review paper by Djärv and Lagergren (2012) aimed to assess the empirical 
evidence on HR-QOL post-oesophagectomy. They described the importance of 
HR-QOL as a concept within oncology and palliative care that emphasises 
patients’ subjective and individual experiences (rather than symptom checklists 
that reflect HCPs’ priorities). This paper recommends that all patients should be 
assessed for HR-QOL and strongly communicates a view that this improves 
every consultation. However, although this principle is appealing, I think that it is 
problematic to assume that improvement will be a definite consequence of 
assessment regardless of the approach taken.
Jacobs et al.’s (2013) systematic review of studies reporting HR-QOL post-
oesophagectomy concluded that the quality of most studies evaluating HR-QOL 
following surgery is poor and limited in ability to inform practice. They highlight 
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three robust studies, which they describe as ‘well designed and well reported’ 
(Zhang, et al., 2011; de Boer et al., 2004; Lagergren et al., 2007). Only one of 
these is included in this review as the other two studies were excluded due to 
the focus on different medical techniques. Given the quality of the Lagergren et 
al. (2007) study, it seems important to highlight their finding that patients who 
survive three years post-oesophagectomy report a good HR-QOL.
1.5.2 Relationship between HR-QOL and oesophagectomy 
Quantitative
Fourteen of the included papers investigated HR-QOL quantitatively, using 
questionnaires. The majority of papers adopted a narrow conceptualisation of 
HR-QOL and despite the value of reporting the findings of tools used in clinical 
practice; they often fail to acknowledge alternative dimensions and the context-
specific meaning of this concept. These quantitative studies also tend to 
measure HR-QOL without a theoretical basis or clearly described
conceptualisation of the meaning of this for participants.
1.5.2.1 HR-QOL post-surgery
Many studies reported HR-QOL measured at one time point, with others 
examining the trajectory of scores at multiple intervals. I will now give an 
analytical summary of the overarching findings (see Appendix A for study 
details).
Viklund et al. (2006a) found HR-QOL to be significantly lower for people six-
months post-oesophagectomy than for both a general population reference 
group and a group of heterogeneous cancer patients. Given the typically long
recovery period following oesophagectomy (at least 12 months), continuing 
physical symptoms and the risks and magnitude of surgery, it is perhaps 
unsurprising that HR-QOL scores would be comparatively low at 6 months. 
These scores are comparable to those for patients with a palliative diagnosis 
(reported by Homs et al., 2004). The authors argue that the findings provide
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evidence against oesophagectomy for palliative patients and that it should only 
be used with curative intent because of the impact on HR-QOL. They 
recommend providing clear and detailed information to inform patients’ 
expectations, as well as contact with a specialist nurse. They also highlight the 
implication that if detailed and honest information is provided, this may influence 
patients’ willingness to agree to surgery, stating that ‘patients should be 
informed of postoperative problems that often occur also since this might 
influence their approval to accept the surgical treatment’ (p.1412). This makes 
an important ethical point about informed consent necessitating realistic 
information. The authors caution against overselling this highly risky surgery. 
Akkerman et al. (2015) found that one year post-surgery, global HR-QOL was 
comparable to a general population group. Hallas et al. (2001) also found that 
the majority of participants had HR-QOL scores comparable to the general 
population group at five years post-oesophagectomy. However, in both these 
studies participants generally reported low HR-QOL on physical functioning, 
reflecting persisting symptoms long after surgery. These authors suggest that 
for the small proportion of patients who had lower global HR-QOL this was 
associated with continuing pain and fatigue. In addition Derogar et al. (2012) 
reported that five years post-oesophagectomy, post-operative complications 
predicted reduced post-surgery HR-QOL. They recommend careful screening 
for symptoms at follow-up appointments and the offer of rehabilitation 
interventions. This supports Hallas et al.’s (2001) suggestion of an association 
between physical trajectory and HR-QOL longitudinal scores.
Wu et al.’s (2015) investigation of symptom distress and HR-QOL in patients 
undergoing postoperative chemotherapy also found that symptom impact and 
HR-QOL were negatively related. They report that participants who worked and 
had lower anxiety often reported lower symptom distress and HR-QOL. The 
active coping strategy of ‘confrontation’ was positively correlated with symptom 
impact. The authors suggest that while confrontation could be considered to be 
an active style (as opposed to avoidance), one coping strategy is not sufficient 
for adapting to O.C. and treatment, as coping is situationally specific and its 
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effects are dynamic (Lazarus and Folkman, 1984). They propose that 
“appropriate avoidance” may be more adaptive for some patients, as 
confronting O.C. may cause overwhelming anxiety and distress. This 
corresponds with Brennan’s (2004) suggestion that a single coping style (such 
as ‘fighting spirit’ which has long been associated with better psychological 
wellbeing in people with cancer; Watson et al., 1991) is unlikely to be effective 
for all situations. 
Derogar and Lagergren (2012) found that the majority of patient’s HR-QOL was 
rated as stable or improved over time since surgery, though a section of 
participants had substantially lower HR-QOL than the general population. The 
majority of participants scored comparably to the general population group at 
five years post surgery. The authors recommend that in order to be able to tailor 
interventions for improved long-term HR-QOL, more research is needed to 
identify which factors negatively impact on oesophagectomy survivors’ 
wellbeing. They suggest that multidisciplinary interventions including dietetics, 
psychological support, and physiotherapy could be protective of HR-QOL. This 
support could be tailored to individuals’ unique needs as in the pre-habilitation 
care pathway. The flexible and person-centred nature of these
recommendations seems compatible with the subjectivity of HR-QOL proposed 
by Calman (1984). 
Conversely, Hellstadius et al. (2015) found that almost half of patients reported 
anxiety, worry and low mood at six months, which for most persisted at five
years. They also found participants who were living alone were less likely to 
report tension, which is contrary to previous research which found cancer 
patients living alone to report more symptoms of depression than those 
cohabiting (Parker et al. 2003) and seems counterintuitive. The authors 
highlight that information about relationship quality for co-habiting participants 
could aid understanding. They also found patients with lower education reported 
more problems with anxiety at six months. They recommend further research 
examining relationships between education and emotional distress to consider
whether job and sick leave arrangements, for example, may play a role in this.  
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This study points to the effects of social context and relationships, raising 
further questions about how these influence patients’ experiences of treatment 
and why the results of this study contrast to previous findings.
Malmstrom et al. (2015) focused on how HR-QOL fluctuated during the first 
year following surgery, suggesting that this would inform understanding of when 
the most support should be timed. They found that HR-QOL was negatively 
affected throughout the first year following surgery, with the lowest point at two 
months post-surgery. They suggest that additional support at two months could 
be helpful in meeting patients’ needs. The authors recommend proactive care 
programmes, discharge preparation meetings and nurse-led telephone calls in 
the year following surgery. Reflecting on the literature as a whole, the authors 
emphasise the importance of multidisciplinary support and co-ordination as a 
buffer to the challenges these patients face. 
Overall these quantitative studies gave patients questionnaires post-operatively 
and found HR-QOL to be reported as significantly lower for people who have 
had oesophagectomy than for the general population and patients with 
heterogeneous cancer diagnoses. In line with what we might expect, several 
studies make links between physical symptoms and reduced HR-QOL. All 
studies found HR-QOL to be lowest soon after surgery with some reporting HR-
QOL improved at 12 months and by five years appeared unaffected. However, 
one study found that reduced HR-QOL persisted at five-years post-
oesophagectomy. Across studies there was little theoretical basis to 
understanding the meaning of HR-QOL to these patients. 
1.5.2.2 Prospective studies
Six studies reported prospective designs with measures both prior to and 
following surgery (see Appendix B). Sweed et al. (2002) in a small pilot study 
found little change in HR-QOL, although in support of previous findings, a
significant inverse association was found between symptom intensity and global 
HR-QOL. While the authors emphasise caution as this is a small study, these 
30
findings are replicated in larger studies. For example, Tatematsu et al. (2013) 
focused on oesophagectomy and HR-QOL and physical fitness. Comparing pre-
and post-surgery HR-QOL scores, they found that physical, role, cognitive and 
social HR-QOL and physical fitness scores decreased significantly post-
surgery.
Chang et al. (2014) found that overall function and global HR-QOL fell below 
baseline at one month following surgery, improving at six months but not to the 
pre-surgery levels. This echoes the findings of Viklund et al. (2006a) that at six
months oesophagectomy survivors scored lower than comparison groups. 
Chang and colleagues found greater financial and social function difficulties for 
younger patients, which they suggest may relate to their working age. Younger 
age has also been associated with more distress in multiple studies (e.g. Avis et 
al., 2012; Van’t Spijker, Trijsburg & Duivenvoorden, 1997). Also exploring the 
influence of age, Cavallin et al. (2015) found that change in HR-QOL pre- and 
post-surgery was comparable for both younger and older age groups. They 
argue that this is evidence that age itself should not be seen as exclusionary for 
oesophagectomy decision-making.
Lagergren et al.’s (2007) study (described as ‘well designed’ by Jacobs et al., 
2013) found that postoperative increases in symptoms and deterioration in HR-
QOL function usually improved within 6-12 months post-surgery. They 
concluded that patients who survive beyond three years usually reported a good 
HR-QOL. The authors hypothesise that at the point of diagnosis patients often
struggle emotionally, becoming more confident after surgery. This fits with 
literature about post-traumatic-growth following cancer (e.g. Jim & Jacobsen, 
2008). Interestingly, although emotional functioning improved between before 
surgery and three years post-surgery, some physical symptoms worsened and 
global HR-QOL was lower at three years post-surgery than pre-operatively. 
Verschuur et al. (2006) explored patients’ self-reported needs (questionnaire) 
and expectations (interview) during the year following surgery. Reflecting other 
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findings (e.g. Malmstrom et al. 2013a), most patients described concerns of 
fatigue, food-related problems and gastrointestinal difficulties. Verschuur and 
colleagues found that patients reported expecting HCPs’ help for physical 
concerns, but that for psychological or social concerns they would look to 
friends and family. This raises concern about patients who do not have this 
social support and the relationship between this and sociocultural expectations 
about the role of HCPs and potential stigma attached to seeking emotional 
support. Notably, in this study they asked patients to evaluate their own health 
on a scale of 0-100 (with 100 indicating optimal health). On average, patients 
chose 70, despite multiple difficult physical symptoms, which seems surprising. 
However, the authors suggest that perhaps this relates to the poor prognosis for 
O.C. and patients’ willingness to accept postoperative physical difficulties. 
These prospective studies also tended to find that HR-QOL increased with time 
following oesophagectomy. As Lagergren et al. (2007) highlight that the initial 
score is described as a ‘baseline’, when a true baseline which could provide 
valuable information, would be prior to diagnosis (despite being beyond the 
limits of possibility). As with the papers described in the previous section, all of 
the quantitative studies seem to lack a theoretical basis for the work, for 
example they do not draw on health psychology theoretical frameworks to 
inform the measured variables. Few acknowledged the narrow 
conceptualisation of HR-QOL provided by quantitative questionnaires. 
Qualitative
A minority of the retrieved articles reported studies using qualitative methods. 
These will now be discussed (Appendix C contains further details). 
Malmstrom et al. (2013a, 2013b) carried out focus groups with patients 
following surgery and wrote two papers where qualitative content analysis was 
used to analyse participants’ reported experiences. The first paper (2013a) 
focused on patients’ experiences of HR-QOL and emotional responses after
surgery. The authors describe that it is well-known that such surgery has a 
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significant impact on HR-QOL but few studies have considered patients’ 
perspectives on this, as the majority of quantitative research imposes particular 
constructions of HR-QOL. This study aimed to address this. They found that 
symptoms continued to have a long-lasting impact on patients after surgery 
(particularly nutritional problems and diarrhoea) which not only affected patients 
from a physical perspective but also on a social and emotional level. For 
example loss of pleasure in eating had a detrimental impact on socialising. The 
authors argue that the study shows coping with the symptoms which can 
negatively impact on HR-QOL depends on patients’ ability to ‘take control’ of 
their new life situation and learn to live with symptoms instead of the symptoms 
constraining their HR-QOL and controlling them. This study provides useful
information from patients’ perspectives. However, the idea of patients’ ability to 
take control of their life is an individualised concept. This could be seen as 
placing responsibility with the patient to ‘take control’, evoking connotations of
effort and competence, without acknowledging the key role of HCPs and social 
context, for example the impact of social support and financial resources. 
However, the authors’ second paper which I will now describe, addresses many 
of these issues. 
Malmstrom et al. (2013b) focuses on supportive care needs. They found that 
patients said ‘honest information’ was necessary in order to develop ‘realistic 
expectations’ and that in line with other studies, HCPs underestimate patients’ 
needs for information (e.g. Andreassen et al., 2006; Wittmann et al., 2011; p. 
25). Bringing this focus to the relationship between HCPs and patients’ 
responses places patients’ needs in context. Access to a specialist nurse is also 
highlighted as being of central importance to improving co-ordination. This 
finding has been reported across research and fits with the aims the pre-
habilitation pathway described above (Viklund et al., 2006b; Viklund & 
Lagergren, 2007). The authors recommended indirect support to patients in 
maintaining contact with friends and involving relatives where possible, as
participants suggested that this would be helpful. They advocate that these 
findings support a great need for tailored programmes of supportive care, 
focussing on HR-QOL. They conclude that following oesophagectomy patients 
are faced with an unknown and frightening new life situation which will have 
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unique meanings for all and therefore patients require a ‘guiding light’ and 
tailored supportive care. This emphasises patients’ subjective experience in a
way that most of the O.C. literature seems to omit.  
Hodgson (2006) focused on improving nursing care for patient’s post-
oesophagectomy, describing this surgery as ‘a major life-changing event’.  From 
a small specially developed questionnaire study, with patients and partners, 
three themes are summarised: ‘food’, ‘activity’ and ‘positivity’. In this article 
Hodgson highlights that the psychological articles on this topic usually do not 
apply their findings to nursing practice, despite nurses’ primary role in 
psychological support within cancer care (Macmillan, 2014b). This article 
acknowledges the context in which patients experience this treatment and the 
role of HCPs.
These qualitative studies illuminate the complexity of patients’ unique 
experiences and the idiosyncratic contextual influences on their responses to 
the same treatment. I agree with Malmstrom et al. (2013b) that understanding 
patients’ experiences is a precursor to improving supportive care. 
1.5.3 Patients’ experiences of oesophagectomy 
Quantitative 
The following papers consider patients’ experiences of oesophagectomy (see 
Appendix D for further details). These papers seem to contain more theoretical
foundations than the studies described to this point. 
Andreassen et al.’s (2007) questionnaire pilot study asked patients, family 
members and HCPs about their experiences of information following a 
diagnosis of O.C. They found that HCPs rated information needs lower than 
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patients and family members. Patients generally reported being more satisfied 
with information provided than family members. As this was a quantitative 
study, the authors recommend qualitative research aiming to understand this 
further. Wittmann, Beaton and Lewis et al. (2011) replicated this with junior 
doctors who rated information needs significantly lower than patients. This 
raises questions about how information is experienced by patients. Further 
enquiry into factors (such as emotion) which might influence how information is 
mediated and processed by patients seems important, as well as tailoring 
information to meet patients’ preferences.
Dempster et al. (2011) drawing on Leventhal et al.’s (1980) self-regulatory 
model, examined patient-carer illness perceptions and psychological distress. 
Interestingly they did not find any significant differences in anxiety and 
depression for the participants without a carer. Carers reported significantly 
higher anxiety scores than survivors and rated the consequences of the disease 
more severely than survivors rated it. This fits with Andreassen et al.’s (2006) 
findings of differences in patients and carers’ experiences. Dempster and 
colleagues also found that carers’ beliefs and perception of O.C. had a large 
impact on the patient’s psychological wellbeing. They report that this study 
shows that illness perceptions and coping styles contribute to variance in 
psychological distress. For example, survivors were likely to report better 
psychological health when they perceived less severe consequences of the 
condition, perceived more personal control and believed they understood their 
condition. Patients who believed their O.C. was caused by stress reported
higher psychological distress.
In another study using Leventhal et al.’s self-regulatory model (1980), Dempster 
et al. (2010) found that the anxiety and depression scores for O.C. survivors 
were comparable to findings for patients with head and neck cancers, but higher 
than for those with prostate, bronchial, gastrointestinal and breast cancers. 
Some parallels can be drawn between O.C. and some head and neck cancers, 
particularly the impact on eating and the serious losses associated with surgery, 
which for both cancer groups often impact on social confidence. Their findings 
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suggest that changes in illness perceptions are associated with changes in 
psychological well-being over time. They recommend that increasing control 
beliefs may improve the psychological wellbeing of O.C. survivors.
Wikman et al. (2014) found that 15.3% of the sample had accessed some form 
of psychiatric care prior to diagnosis and 35.8% of the whole sample, who had 
previously not accessed psychiatric care, did so following oesophagectomy.
This may reflect the highly stressful impact of O.C. The authors infer ‘psychiatric 
morbidity’ from accessing psychiatric care data, which they admit is problematic 
as many patients who are struggling are unlikely to access support. Despite the 
widely recognised critiques of psychiatric diagnosis as pathologising distress 
(Rapley, Moncrieff & Dillon, 2011), anxiety, adjustment disorders and
depression diagnoses are commonly utilised and measured in oncology
(Brennan, 2004). 
Qualitative
The following diverse qualitative studies explore patients’ relationships with self
and others, the importance of eating, impact on carers and information-giving. 
For further details see Appendix E. 
Clarke, McCorry & Dempster (2011) used semi-structured interviews and 
Interpretive Phenomenological Analysis, arguing that understanding the 
meaning of patients’ experiences is an important precursor for meeting their 
needs. They found that patients gave highly detailed, contextualised accounts 
of their experiences which always included a sense of ‘change’ from before 
O.C. This was described as having an impact on their ‘self-concept’. For some 
participants this was linked with loss but others described stories of personal 
growth and positive consequences from coping with challenges.
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The study found that readjusting to a changed relationship with food was a key 
challenge, which included a sense of loss for many, as well as changed social 
roles. Patients also described navigating tensions between former and new 
identities (and at times negotiating this with family members). Particular to this 
disease, the authors suggest that eating was the most obvious reminder of the 
cancer. Participants reported similar experiences in relation to identity as those
described by cancer patients’ more broadly, for example a wish to be viewed as 
their nuanced and unique selves rather than as defined by cancer.
Clarke, McCorry & Dempster (2011) highlight that during the analysis of 
interviews, the concept of identity became particularly salient in participants’ 
assigning of meaning to their experiences. Participants described feeling 
depersonalised, particularly during early stages of the illness. Personalised 
relationships with HCPs are highlighted as a crucial antidote to this. Another 
theme was the value of hearing from peers early in the process, particularly 
those who had survived O.C. for several years. Participants described thinking 
that peers could provide reassurance, hope and normalising in ways that could 
enable talking in a more personal way about their fears and experiences. The 
authors link this with a need to develop a shared identity. They also emphasise 
the importance of preparation for these changes, through pre-operative 
information and the power of HCPs to reduce depersonalisation which in turn 
nurtures patients’ sense of self and provides opportunities for positively 
contributing to patients’ experience of the illness process. The study took a 
contextualising approach highlighting the individual impact of this disease. It 
seems to capture the nuances of patients’ experiences in a way that a 
quantitative measure alone is unable to. 
Wainwright et al. (2007) focus on ‘remapping the body’ which they describe as 
socially adapting to physical changes post-oesophagectomy. They suggest that 
it is impossible to separate physiological and psychological consequences of 
surgery. Thematic analysis of semi-structured interviews led to three key 
themes: the meaning of weight loss and physical change, remapping the body, 
and eating as a social activity: stigma and embarrassment. This study 
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demonstrates the potentially far-reaching effects of eating difficulties for people 
after oesophagectomy. Eating is an activity that most people find pleasurable, 
sociable and satisfying. However, post-oesophagectomy it often becomes a 
chore which is replaced by unpleasant symptoms like diarrhoea, nausea and 
embarrassment, leading patients to avoid eating with others. The authors 
highlight that although oesophagectomy is a physical procedure, it has great 
consequences for patients’ sense of self and social identity. For this reason they 
emphasise the importance of integrated physical and psychosocial care and the 
impossibility of separating nutritional support from psychosocial support. 
Jaromahum and Fowler (2010) also looked at experiences of eating after 
oesophagectomy, using a phenomenological approach. During interviews 
between the first and third meals post-operatively, three major themes were 
identified: physical, psychosocial, and psychological, with key subthemes of 
gastrointestinal problems, fear of going home, and positive feelings toward 
eating. The authors describe nurses and patients as sharing a role in achieving 
optimal eating post-oesophagectomy. They also emphasise the importance of 
holistic care through understanding the meaning of eating for patients, for 
example through acknowledging the significance for many of eating for the first 
time following surgery. They suggest turning this event into a ‘celebration of life’
(p. 100).
McCorry et al. (2009) focused on patients’ and carers’ adjustment post-
oesophagectomy using focus groups and thematic analysis. Participants ranged 
from seven months to 17 years since oesophagectomy. The range in time since 
the surgery is likely to have brought high variability in stage of recovery. 
Patients talked about hearing the diagnosis and immediately thinking about 
death and feeling surprised that there were treatment options. Both carers and 
patients emphasised the benefits of peer support. In line with Clarke, McCorry 
and Dempster (2011) participants also talked about challenges in negotiating 
changes in role (for example being unable to work or care). This study is helpful 
in emphasising the value of patients and carers’ perspectives. The findings of 
this study fit with those of Wainwright et al. (2007) who described the process of 
38
‘remapping the body’ and learning to eat again after surgery for O.C., in a 
similar way to learning to walk again after lower leg amputation. McCorry et al. 
state that the study provides evidence to show that ongoing person-centred, 
holistic support is necessary for these patients as they adjust to physical, social 
and emotional changes after surgery. 
Andreassen et al. (2006) capture themes of patients’ experiences of
investigations, diagnosis and treatment using qualitative content analysis of
interviews. Most participants described that when hearing the diagnosis, they 
did not know anything about O.C. The authors therefore emphasise the role of 
information-giving, as patients are reliant on HCPs to provide information. The 
findings of this study suggest that patients perceive their partners to be more 
psychologically affected than they are themselves, finding that caregivers 
sufferered higher levels of recurrence fears.
Henselmans et al. (2011) adopted an open focus in their study of patients’ 
views on communication and patient participation barriers and facilitators 
through qualitative interviews analysed by content analysis. In line with 
Verschuur et al’s. (2006) findings, they found that patients did not tend to expect 
HCPs to meet psychosocial needs. They found that patients’ needs and 
requests for information were often related to symptoms like dysphagia, inability 
to do specific activities, the likely course of symptoms and how to respond to 
them, as well as the cause of symptoms or rationale for tests and medication. 
The majority of patients emphasised the importance of the outcome of surgery 
and keenness to know about the results and the risks of recurrence. They 
identified 16 barriers that obstruct patients’ influence on medical consultations. 
The authors described being able to categorise these into ‘values’ and 
‘hindering beliefs’ or ‘lack of skills’, however noted that emotions are not 
reported by patients as hindering communication in consultations. They also 
found some participants highlighted HCP characteristics as barriers or 
facilitators to communication (see Appendix E). This article particularly 
emphasised wide variation in patients’ responses and the importance of HCPs
tailoring support to patients’ needs, acknowledging individual meanings, 
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contexts and differences, in a way that is missed in much of the quantitative 
research in this area.  
Mills and Sullivan (2000) qualitatively interviewed patients retrospectively about 
their experiences of treatment with curative intent for O.C. Key findings using 
thematic analysis were that while participants reported overall feeling well-
informed, they valued staff providing honest information and saying explicitly if 
they did not know the answer to questions. They also highlighted perceiving 
staff who gave their time to sit down and speak with them as showing interest 
and worry about them as a person. Participants reported that in contrast, staff 
appearing too busy or inaccessible negatively impacted on their experience. 
Patients were keen to convey the importance of a specialist nurse in clarifying, 
reassuring and informing them about what to expect. This provides further 
evidence for the value of specialist nurses and tailored support. 
1.5.4 Critical evaluation 
These papers demonstrate that although this is a growing area of research, 
many studies have so far adopted a narrow and often reductionist 
conceptualisation of HR-QOL, rendering other aspects of patients’ experiences 
invisible. Although identifying proportions of patients with high scores on HR-
QOL screening tools may be important, it is crucial to acknowledge that these 
tools screen patients for factors defined by professionals as relevant to HR-
QOL. This is counter to the original assumptions of HR-QOL as subjective and 
self-defined (Calman, 1984; Rapley, 2003). While studies have spanned a 
diverse range of topics, few have explored the experience from patients’ 
perspectives. Several studies have highlighted differences between HCPs’
assessment and patients’ reported experience (e.g. Malmstrom et al., 2013b; 
Andreassen et al., 2006; Wittmann et al., 2011).
As highlighted by Clarke, McCorry & Dempster (2011), in recent years, patients’ 
descriptions of their experiences have taken a more valued position in research 
along with an increasing acknowledgement of the importance of understanding 
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their perspective. This fits with NHS aims of identifying and meeting patients’ 
needs through the development of services, as well as by understanding the 
relationship between professional, cultural and societal responses to cancer 
(Crouch & McKenzie, 2000). It also corresponds with a general rise in 
appreciation for qualitative health research findings (Sandelowski, 2004). 
However, when compared with breast cancer, where there is a high level of 
public awareness and discussion, O.C. is not widely known or understood by 
the public (Kaiser, 2008). Clarke, McCorry and Dempster (2011) suggested that
this makes such patients ‘a somewhat marginalized group’ (p.100). Research 
with people with potentially curable O.C. is especially challenging because of 
the comparatively small numbers, rapid progression and high morbidity.
Studies that have focused on patients’ experiences and individual 
conceptualisations of the impact of treatment for O.C. and how they navigate
this, have brought rich findings. For example, the impact on changing roles, 
identity and distressing symptoms. This seems to bring forth nuanced 
descriptions of experience that are made invisible if we do not acknowledge the 
limitations of quantitative measures such as HR-QOL questionnaires. Such 
questionnaires can clearly have great value when used alongside methods of 
understanding patients’ individual concerns and experiences. However, to 
enrich understanding and inform clinical practice, qualitative research to explore 
the meaning of patients’ experiences is required.
1.6 Rationale
This chapter has demonstrated that treatment for potentially curable O.C. has 
unusual characteristics, most notably the highly risky surgery, long pre-
operative preparation and great uncertainty and potential losses. The current 
evidence tends to focus on patients post-operatively, primarily using symptom-
focused questionnaires with an absence of attention paid to how patients 
describe their experiences and adjustment whilst going through treatment and 
the meaning of this. However, it seems important to understand patients’ 
41
experiences of the period of intensive preparation in order to inform optimal 
support for patients in this unique context. Although this pre-habilitation
treatment pathway offering intensive support is currently novel and unique, it is 
likely to become more widely used soon. The relative homogeneity provided by 
studying patients on the same treatment pathway at one cancer centre will offer 
more consistency than much of the previous research as highlighted by 
Wikman, Smedfors and Lagergren’s (2013).
My aim is that this study will make a novel contribution to the literature through 
hearing patients’ descriptions of their experiences during interviews. With the 
hope of increasing understanding of patients’ experience, I also plan to 
interview staff who can describe their knowledge of patients’ experiences. Staff 
will uniquely be able to base their descriptions on their experiences with multiple 
and varied patients, including those who would be unlikely to participate in 
research. Staff are a crucial part of the system, offering a valuable observer
perspective on patients’ experiences of the pre-operative treatment process.
Given that the approach to gathering data influences the data itself, I hope that 
this will offer a method that goes beyond an individualising and universalising 
approach. I also hope that this will provide opportunities to understand parallels 
and differences between the contrasting perspectives. 
1.6.1 Aims
This study aims to inform understanding of patients’ experiences of this 
treatment from the perspectives of patients themselves and multidisciplinary 
staff. Findings from this study will aim to influence research-driven approaches 
for supporting patients. The proposed study will explore this by: 
 Qualitatively interviewing patients with O.C. who are undergoing pre-
operative treatment in order to explore their experiences of treatment 
and what has influenced this.
 Qualitatively interviewing multidisciplinary staff working with patients on 
the same treatment pathway about their observations of a range of
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patients’ experiences of pre-operative treatment and what they think 
influences this.
1.6.2 Research questions 
A qualitative design will address the following research questions through 
interviews with patients and multidisciplinary staff: 
 What are patients’ experiences of pre-operative treatment for 
oesophageal cancer?
 What do patients describe as helpful and unhelpful during the pre-
operative treatment process?
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2. METHODS
2.1 Overview 
In this chapter, I will first articulate the critical realist stance of the study and the 
relationship between this and the methodology and research questions. 
Following this, I will describe the procedures of carrying out this research, 
including ethical approval, design and data collection processes. I will then 
outline the approach to analysis. 
2.2 Epistemology 
Epistemology can be defined as the philosophy of knowledge (Barker, Pistrang 
& Elliot, 2003). I take the position that the epistemological assumptions 
underpinning any research are important to make explicit in order to situate the 
foundations upon which knowledge is sought (Willig, 2008).  
Research considered to be scientific, which makes essentialist claims, has 
commonly been taken to hold the dominant epistemological stance and top 
hierarchical position for evidence across healthcare. Examples of this include 
randomised controlled trials and experimental designs which claim to yield 
‘scientific truths’. Such approaches are based on the realist assumption that it is 
possible, through ‘objective’ science, to prove reality (Clarke, MacIntyre & 
Cruickshank, 2007). Healthcare research which meets criteria for evidence-
based practice has tended to fit with this paradigm, in line with the idea that 
treatments and approaches must be proven to be safe and effective in order to 
be concordant with professional and ethical duties. Despite the infallible and 
objective appearance of ‘scientific evidence’, Marks (2009) has highlighted that 
all evidence is subsumed by value-laden, context-specific and subjective 
assumptions. Psychological screening measures can be used to demonstrate 
this as they are based on assumptions about both what is important to measure 
and the meanings of concepts. This often implies an assumption of universality, 
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yet many psychological phenomena vary between cultures and languages 
(Cooper & Denner, 1998). Social constructionism argues that the search for 
facts is flawed, because there are multiple realities and research findings will 
always be mediated by context (Burr, 1985). 
Critical realism was developed in response to the perceived shortcomings of 
both realism and social constructionism, aiming to take elements of both 
approaches. Critical realism therefore views reality to exist, but as highlighted 
by Bhaskar (1989), our perception of human sciences is steeped in social 
structures and values, and research findings may be influenced by 
unobservable events. As articulated by Pilgrim (2013; p.158) critical realism 
works on the premise that ‘the map is not the territory. The territory does exist; it 
is just very challenging to investigate’. 
Marks (2009) suggested that in healthcare there is a large and growing 
discrepancy between research and what is important to patients. This study’s 
design intends to address questions about patients’ experiences that are closely 
relevant to patients, healthcare professionals, organisations and 
commissioners. I am approaching this with a critical realist stance. For example,
accepting that while realities such as cancer exist, the frameworks through 
which we understand these realities are informed by subjective assumptions 
and biases, mediated through language, which in turn shapes experience. This 
stance rejects the positivist suggestion that objective facts can be searched for 
and found or proven, without taking these assumptions and biases into account 
(Mackay & Petocz, 2011). For example, the meaning of cancer is idiosyncratic 
and culturally specific and experiences of cancer are influenced by wider 
discourses, which also determine which constructs are seen as worthy of 
measurement within research and clinical practice.
2.3 Design
In order to address the research questions, I chose a qualitative design to 
explore patients’ experiences through the openness of semi-structured 
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interviews with both staff and patients. This multiperspective approach aimed to 
maximise the scope of the research to contribute to understanding. The 
qualitative design aimed to adopt an exploratory stance as this specific area has 
received little research (Kimble, 1984). The approach to analysis of thematic 
analysis was chosen because of its flexibility and theoretical openness. As it is 
not aligned with a particular paradigm, it is compatible with the critical realist 
position and our hope to provide a contextualised account (Braun & Clarke, 
2006). 
2.4 Ethics 
Ethical approval for components of the study involving patients was granted by 
a Research Ethics Committee (Appendix F) and the University of East London’s 
(UEL) Ethics Committee (Appendix G). For the staff component of the study, 
approval was granted by the UEL Ethics Committee (Appendix G). Approval 
was also sought and granted for all aspects of the study from the local 
Research and Development Department at the recruiting Trust.
All participants gave written consent (Appendices I & J) and verbal and written 
information was provided to all potential participants aiming to ensure informed 
consent. I emphasised all participants’ right to decline, or if giving consent, to 
withdraw at any time without providing a reason and with no disadvantage or 
implications for them, their medical care (for patients) or their employment (for 
staff). Confidentiality and exceptions to this were also explained.  
I considered the sensitivity of this research topic at all stages of the research. 
However, I agreed with my supervisor that discussing cancer with patients and 
staff during this treatment was unlikely to increase distress, particularly as this 
was a topic they were frequently talking about as part of the intensive treatment 
pathway. However, as highlighted by Brinkmann and Kvale (2008), the meaning 
of talking with a researcher is likely to be individual to each person and ethical 
46
research goes beyond simply following rules. My intention was that participants 
would not only be protected from harm during the process but also that I
maximised the potential for them benefiting from the experience. 
I took a cautious approach during interviews, continually monitoring distress 
levels and offering to pause or stop the interview when these seemed to be 
high. I hoped that the opportunity to talk about experiences would offer 
participants a potentially helpful expressive space. Many participants told me 
that they had found the interview an “enjoyable” experience which in some 
cases helped them to make sense of their experiences. Staff also told me that 
the interview was helpful to their self-esteem, as through describing their 
experiences to me they noticed how much they had learnt about supporting 
patients. 
A debrief was offered after the interview with the possibility for participants to 
speak about any issues raised. All participants were given my contact details 
and I emphasised that they could contact me afterwards should they wish to 
discuss the research. Patient participants were reminded of the Trust’s psycho-
oncology service and told that their Clinical Nurse Specialist (CNS) could offer 
advice and support to access this if necessary. With staff participants the 
possibility for support from supervisors and line managers was discussed. 
To ensure anonymity all confidential information was stored on password 
protected files (using participant numbers and pseudonyms) and in accordance 
with NHS policy. I was the only person who had access to identifiable 
transcripts and recordings, which will be destroyed 12 months after the study’s 
completion. 
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2.5 Recruitment and research procedure 
2.5.1 Patient inclusion criteria and procedure
Patients on the treatment pathway (described in chapter one), where the 
multidisciplinary HCP deemed it clinically appropriate and where the person 
was towards the end of chemotherapy treatment, spoke fluent english and had 
capacity to consent to the interview. Staff were asked to invite patients meeting 
this criterion to take part by giving them an information sheet (Appendix I). Staff 
then asked potential participants for their permission to be contacted. Where 
patients said yes and met criteria for the study, the team member passed me 
their details and I contacted them by telephone. I introduced myself and 
explained the study, answering any questions they had. Where they agreed to 
proceed, we arranged a time to meet at a private location of their choice.
The full consent procedure (outlined in section 2.4) was then carried out before 
audiorecording and the interview commenced. During the recruiting period 
(October 2015-February 2016), the aim was to recruit six to eight patient 
participants. Ultimately seven patient participants gave their consent and were 
interviewed. 
Table 1 summarises key demographic information concerning the seven patient 
participants5. The sample approximately reflected the gender, age and ethnicity 
ratio of O.C. patients in the UK (CRUK, 2016a). Four of the participants chose 
to be interviewed on the hospital site, with three selecting to be interviewed at 
home. All patient participants were at least one month into the pre-operative 
treatment pathway. However, due to individualised treatments it was not 
possible to interview patients at exactly the same point. While the standard 
chemotherapy treatment is nine weeks Audrey’s treatment had been paused 
due her being too unwell to continue. Conversely Joe and Matthew reported few 
side effects or physical difficulties. Carole, Abdul, Peter and David all described 
                                                            
5 All names are pseudonyms.
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finding chemotherapy side effects challenging but reported that having 
completed several cycles, they had learnt what to expect.  
Table 1: patient participants: demographic information 
Age Gender Ethnicity Place of 
interview
Joe 58 Male White British Hospital
Audrey 61 Female Black Caribbean Home
David 60 Male White British Hospital
Matthew 69 Male White Irish Hospital
Abdul 65 Male Indian Home
Peter 71 Male White British Home
Carole 52 Female White British Hospital 
2.5.2 Staff inclusion criteria and procedure
For the staff part of the study, members of the multidisciplinary team (MDT) 
working on the care pathway described in chapter one, have been consulted in 
planning the research. I contacted each member of the team to explain the 
process and to invite them to take part. Where they said they were willing to be 
interviewed, I sought their permission to meet and audio record the interview. 
On the agreed date, I followed the consent procedure described in section 2.4. 
and audio recording began.
I aimed to recruit six to eight staff participants and ultimately eight members of 
the staff team consented and participated. The following staff participants were 
interviewed: 
 Sean 
 Josh
 Emma 
 Lucy 
 Jay 
 Olivia
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 Sarah 
 Cathy 
They were multidisciplinary team members whose specialties included: surgery, 
exercise therapy, internal medicine, dietetics, specialist nursing and project 
management. To retain confidentiality and anonymity, the roles of each 
participant will not be stated, as although pseudonyms are used throughout, 
revealing the speaker’s role would make them identifiable to those familiar with 
this small specialism.
2.6 Interviews and transcription 
Semi-structured interviews were guided by the interview schedules (Appendix K 
& L), from which questions were used flexibly. Questions were intended to be 
neutral, open and curious, encouraging participants to speak freely. The 
questions were guided by the key area of patients’ experiences of treatment 
and any factors that influenced, helped or hindered this. However, I followed 
topics patients raised, aiming to facilitate the conversation rather than impose 
particular types of descriptions upon them. 
I semantically transcribed recordings verbatim which Willig (2008) describes as 
a ‘translation of spoken word’. I used conventions described by Parker (2005; 
Appendix M), removing all identifiable information. I then repeatedly checked 
anonymity and accuracy of transcription through listening to the recording 
multiple times (Gibbs, 2007). One perspective is that this form of transcription 
limits information on the interactional nature of interviews (Parker, 2005). 
However, I felt it was sufficient for the current analysis.
2.7Analysis
The qualitative data were analysed using inductive thematic analysis in order to 
identify patterns and themes in the data. As there were two groups of data, with 
staff and patients speaking from different perspectives, I decided to analyse 
each group separately. Guided by the stages recommended by Braun & Clarke 
(2006), I undertook the following steps of analysis for each group: 
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1. I considered transcription to be the beginning of the analytic process 
(Braun & Clarke, 2013). 
2. I read each transcript several times to familiarise myself with the data, 
making notes on anything that struck me from the text. I selected and 
highlighted areas of potential interest (Appendix N). I also re-read the 
field notes I made following each interview. During this process I wrote 
down thoughts and observations, which later usefully informed my 
thoughts about the analysis.
3. I then took one interview at a time and coded the text, initially using pens 
and paper to connect with the participants’ narrative. I then used a table
to record each code and corresponding quotes (Appendix Q). I aimed to 
code extensively in line with Braun and Clarke’s (2013) 
recommendations. Many extracts therefore had multiple codes. I aimed 
to code from the text, being careful to acknowledge and challenge my 
own assumptions. Repeated reading helped to make these explicit. I kept 
in mind the research questions but also stayed open to anything 
participants raised and I avoided imposing theoretical constructs on the 
data at this stage. This process produced 76 codes across the seven 
patient interviews and 156 across eight staff interviews (Appendices O & 
P). 
4. After all interviews had been coded I began connecting codes together. 
There was some overlap between codes and I was able to reduce the 
number of codes whilst retaining the semantic level of analysis. 
5. I then used mind maps to begin to map potential themes by identifying 
recurring commonalities within the codes, considering possible 
overarching concepts (Appendix R). This was also informed by the notes 
I had made during the familiarisation and coding processes. 
6. Once I had candidate themes, I re-read all transcripts and considered the 
coherence of the themes and how they fitted with the whole data set. 
This led to some revisions of the initial map (Appendix R). 
7. I then worked to define and write summaries of each theme and 
subtheme and continued to try different names that seemed to best 
capture their content. 
8. Once I began writing to produce the report, I continued to take an 
analytical position, aiming to finesse and tweak the analysis. 
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This was an iterative process which was repeated for the staff analysis once the 
patient analysis was complete. 
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3. ANALYSIS
3.1 Overview 
This chapter presents the findings of the analysis, firstly for the patient group 
and then for the staff group. 
3.2 Patient Analysis 
3.2.1 Setting the context
The interview schedule invited participants to describe their experiences with 
O.C. and they all told their story from the point of experiencing first signs and 
presenting to a GP. Many patients talked about long and difficult processes 
leading up to diagnosis. Some participants felt that their local hospital moved 
too slowly, whilst others described feeling regret that they presented after a 
delay. They described a radical change in pace from pre-diagnostic tests at 
local hospital to the speed of the specialist cancer centre. One participant 
described this as “going from slow motion to warp drive” (David). 
3.3 Patient Thematic Analysis
After completing the stages of analysis described in chapter two, I developed 
three main themes and six subthemes, as depicted in table 2. The subthemes 
are named using participant quotes. 
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Table 2: patient analysis themes
THEME SUB THEMES
Fear and the unknown “Life changes with surgery” 
“Up and down”
Treatment brings hope and 
uncertainty
“Surgery means survival” 
“Cancer takes over”
Committing to getting 
through treatment
“I'm doing what I can”
“Not letting cancer take over”
THEME ONE: FEAR AND THE UNKNOWN
The first overarching theme concerned participants’ descriptions of the 
unfamiliarity of O.C. and their fears in relation to the anticipated surgery. They 
all expressed that worries about surgery felt greater than fears about any other 
aspect of treatment. The situation in which they found themselves was 
characterised by the new and frightening nature of a life-threatening diagnosis, 
while participating in the pre-operative preparation programme. Participants 
described this experience in diverse ways.
Subtheme 1: “Life changes with surgery”
The goal of pre-operative treatment is optimising the patient physically and 
preparing for surgery. Patients without exception referred to the surgery as both 
“life-changing” and “frightening”. In the following quote Peter describes an 
awareness of surgery throughout the pre-operative process:
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Peter: You know your life changes at that point. At the moment I feel no 
different than I’ve ever felt. I’ve been aware of it all the way through () 
that you know once you have this operation () your life changes…my 
actual thing has been ‘let’s string this out as long as possible’. You know 
the operation is the only thing I’ve got any fear of… it’s not just the 
operation, it’s 10 days in ITU. You know your life changes at that 
point. At the moment I feel no different than I’ve ever felt.
Interviewer: How has it been to have that awareness all the way through 
this?
Peter: Sanguine is the answer. It’s better than the other option. That’s 
what I say if my wife says ‘how do you feel’; the other option is not being 
here. You know being dead, so you know being not exactly whatever I 
was before, mentally I’ll be the same I’m sure, I might lose some weight, 
it might be good for me you never know.
There was a recurrent sense in all interviews that the surgery was a defining 
point in participants’ lives where their life could be saved, but at great risk and 
with irreversible consequences. However, after referring to his fear of surgery, 
Peter seemed to revert rapidly to a rational rather than emotional focus. For 
example, he refers to the losses he expects to encounter but then describes his 
feelings as “sanguine”. He reflects on the positives and divides the options into 
a dichotomy between surgery and death. Peter refers to some anticipated 
physical effects in the aftermath of surgery, but turns the negative nutritional 
effects of “losing weight” into a potentially good thing. His assertion that he will 
be the same “mentally” also builds a sense of impervious strength which seems 
counter to the fear he describes about surgery. 
At times, participants touched on worries about the imagined consequences of 
surgery, as demonstrated by Matthew and Carole: 
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Matthew: The only thing I don’t like about it is the after effects of this 
operation, loss of weight, no strength, not being able to carry on…That’s 
if I’m alive and I come through it. If I don’t come through it I don’t give a 
shit about it. It’s a long drawn out project, not something you’re going to 
achieve overnight, anybody who thinks it will is kidding themselves.
Carole: I shed a tear [when I found out about the operation] and said to 
the CNS I am scared about that, what kind of happens, how do you eat. 
To me it’s still a horrible idea () and she said apparently you can have a 
relatively normal life after the surgery, she has explained to me how 
they’ll link one part of the body to another and that you’ll have to have 
smaller meals you know and initially there may be problems but 
eventually it should be relatively OK. So that was a bit () to be told () 
getting that information and they were clear from day one () they were 
clear about what needed to happen.
Whilst dread of the surgery or its effects was unanimous, there were differences 
in how participants conceptualised time with some speaking with urgency and 
others with avoidance. The above quote from Peter (p. 54) depicts this, as he 
described wanting the surgery to be delayed for as long as possible. The 
following quotes from David, Matthew and Joe demonstrate the variation in 
attitudes to the timing of the surgery: 
David: I suppose it is a long wait but it has to be because of the 
timeframe for the chemotherapy to be out of your system. So yes it has 
been quite a long time…I said today I wish it could be tomorrow. Even at 
the time I felt like I’d rather have it today () to get it over with. 
Joe: …then you see, I don’t want to have the operation () so you know if 
they said we’re not going to do it for another four years. That would be 
fine I’d go ‘ok good’, because () you know my life is going to be much 
worse for a period of time because of having the operation. Because I’ve 
got no symptoms except for catching the food…apart from saving my life 
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the operation’s just going to be bad news for me. Apart from saving my 
life. So I’m not stupid enough to think I shouldn’t do it, but I don’t want it 
to happen because it’s going to be a whole pile of unpleasant for quite a 
lot of time.
Matthew: It’s worse waiting for it…I want to get it over and done with and 
see what kind of a skeleton is going to be left.
From David there’s a sense of wanting to get the cancer removed as soon as 
possible, while rationally outlining that there are reasons for the timescale to be 
as it is. From Joe there is a feeling of wanting to delay the surgery and the 
associated losses for as long as possible, though stating that it would be 
“stupid” to not have the surgery. Matthew’s description is shocking, as on the 
one hand he describes in pragmatic terms wanting to get the surgery “over and 
done with…” and yet, he uses emotive language to describe an image of his 
future self as a “skeleton”. To me, this evokes imagery of the walking dead, 
someone only half alive, and even concentration camps. This could be seen as 
a macho way of talking which masks feelings of distress and fear, however, the 
use of language implies that strong feelings are likely to be present. Perhaps 
gendered influences render such feelings hidden. This could also be a 
hypothesis in relation to the strength Peter conveys (p. 54). These quotes 
demonstrate a strong sense from patients that the operation was hanging over 
them and while they feared it and dreaded the potential consequences, they 
believed it would keep them alive. This leads to a tension between rational and 
emotional responses.
Subtheme 2: ”Up and down”
This subtheme reflects patients’ repeated descriptions of experiencing the 
period of pre-operative treatment as highly unpredictable and unfamiliar. There 
seemed to be three distinct components of this: lack of knowledge about O.C., 
unfamiliarity with treatment and the alien experience of unknown procedures in 
a disorienting new system. These all exacerbated feelings of disorientation and 
unfamiliarity for patients going through this treatment. 
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Firstly, many participants talked about never having heard of O.C. previously: 
Interviewer: Did they explain to you what this type of cancer meant?
Audrey: I’d never heard of oesophageal cancer before, I heard about 
breast cancer and all sorts of cancer () but oesophagus, I never knew 
you could have it where your food's going down.
Abdul: ...I went on Google to find out why am I suffering from  these 
symptoms, if that was like a stomach cancer, I didn’t know about the food 
pipe cancer tumour () I just was thinking I had something like a stomach 
cancer. 
These examples from Audrey and Abdul reflect a strong sense from many 
participants that O.C. was far less familiar to them than other cancers, which 
heightened a sense of unknown. The following extract from David articulates 
this unknown quality of both O.C. and treatment. He also suggests a connection 
between knowledge and feeling prepared for treatment. 
Interviewer: What were your ideas about chemotherapy before you 
started?
David: Of course at that time I had almost no knowledge about the whole 
cancer subject or chemotherapy. In my mind () and I think in most 
people’s minds actually chemotherapy, you have generic knowledge and 
because you don’t know. I had no idea that chemotherapy’s so different 
for everyone. I had no idea… I think with the first round I didn’t have any 
understanding. It was tough... I was absolutely not prepared for the effect 
it would have on me and how I felt afterwards. People can tell you you’ll 
feel wobbly or you’ll feel unwell () but I was just not ready. That’s 
58
nobody’s fault as such, I just had no idea of the impact that the 
chemotherapy would have.
This extract from David highlights differences between expectations and lived 
experience which were described by many participants. I think that this reflects 
the generic understanding many people have of cancer, without realising the 
great differences between specific cancers. In many ways this adds to the 
unpredictable nature of this experience, where patients are required to adapt to 
great uncertainty as well as their experience differing from expectations. This 
extract suggests that not knowing what to expect added to how “tough” the 
process was for David initially. 
Throughout this unfamiliar pre-operative treatment process, patient participants 
talked about the “up and down” of hope and disappointment as treatment 
decisions were made by the medical team. Joe described the experience of 
uncertainty, firstly about whether he had cancer and then whether he would 
need to have chemotherapy treatment.
Joe: And the worst bit of the whole process has been the up and down of 
information of ‘yes you have’, ‘no you haven’t, ‘yes you have’, ‘no you 
haven’t’. And I understand that nobody’s in any position to do 
anything…once I know what the deal is it’s easy enough to deal with it, 
it’s the process of having hopes raised and then lowered that is a bit 
harder to deal with. Certainly each time that happened, I had a crash of 
mood about it and had to pull myself back out. 
The disappointment and hope Joe articulates fits with numerous other examples 
from patient participants of trying to adapt to great uncertainty with potentially 
grave consequences which was highly stressful. I was struck by Joe’s 
description that this was the “worst bit of the whole process”. Knowing that he 
had encountered physical complications during chemotherapy that led him to be 
hospitalised repeatedly (p. 62), contextualises his report that the psychological 
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effect of hopes raised, then dashed, was most difficult. This fits with David’s (p. 
57) description that not knowing made the experience of treatment more 
difficult. 
Many participants described arriving for treatment at the beginning and feeling 
confused and unsure of what was expected of them. They described feelings of 
disorientation in this unknown healthcare system, compounded by them feeling 
that it was assumed they knew what to do. Peter described that along with the 
novelty and unfamiliarity of every aspect of this treatment, his perception that it 
was assumed he would know what to do was particularly difficult: 
Peter: It’s this funny thing, it’s not unkindness or anything it’s just people 
assuming that you’ve been there before and you know it and you haven’t.
At this time of high emotion and uncertainty, patient participants described 
going through a process of “catching up” and getting to be familiar with the 
systems during pre-operative treatment. The following extracts from Audrey and 
Abdul depict these processes in relation to where to go and how to get there, 
but also in expectations of how they would feel with chemotherapy.
Interviewer: What was having chemotherapy like for you?
Abdul: That was very new to me [chemotherapy] and it was very hard. 
First 10 days, all the time, whenever I get up or whatever I’m going to do
I was dizzy all of the time, and after 10 days I’m getting used to it and 
getting normal but my taste buds are tired and I can’t feel hungry, for 10 
days () very hard… It’s OK I’m getting used to it you know. It was hard 
but I had to.
Audrey: To be honest with you the first time you go to the hospital you 
don’t know A from B, and the more you go there the more you get used 
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to it. You don’t know what department this is, what bus to take, what train 
to take, but the more you go there the more you get used to it.
This subtheme illustrates that initially patients experienced all aspects of this 
process as new and unfamiliar. While experiencing threat we particularly crave 
certainty and safety, and yet patients perceived an expectation that they must 
participate in their treatment and become familiar with this foreign world in order 
to adhere to the treatment programme. Many participants began from a point of 
knowing little about O.C. which compounded feelings of fear and uncertainty.
THEME TWO: TREATMENT BRINGS HOPE AND UNCERTAINTY
I identified this theme as all participants talked about a tension between surgery 
offering hope and the only chance of cure, whilst also bringing life-changing and 
uncertain consequences. I noticed that no participant directly spoke about 
surgery as a difficult decision; rather, they showed a belief that surgery would 
save their life. They were all very clear and certain about it being the obvious 
decision for them to have surgery, despite occasional acknowledgement of the 
risks that they may not survive (Matthew, p. 55) and that if they did; there would 
likely be negative consequences (Joe, p.p 55-56). 
Sub-theme 1: “Surgery means survival”
This subtheme relates to participants' portrayal of treatment as an opportunity 
for survival. Participants spoke about the choice to have surgery as a ‘no-
brainer’ as it offered the chance of cure. David demonstrated that life-saving 
treatment was the priority above all else.
David: ...you get this feeling of muted elation you know [when offered the 
surgery] and ok it’s good news in the way that they’re now saying that 
we’re going to operate to remove it but they’re tempering it with () and of 
course the medical profession are ultra-conservative, they’ve got to 
downplay it and I get that…Not being treated for it was not going to be an 
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option, instantly () that’s not going to happen, so what’s the best form of 
treatment with the best outcomes… They said, ‘well what do you want? 
Do you want to go away and think about it?’ and ‘No? Good, OK you can 
start the chemotherapy tomorrow’. For me there was no decision to be 
made, go away and die in six months or start the chemotherapy. 
David’s comment that “the medical profession are ultra-conservative” implies 
that he thinks they may be downplaying the odds of success, which could be a 
way to reduce uncertainty and protect his hopeful outlook that treatment will 
indeed lead to cure.  Patients also described thinking that the option of surgery 
indicated professionals’ belief that a good outcome was likely, reflected in the 
quote below from Carole:
Carole: I kind of think erm () they wouldn’t be offering me the operation 
was the outcome not going to be worthwhile. So you know because 
obviously there is a cost, so I kind of think you wouldn’t be put forward for 
surgery if people didn’t genuinely believe there could be a good outcome 
so you know you can’t think any other way () I’ve got an opportunity even 
though it’s a scary one.
Both of these examples demonstrate treatment representing hope of cure. 
However, I interpret Carole’s statement that “you can’t think any other way” to 
imply that she is purposefully controlling cognitions, as though to ensure her 
thinking remains positive and hopeful rather than veering towards the fear she 
feels. 
Sub-theme 2: “Cancer takes over”
This sub-theme captures participants’ recurrent descriptions of the impact of 
O.C. on relationships, normal routines and basic activities like eating. The 
following extract depicts the interruptions pre-operative treatment causes to 
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daily life. As demonstrated by Joe, there seemed to be a contrast between 
predictable, scheduled treatments and the unexpected and unpredictable 
events such as being hospitalised.
Joe: Once you get the structure of it () going to and from the hospital 
every day for half-an-hour’s treatment 23 days…and then at the 
weekends I was in bloody hospital every time. You have to go to A&E if 
your temperature goes up above 47.5 for 2 hours or 48 once because 
you get this thing called neutropenic. It happened the first weekend…so I 
went into A&E and they put me on a drip and tested me…Then the next 
weekend I collapsed and just slept for the whole weekend and then the 
next weekend I was back in because my temperature was high again… 
The weekend after my treatment finished I was admitted again and they 
kept me in for four days... So I was going there for A&E every weekend 
and then going here to the cancer hospital every day. 
The impact on relationships was also great and Joe went on to describe that his 
relationship with his wife had “broken down” a few days before the interview and 
he described this as precipitated by her worries about the possibility of his death 
and also her response to him not seeking her support: 
Joe: So () so () I think she’s frightened about what might happen with me 
() whether I’m going to die or not. I have a 13-year-old daughter. Scared 
I’ll die on the table. Scared I’ll die afterwards. Scared I’ll die. Erm () But 
also, I think the concept that I got cancer and didn’t collapse into her 
arms seeking her support all of the time, I just got on and dealt with it and 
part of her constant belief is that I don’t need her (). Is it partially true on 
a day to day, I don’t really need support from people?
Joe’s description could also relate to gender, as a reluctance to discuss cancer 
would fit with the traditional ideas of masculinity which will be discussed in 
relation to hegemonic masculinity in chapter four. This paradigm can also be 
applied to participants’ descriptions of worrying about the impact of O.C. on 
their loved ones as demonstrated by the following extracts: 
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Peter: [My wife] she’s really worried about me you know. She’s my 
guardian angel she makes me do my exercises, she comes out with me 
to do my exercises and it’s good, but the strain shows. And I worry about/ 
it’s good I’ve got something better to worry about than a tumour in my 
oesophagus. We’re very close you know. She’s been brilliant.
Carole: It is kind of horrible because you know sometimes you also worry 
about other people and how the impact of you being ill is going to affect 
them psychologically <tearful> sorry. Oh yeah. You know I’ve got an 
elderly mum and so it was quite hard for her to digest that news, I’m still 
not 100% sure that she fully understands or wants to believe, I think she
would still like to think that it’s not the diagnosis that I’ve got, but it is.
These extracts demonstrate an interesting contrast, with Peter’s wife seeming 
to take responsibility for his health while Carole speaks as a carer concerned 
about her mother’s wellbeing, trying to help her to understand. While both 
extracts depict participants’ concern for their relatives, Carole positions herself 
as a carer and Peter as cared-for by his wife. This fits with traditional gender 
roles. 
The impact of treatment was also discussed in relation to the physical effects of 
chemotherapy, which were varied. Some participants described being less 
affected than they had anticipated and others described fatigue that made life 
difficult. Only one participant had a feeding tube, due to the quick progression of 
dysphagic symptoms. She described the immense loss she felt of being unable 
to eat and the ways this led her to feel excluded: 
Audrey: It feels a big loss to me to be honest to not be able to eat, to 
have this tube inside of me instead. Food is important to everybody, 
every animal, even butterflies, bees, food is a very essential thing. If we 
don’t have a mouth to eat we starve to death and food is very essential. I 
mean I am jealous, if I see you eating right now I would be looking in 
your food and watching you putting it in your mouth, it is very hard I’m 
telling you. Even the advertisement on the television I have to turn over. 
And walking down the street seeing shops and people eating and 
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sometimes I look in their plates and sometimes I feel so bad I have to 
turn my head, like I’m starving. It is bad it’s a bad feeling. 
This moving account of the loss Audrey is experiencing fits with the idea of 
eating as a primal process, which gives us nourishment, social connection and 
inclusion. To be unable to eat has far-reaching circumstances. Although Audrey 
was in unique circumstances amongst this group of participants as she had a 
feeding tube, notably other aspects of her reported experience were consistent 
with others in the sample. 
Another way that participants described the impact of treatment was through 
speaking of control being out of their hands, rather located with professionals 
and other factors including luck. Abdul described feeling relieved when following 
diagnosis he arrived at the cancer centre.
Interviewer: You described that hearing the diagnosis understandably 
was very emotional and difficult, in the week between having the 
diagnosis and then going to the cancer centre (). Did it stay the same or 
different?
Abdul: Then I feel a bit different, then I’m going to the professionals’ 
hands you know () they can sort it out. I feel less bad than before.
Interviewer: Would you say a bit more about being in the professionals’ 
hands and what impact that had emotionally?
Abdul: That relieved me more you know. 
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Whilst loss of control can often be construed as negative, the above extract 
shows the relief that being “in professionals’ hands” brought to Abdul, which led 
me to consider the reassurance expertise can provide at times of illness. This 
was also the time when death was spoken about by participants. 
David: ...so you put yourself in their hands and what you then want to 
see is they are doing it as fast as they can. And they were... You take the 
anaesthetic and you know nothing more about it, you either wake up or 
you don’t.
Participants also frequently spoke about luck, both in relation to getting O.C. in 
the first place (as depicted in the below quote from Audrey) and in relation to 
the success of surgery (as described by Abdul). 
Audrey: I was talking in my lunch break to an old lady 85 who's been 
smoking since she was 15 and they don’t have no cancer so it all 
depends you know, some people are lucky, some people aren’t, it’s just 
one of those things…I would say to be truthful we’re all born with cancer 
but it all depends on how things comes out of your body.
Abdul: That’s what the surgeon said to me, that definitely, he said ‘we’ve 
got everything here these days but at the end of the day I’ve got my 
fingers crossed’ () that’s what he said.
There is a strong sense from both Audrey and Abdul that chance is a central 
component in the outcome of this treatment. This emphasises the uncertainty of 
the situation they are in. Regardless of the precision of the description of the 
surgeon’s words (“I’ve got my fingers crossed”) Abdul’s description depicts the 
fatalism and profound sense of chance about the outcome of this treatment.
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THEME THREE: COMMITTING TO GETTING THROUGH TREATMENT
This theme refers to the underpinning assertion from all patients that they were 
committed to getting through treatment. They described varied methods that 
they employed to adapt to O.C.
Subtheme 1: “I'm doing what I can”
Through taking power and control participants spoke about trying to reduce the 
power the disease had over them, whilst preparing for surgery. There was a 
strong sense of participants wanting to do their ‘part’, as well as the belief that 
their behaviour prior to surgery would have implications for the outcome. There 
was an idea of reciprocity from patients, that while they acknowledged that 
many aspects of this were beyond their control, they spoke about exercise as 
the element that was in their power.
Peter: …he says [the surgeon] you know that’s my part of the bargain 
getting really as fit as I can and I’m doing that…
Some patients also talked about taking responsibility through expressing regret 
for their own actions that may have increased their risk of O.C. (for example 
smoking, drinking and being overweight): 
Audrey: To be honest when they told me it’s near to me throat, because 
I’m a smoker and I was drinking. Because I started smoking when I was 
21. I have tried to give up cigarettes before but it’s very very hard. I give 
up cigarettes now because I have cancer in my throat, so it’s not a good 
reason for me to give up but I should have give up () because I  was 
smoking 20 cigarettes a day and before  I had cancer I was smoking 15 
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roll ups a day so the drink and the cigarettes have some part. It could 
have.
Joe: I’m at least 5 stone () overweight yeah so erm () really I’m taking the 
piss and I don’t do any exercise. I have no right to be as healthy as I am. 
I have poured a significant amount of alcohol down my throat over the 
years especially when I was younger, I smoked 30 a day for much of my 
life. I’ve put other stuff in me that may or may not have had an effect, I 
don’t blame myself for the cancer, I recognised it could happen, but I also 
recognise that probably if I had lived a different lifestyle, I might have 
reduced the chances of it happening.
Hearing these self-critical descriptions was poignant in the context of
participants’ current situation. However, Joe’s comments contained interesting 
contradictory sentiments as he reflected on feelings of responsibility for 
increasing the risk of O.C., but then said “I don’t blame myself”. This suggests 
that there are limits to taking responsibility or perhaps this was a way of 
softening difficult emotions. 
Another aspect of taking responsibility was conveyed through participants 
speaking about relying on themselves during this process as articulated by 
Matthew. His description in the following extract is also consistent with 
hegemonic masculinity.
Matthew: And when they said the biopsy () it’s cancer you kind of go 
<sharp intake of breath> even though you know it and then it knocks you 
for a certain amount of time and then you get over it.
Interviewer: How did you cope with that, when it knocked you?
Matthew: No problem, you just get on with it. Like you hear so much bad 
things about cancer, it’s everybody’s fear and everybody’s ready and if 
you hear somebody’s got cancer, in fact I was a bit like it myself, if you 
came up to me and told me you’ve got cancer here or cancer there you 
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don’t quite know how to speak to them. And I’ve found this myself that 
some people they just don’t know how to handle, that’s kind of a general 
thing and that’s the thing in general. It’s not difficult, it knocked my 
confidence for a week or more alright because you’re thinking of 
everything of what you’re going to do and what’s going to be done you
know, and then after a while it just all disappears and you just carry on. 
You just carry on. I was always a happy go lucky guy anyway. What’s to 
be is what’s to be and that’s it…Nothing you can do for me to make me 
feel better. I’m as good as I’m going to feel. There’s nothing you or 
anybody else can do to make me feel better. You can be sympathetic or 
you can say get on with it, it’s happening every day of the week. You can 
go plan a or plan b.
While describing the way the diagnosis “knocked” him, Matthew quickly moved 
to describing “carrying on” and that it “disappears”. It struck me that the move 
from being “knocked” to “carrying on” seemed like a quick shift from one fixed 
position to another, as though there were two available options of “plan a” or 
“plan b”, rather than a continuum or spectrum of emotions that patients may 
oscillate between. This is representative of how participants generally spoke 
about their feelings and I wondered whether the necessity of getting through 
treatment engendered this attitude of “carrying on” in order to cope. He also 
described the responses of others, connecting with how he responded to people 
with cancer in the past. One plausible contributory factor to relying on oneself 
could relate to negative or isolating responses from others. He also described a 
fatalistic approach (“what’s to be…”) which may relate to him acknowledging a 
loss of control. 
Sub-theme 2: “Not letting cancer take-over”
This sub-theme refers to patients’ descriptions of different ways of trying to 
prevent cancer from dominating their thoughts and identity through remaining 
connected to things and people that they valued. In the following extract Carole 
articulated techniques she has used to stop cancer from “ruling”: 
69
Interviewer: During this experience as a whole, what’s been the most 
difficult part of it?
Carole: To be honest, I think…desperately what I’m trying to do, like I 
said before is I don’t want cancer ruling my life. I want to carry on as if I 
hadn’t got cancer () so it’s kind of just trying to make my life normal () as 
normal as I can . I don’t want to be miserable because if I’m honest I 
don’t feel too bad at all and as long as I’m feeling OK, then I must focus 
on you know carrying on, staying in touch with people, erm not kind of 
becoming isolated, so getting the diagnosis was horrible but the battle is 
to make sure you’ve got a, you know, a happy life and that you’re not 
allowing the kind of cancer to swamp your mind so that all you think 
about is cancer, the operation and chemotherapy. Don’t want to.
Carole’s description is representative of numerous other examples where 
patients spoke about a conscious effort to prevent cancer from taking over their 
life and thoughts. Many participants spoke about trying to think positively and 
“get on with it”, trying not to think about cancer too much. In contrast to
Matthew’s descriptions (pp. 67-68), however, Carole depicts an ongoing 
struggle between despair and hope, as well as emphasising the importance of 
staying connected to others. Audrey describes her approach to this in the 
following extract. 
Interviewer: What is the most difficult part of all of this?
Audrey: Well you can’t eat, that’s part of it. I think having cancer is 
difficult. But it’s how you cope with it is harder. Just ignore it the best you 
can, you know, don’t think about it too much don’t let it play on your mind 
because once it’s playing on your mind you’re going to feel miserable, 
feel sorry for yourself, want to lock up in your house and don’t want to 
socialise with anybody. Don’t feel sorry for yourself still do what you have 
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to do. Well try and read as well, make sure that your mind is functioning 
and then look at the television and I go for a walk…if there’s a friend 
nearby just go and have a little chat with her. Sometimes other people 
are too helpful, sometimes I don’t want them to come to my house 
sometimes they phone too often but I think it’s because they care. 
Because even my work colleagues came and visit me on Saturday and I 
get phone calls from all over the world and that feeling’s good. 
Audrey, like Carole, emphasises connections with others. Although her 
description shares some similarities with Matthews’ (pp. 67-68), for example 
“ignore it” is similar to “carrying on”, however she more directly acknowledges 
that “…having cancer is difficult”. 
In line with Audrey’s description of keeping busy, many participants spoke of 
ways of trying to reduce the time they thought about the operation in the lead up 
to it. 
Abdul: ...so if I stay here, I’m thinking all the time about the operation 
‘what’s happening, what’s going on’, but if I go [on holiday] for two 
weeks, building, makes my mind strong, thinking about something else, 
not thinking all of the time about the operation you know". 
Joe: "Then I just went into practical mode you know ‘how am I going to 
deal with this, how can I put the appointments in to fit with work?’ 
because I was determined to work, and I’m bloody glad I did because 
otherwise you’re just giving yourself time to be miserable otherwise. 
These extracts show that as well as trying to maintain a positive attitude, 
participants worked to structure their lives in ways that distracted from thoughts 
about cancer and surgery. This sub-theme led me to consider identity and the 
wish by cancer patients to not be defined by cancer, as well as the protective 
function of avoiding difficult thoughts and feelings. This could be seen as an 
adaptive way of coping in a situation that requires them to retain functioning in 
order to adhere to the programme of preparation for surgery. 
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3.4 Staff Thematic Analysis
Two overarching themes were developed, each with two sub-themes as 
depicted in the below table.
Table 3: Staff analysis themes
THEME SUB THEMES
“Between the devil and the 
deep blue sea”
“Long journey to the goal of surgery”
Dilemmas of surgery
Predicting the 
unpredictable
“More complicated than one factor”
“Supporting patients to take ownership”
3.4.1 Setting the context
The interview schedule invited staff participants to describe their experiences 
with patients and encouraged them to draw on their knowledge gained from all 
patients they have worked with. Many staff talked about the extremely wide 
variation in patients’ experiences of this particular form of cancer, in contrast to 
other oncology specialties they have worked in.  
THEME 1: “BETWEEN THE DEVIL AND THE DEEP BLUE SEA”
This theme captures staff participants’ description of pre-operative treatment 
and the tensions this brings through the long journey to prepare for surgery, 
with it offering a potential cure while bringing great risks and uncertain 
consequences. 
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Subtheme 1: “Long journey to the goal of surgery”
Participants described the team and patients working towards the goal of 
surgery. They spoke about the hope and potential cure that surgery offers to 
patients: 
Interviewer:  From your experience what do you think the process from 
diagnosis leading up to surgery tends to be like for these patients?
Cathy: I think if you look at the transitions or the journey that people go 
through, when you’re first diagnosed I think you go through the shock of 
‘oh my god am I gonna die, if I die..’ and just the reverberations of what 
that means and you go to the worst case scenario and back. But then 
your healthcare team give you hope and they say ‘but don’t worry you 
know we’ve got a treatment for you or several treatments, this is what 
we’re going to do’ and I think a lot of people while anxiety and worry 
might be there () the actual processing of what’s happened to them is 
often pushed back and put in a little box because they are actually in 
survival mode and actually getting through day-by-day those treatments, 
particularly chemo.
The above extract from Cathy shows the dynamic processes patients 
experience and the ways that surgery can provide reassurance that there is a 
treatment, despite the risks. She also suggests that in getting through the 
treatments day-by-day, patients’ emotions may be overridden by a focus on 
“survival mode”. 
Staff also described the motivating effect of surgery acting as a goal to work 
towards and that having worked with patients with different cancers, the focus 
on surgery brings unique characteristic as articulated by Emma: 
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Emma: I find the sense of seriousness is much more pronounced… so 
the understanding of how close they are to not making it is much more 
pronounced and the willingness to do anything that’s advised is much 
bigger too… It is a huge goal () I find them incredibly wilful and strong 
that they work towards this. It’s very interesting to experience this. I have 
not experienced this in this strong sense in other patient groups… It is 
partly the chemotherapy () and being so focused on surgery and getting 
the chemotherapy to work. They often have such hopefulness that the 
tumour will shrink but they understand if it can’t shrink it won’t be taken 
out… It is a different journey really [to other cancer treatments], very 
driven by the focus on the surgery.
It is interesting to consider what makes the experience of this treatment seem 
different from the other cancer contexts staff had worked in. Emma articulates 
thinking that the long journey to reach the “huge goal” of surgery and the risk of 
death differentiates the experience of this treatment from others. The continuing 
uncertainty during pre-operative treatment was described as a difficult balance
for staff between wanting patients to be hopeful but also aware of the risks.
Emma stated that patients have awareness of the uncertainty and yet strong 
“hopefulness”. While reporting that patients often view surgery as symbolising 
hope, staff talked about the importance of fostering realistic expectations during 
this time and supporting patients to prepare psychologically for surgery: 
Jay: ...obviously what we don’t appreciate is the psychological 
preparation for surgery. They’ve got to know what to expect. If they don’t 
know what to expect in terms of what they need to do but also in terms of 
the drastic complications of such a serious operation then they just fall in 
a heap. So if they know what they need to do…then they are much more 
likely to do those things because they feel that they are contributing to 
their own erm () improvement, their recovery...
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As demonstrated by Jay, many staff made a link between patients being aware 
of what to do and feeling in control of their own recovery. During the period of 
preparing for surgery, staff described exercise as relating to control:
Lucy: She [a patient] realised she could do more than she thought she 
could do, which gave her a huge psychological boost…She said, ‘I feel 
back in control again’ (). That's the one area where they have full control 
over. The rest of it is down to everyone else, but this is the thing that () 
we can guide them, but they need to do the stuff. So it's control I think, 
that's the key thing.
They described that during this time it is hard for patients to know what is ahead 
and the focus often moves from getting through chemotherapy to surgery:
Cathy: Then comes the point that the surgery’s looming nearer and 
nearer, they’ve been told about the surgery from the beginning and it’s 
not that they’re ignoring it, but I think they’re so focused on getting 
through the treatment and not worrying about it just now because 
actually they need to get through the chemo, also they’re going to have 
to be scanned to know whether the chemotherapy is having an effect. 
The certainty in this is the treatment but I think there must be uncertainty 
there. Everybody has a plan, I’m going to have this treatment, this many 
cycles and then I’m going to have surgery, but it’s not until they get to the 
scanning bit that the uncertainty becomes a reality in that it’s how you 
responded to chemo means whether you have the operation or not.
It seems significant that during this period of active treatment, there was a 
sense from staff that patients are in “survival mode”, trying to successfully 
overcome each obstacle to access the cure. Staff described it as frightening for 
patients to know that surgery and its potential consequences are ahead. Cathy 
in the above extract and Emma (p. 73)  implied that the uncertainty of whether 
or not patients could go forward for surgery may be concealed by their focus on 
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getting through treatment. It seemed that perhaps the hopefulness and focus on 
treatment leads the uncertainty to become hidden for many patients. 
Many staff conveyed the idea that patients who understood the treatment 
process coped better but equally patients who were struggling may decline 
information: 
Interviewer: So it is a really tricky balance of how much information to 
give?
Olivia: I think it’s experience you get to know and you get a feel for how 
much information people may want, it’s got to be a phased approach and 
you’ve got to be guided by them as well so I tend to… go through the 
surgery and what to expect and when to expect it… It’s trying to give it 
them in a phased approach, trying to be responsive to their body 
language, some people say, ‘look I don’t want to know anything’ () you 
have to, you just have to negotiate a little bit because you know from 
experience if people don’t want to know anything then sometimes they 
are doing themselves a disservice and then maybe at that stage you say, 
well come back, you just have to tailor. We’re lucky we haven’t got huge 
numbers so we can tailor the preoperative information to their needs. 
You might give them just a little bit of information you won’t go into the 
nitty gritty of what happens in the surgery etc. So it’s as much about 
offering them psychological support as it is about giving technical 
information.
As described by Olivia, tailoring information to patients’ different wishes and 
needs was a consistent dilemma staff discussed. I wondered how emotion and 
information preferences related to one another, and the ethical issues raised in 
relation to decision-making when patients request no information despite the 
magnitude of the surgery. It was clear from staff’s descriptions that the role of 
this surgery, the long lead-up to it, intensive preparation and the high risks 
means that O.C. treatment has a distinctive quality to other cancer treatments.  
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Sub-theme 2: Dilemmas of Surgery 
Staff participants described the risks of oesophagectomy as amongst the 
greatest of any surgery and that while potentially lifesaving, the seriousness of 
this surgery and the potential consequences are immense and may not be 
possible to understand prior to experiencing it. 
Josh: I think what a lot of people don’t understand…is that 
oesophagectomy involves at least 2 organ cavities…and sometimes 3 
stages to the operation. So that means not only a major operation 
opening the abdomen but also a major operation opening the thorax and 
also sometimes the neck erm () and the physiological insult is absolutely 
astronomical, it takes sometimes 12 hours to do this operation… So it’s a 
hugely intense physiological hit and even the fit young patients who have 
it () you know take weeks and months to recover and I think people, 
patients in particular, probably don’t understand the implications of that, 
of all the patients who have this surgery mightn’t expect to be back to 
normal for months after surgery, if at all and for many people it will be a 
life-changing process who will never retain their previous independent 
living and quality of life. So I think those are the key things and they are 
not necessarily talked about.
The above extract captures the physiological impact of surgery as well as its 
effect on HR-QOL. Josh’s descriptions of patients not understanding the 
consequences of such major surgery points to ethical questions of how much 
understanding is necessary for informed consent. His discussion of the 
potentially brutal implications of surgery highlights systemic influences of the 
implications not being spoken about. In line with Josh’s suggestion that the 
gravity of this treatment may not be talked about, staff consistently described 
grappling with how much information to share with patients. These dilemmas 
were articulated by staff as challenging. There was a feeling that no matter how 
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much information patients are given, it may be impossible for them to grasp the 
seriousness prior to surgery, as described by Olivia.
Olivia: I tend to use this with patients you get the impression that they 
feel they’re stuck between the devil and the deep blue sea, on the one 
hand they desperately don’t want to have the surgery and they’re terrified 
of it and the impact it will have and the way it will interfere with their life 
as they know it, but on the other hand they know that it’s the only key to 
life and living and so it’s that huge unknown. Nobody would ever want to 
be in that position and trying to see as well that with a lot of people as 
well, when you’re giving them information they’re processing it to a 
certain extent but invariably you’ll see them after the operation and then 
they’ll say, no matter how much information you try and give them no 
matter how much peer-to-peer support or how much you try to prepare 
them invariably there’ll always be a part of them that will say ‘I had no 
idea it was going to be so big… and we really need to improve on that. 
So we can just alleviate their fears and anxieties to the extent that they 
do start to have some realistic concept of what life will be like after the 
operation and they can start to plan accordingly.
Olivia raises the question of whether it is possible to understand the implications 
of surgery prior to going through it and whether more could be done to prepare 
patients so that their expectations are closer to the reality of surgery. This was 
discussed by many participants as raising ethical dilemmas, particularly in 
relation to informed consent and shared decision-making. Central to the 
dilemma for staff is wanting patients to understand and prepare for potential 
consequences whilst not wishing to frighten or dissuade patients from life-
saving treatment.
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THEME TWO: PREDICTING THE UNPREDICTABLE 
This theme was chosen to capture staff participants’ views on factors that may 
influence patients’ experiences. While many shared ideas about demographic 
factors, they described that patient engagement and adherence was the most 
crucial variable in patients’ experience and surgical outcome. However, the 
resounding message was that predicting which patients are likely to engage is
complicated and intangible. Staff articulated that the care pathway aims to tailor 
support to individual needs in order to increase engagement. 
Sub-theme 1: “More complicated than one factor”  
There was a strong sense with numerous examples that physical effects alone 
could not predict experience or adjustment and some participants suggested 
that this might relate to an attitude: 
Sarah: If patients know why they are getting the toxicities, I think they 
cope a little bit better with that…patients who tend to be positive 
whatever that means because I don’t know if I can quantify being 
positive, I don’t mean a patient who’s always happy but I mean a patient 
who doesn’t spend too long wondering ‘why did this happen to me’. In 
here the majority of patients I see say ‘why me’, I don’t know how many 
times I hear that and it depends how long, I call it the ‘why me’ stage… 
and I think the longer the patient spends there determines how well they 
cope with their chemo essentially. If they spend too long with ‘why me 
‘()… Even if they don’t have toxicities they still struggle. I don’t think 
toxicities from chemo are the determining factor in how people cope… I 
used to think because people have someone supporting them but now 
I’ve seen a mixture of patients suffering just equally as much () I think it’s 
a little bit easier when you have support but I don’t think that completely 
is the reason because I’ve seen people having an amazing support 
around them but they’re completely not coping because they are 
spending so much time in that period ‘why me’.
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Like Sarah, many other participants described believing that social support was 
the strongest influence with family members acting as advocates, motivators 
and reasons to live for, however, it was clear that this was not the only factor. 
Others talked about class and education, with some saying that more educated 
people were more anxious and struggled more than those who were less
educated. Others described more educated people as more likely to fully 
engage with the programme. Masculinity was repeatedly spoken about as 
influential, with the demographic of this cancer as mostly older men, some staff 
felt that perhaps this influenced their relationship to help: 
Sean: It seems a lot of the male patients coming in have come in with a 
sense of bravado. They look at the self-efficacy and the social support 
questionnaires and they meet the question how confident do you feel 
about this this and this and it’s maximum scores just circling 10/10 10/10 
10/10. Now when I see that I question in my mind what’s that about 
because when you see and speak to them…they’re actually 
demonstrating they’re quite anxious and worried about things but when it 
comes to filling out forms, they don’t want to put that down on paper.
Overall staff reported that patients’ experiences are much more complicated 
than one factor: 
Interviewer: Do you have a sense of what makes a difference to how
patients experience this treatment? Are there factors you think predict 
how patients experience it?
Olivia: No it’s really interesting… So it never ceases to amaze me, you 
know you’d love to, because our patient demographic tends to be 
predominantly older men and you’d love to say they’re going to be 
disengaged, they’re not going to be interested. We do love to stereotype 
people, but I am permanently surprised, you know you can have young 
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females who are in their 30s and they’re totally disengaged. So I would 
say the one factor that we need to look at is patient activation 
[engagement] and how activated they are at the outset and how we can 
move them up that trajectory. So I wouldn’t say that social factors come 
into play or the tumour burden or anything like that, I think it’s far more 
complicated than that personally.
As well as describing that patients’ experiences are more complicated than a 
quantifiable social or physical factor, Olivia identified that using stereotypes to 
predict patient responses, whilst being an appealing idea, could impede 
clinicians’ idiosyncratic understanding. These quotes suggest that there is vast 
variation in all aspects of patients’ experiences. For example, at diagnosis O.C. 
can range from asymptomatic to extremely symptomatic (as demonstrated by 
the patient analysis). Patients’ emotional responses are also diverse with some 
who seemed to particularly struggle to adapt at first to the diagnosis, coping 
surprisingly well later in the pre-operative process and others struggling more 
than anticipated. 
Sub-theme 2: “Supporting patients to take ownership”  
This sub-theme was chosen to capture staff’s belief that patients who were 
most engaged with the care pathway had less difficult experiences of treatment 
and adhered to medical advice, which led to better physical health. They 
described that the aim of the care pathway is for staff and patients to work 
together in order to bolster a sense of “ownership”, “activation” or “engagement”
which they said in their experience more strongly relates to patients’ 
experience, adherence and medical outcomes. 
There are wide variations in patients’ engagement with preparation for surgery. 
The team described working to support all patients to engage in the programme 
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because they know this leads to the best outcomes, but for some patients this is 
more challenging: 
Jay: …obviously not everybody is going to be as engaged with a patient 
engagement programme and it all depends on how engaged, there’s this 
term called ‘activation’ how activated a patient is. And obviously speaking 
there are some of us, all our lives we’ve been told what to do and even 
though we’ve been told what to do we don’t listen to them, other people 
telling us what to do. That’s our personality, and on the other hand 
you’ve got people who are totally active in their own care, they’re 
organised people, they want to be well-informed. They want to know 
exactly what’s going to happen… So there are different levels of 
engagement and activation amongst human beings and it’s similar with 
patients as well.
Jay’s description highlights the great variation in patients, which interacts with 
the diverse treatment context. Staff continually described trying to adapt their 
approach to wherever patients were on the continuum of ‘patient ownership’.  
They reported that the care pathway was designed with all of these differences 
in mind, aiming to offer a very different context to traditional paternalistic 
healthcare which positions patients as passive recipients of expert medical 
care. In contrast, patients are expected to influence care and staff aim to build 
strong alliances based on person-to-person communication, seeing beyond the 
cancer diagnosis and aiming to provide personalised and holistic care as 
outlined by Sean: 
Sean: I always had a habit of giving out my mobile number… A direct 
number to get through to someone in hospital is basically non-existent 
these days… but even just having a direct line makes a massive 
difference and because we are seeing patients numerous times… having 
that personal relationship with patients I think makes a difference for 
them and for the team. Bringing everything closer together, I think it has 
made a difference to a lot of people.
Participants reported that the pathway’s cohesive support structure offers 
patients confidence through knowing that they are cared for by a whole team 
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rather than just one member of staff. The structure and clarity of the pathway 
aims to foster increased ownership and realistic expectations, consequently 
improving motivation and adherence. These are all things that the team have 
found helps patients to be in the best possible position when the time for 
surgery arrives. 
Jay: There are quite a few patients who say things like ‘if the team are 
investing so much in us, we’ve got to do the something for ourselves as 
well’ and I think that’s the feeling that they get ‘people are looking after 
us and if people are giving so much energy and time to looking after us, 
then let’s help them by us engaging with them and helping ourselves. 
The idea of reciprocal efforts with both the team and patient investing in 
preparation for surgery was described by many.
Interviewer: Would you be able to say a bit more about what difference 
you think it makes to patients having that experience where you’re 
looking at them as a person rather than just the diagnosis?
Olivia: Again it just goes back to, it makes a huge difference, you’ll read it 
everywhere all the clichés, patients are people just like we are, just 
because they’re in a hospital setting doesn’t mean we need to label 
them… It’s just person-to-person, as opposed to clinician-to-patient 
because then that sounds very hierarchical, paternalistic. I often say to 
patients that they are like the nucleus of the whole programme, if they 
are not engaged then all of us around them flounder, they are the one 
constant in the whole pathway, if they can make it work then we’ll fall into 
line around them so I think it makes a huge difference.
The above extract depicts the primary responsibility held by patients in adhering 
to medical advice perceived to enable the optimal chance of cure. 
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4. DISCUSSION
4.1 Overview
In this chapter I return to the findings, considering them in the context of the 
study’s aims, methodology and the literature. I will then suggest a critical 
appraisal of the methodology, making suggestions for future research and 
practice. I have aimed to write reflexively and critically throughout, making links 
to my own position and thought processes and I will conclude with a reflective 
section. I have made connections between the findings and a range of 
theoretical paradigms, recognising that in line with this study’s critical realist 
stance, connections I make to theory are one possible way of thinking, rather 
than claiming any ‘truth’ about facts. 
4.2 Contextualising the Analysis 
The overarching objective of the study was to explore patients’ experiences of 
pre-operative treatment for O.C. through hearing their perspectives as well as 
staff descriptions based on a plethora of experiences with patients. In particular, 
I hoped that the qualitative analysis would increase depth of understanding of 
patients’ experiences and the psychosocial impact of this gruelling treatment 
process. I was interested in finding out about the connections patients and staff 
made between different aspects of their experiences and how they made sense 
of relationships between their context and emotional responses, and what was 
helpful and unhelpful to them during this process. I hoped that this 
understanding would provide opportunities to consider the shared and unique 
aspects of this treatment in relation to findings with people with other cancers 
and that this could inform clinical practice and future research.
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4.3 Summary of Findings
4.3.1 Patient analysis 
Participants conveyed seemingly unwavering confidence and certainty in their 
decision to have surgery. They communicated wishing to avoid the suffering 
and constraints that surgery would cause. Yet with the knowledge that it was 
the only chance for cure, they expressed strong commitment to the process. 
Juxtaposed with this certainty about their choice, patients’ descriptions showed 
an awareness of the intensely unpleasant and frightening consequences they 
would likely face following surgery. For example, weight loss was alluded to by 
many participants, on occasion in the emotive terms of becoming ‘a skeleton’. 
However, all participants described measures they took to control cognitions 
about this, with a rational approach of “getting on with it” seeming to dominate 
expressions of emotional responses. There was a tension between feelings of 
fear about surgery and their commitment to adhering to medical advice and 
trying to prevent O.C. from taking over too much of their life and thoughts, with 
an idea that they must remain positive and focused on the goal of curative 
surgery.
Patients articulated a strong sense of the surgery hanging over them throughout 
the pre-operative treatment process, like an ever-present threatening ‘sword of 
Damocles’. They faced immense uncertainties, both in a day-to-day sense with 
potential hospitalisations and highly unfamiliar systems and processes, and with 
survival, efficacy and consequences of treatment all remaining unknown.
However, in spite of this patients articulated a sense of hope, which appeared to 
motivate them to work towards the goal of surgery. 
4.3.2 Staff analysis 
Staff described the predicaments and challenges of this treatment for patients 
who were required to make a drastic decision between the option of the 
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extremely high risk surgical treatment, with no guarantee of cure or alternatively 
choosing non-curative treatment leading to almost certain rapid O.C. 
progression and a short prognosis. Once patients have decided to pursue 
potentially curative treatment, staff reported that patients tend to experience the 
period between diagnosis and surgery as a long and arduous process. 
However, they also portrayed that the imminence of the surgery tends to 
provide patients with a sense of direction and focus on the ‘goal’ of surgery. 
Staff highlighted that as well as active treatment and exercise therapy, 
uncertainty about whether surgery can go ahead persists during pre-operative 
treatment, awaiting scans to check the efficacy of chemotherapy. They alluded 
to patients’ rare acknowledgement of this, stating that while patients know about 
the uncertainty, they typically focus more on remaining hopeful and focused on 
pre-operative treatment and the goal of surgery. Staff however expressed an 
awareness from clinical experience that some patients do not reach surgery. 
Staff spoke candidly about the risks of oesophagectomy, reflecting on the 
experience of this treatment feeling experientially different to other cancer 
specialties they had worked in. They described thinking that this related to the 
seriousness of O.C and the high risks associated with it. They highlighted that 
while the shocking risks were known by patients, the uncertainty was often 
hidden by their concentration on getting through pre-operative treatment and 
reaching the goal of surgery. This raised many dilemmas for staff when 
considering decision-making about surgery and the limits of informed consent.
There was a strong sense that patients’ experiences of this treatment were 
idiosyncratic and varied. Although some suggested that social support, 
educational level or gender might make a difference, the overarching message 
was that it was impossible to predict. However patient engagement or 
‘activation’ was described as a predictor of patients’ experiences, adjustment 
and health outcomes. They described that it seemed impossible to predict 
which patients would possess this. Staff spoke about the multidisciplinary pre-
habilitation care pathway being designed around these great differences and 
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that it attempted to foster greater ‘ownership’ and adherence in all patients in 
order to maximise the likelihood of successful cure. 
4.4 Connections between patient and staff themes
The patient and staff themes, although originating from different perspectives, 
have many related features. The following figure depicts the relationships I see 
between patient and staff themes. 
Figure 4: diagram of themes
PATIENT THEME 1: FEAR
AND THE UNKNOWN
- “Life changes with surgery”
- “Up and down”
PATIENT THEME 3:
COMMITTING TO GETTING
THROUGH TREATMENT
- “I’m doing what I can”
- “Not letting cancer take-over”
STAFF THEME 1:
“BETWEEN THE DEVIL
AND THE DEEP BLUE
SEA”
- “Long journey to the
goal of surgery”
- “Dilemmas of surgery”
STAFF THEME 2:
PREDICTING THE
UNPREDICTABLE
- “More complicated than
one factor”
- “Supporting patients to
take ownership”
PATIENT THEME 2:
TREATMENT OFFERS HOPE
AND UNCERTAINTY
- “Surgery means survival”
- “Cancer takes over”
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Figure 4 shows connections between the patient themes of fear and the
unknown and treatment offers hope and uncertainty and the staff theme of 
“between the devil and the deep blue sea” as they all depict the characteristics 
of traversing pre-operative treatment. All of these point towards both the 
harrowing effects of treatment and its status as offering the sole possibility for 
survival. Staff alluded to the clash between the apparent hopefulness of 
pursuing treatment juxtaposed with the seriousness of the somewhat bleak 
circumstances they face. The staff theme of predicting the unpredictable is also 
connected to “between the devil and the deep blue sea” as patients’ responses 
to this extreme situation are unique and difficult to predict. The second staff 
theme of predicting the unpredictable is connected to the third patient theme of 
committing to getting through treatment, because all participants spoke of ways 
to do their ‘part’ and  take ‘ownership’ of the process which fits with staff’s 
emphasis on patient engagement as a predictor of experience and outcome. 
Patients demonstrated awareness of the medical advice and commitment to 
following this, for example through describing exercise therapy as their “end of 
the bargain”. Staff described patients’ focus on the end goal of surgery driving 
them to get through the pre-operative preparation processes and that exercise 
gives them a sense of control.
Although patients and staff were speaking from completely different positions, 
there were many similarities between their descriptions. For example, both 
groups described patients’ dread of approaching surgery, as well as keenness 
to go ahead with it, perceiving it to offer a cure providing them with an 
unmissable opportunity. The main difference between staff and patient accounts 
was staff’s direct discussion of the risks and potential consequences of O.C. 
and the problems this can present for decision-making and consent. Patients, 
conversely, spoke with certainty about surgery as providing cure and hope. 
Although patients are likely to have been made aware of the continuing 
uncertainty of needing to be re-scanned to determine whether the surgery can 
go ahead, no patients spoke about this directly. Staff described that this 
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uncertainty often remained concealed despite repeated conversations with 
patients about this process and risks. 
4.5 Contribution Towards Understanding of Patients’ Experiences
This section will pick up some key elements of the findings, suggesting what 
this might contribute to understanding of patients’ experiences of pre-operative 
treatment for O.C. I will draw connections with the wider literature and highlight 
some outstanding questions.
Overall, patients conceptualised their experiences of this treatment as both 
offering salvation and bringing unknown but potentially overwhelming changes 
to their lives. On one level, patients were determined to progress to surgery and 
expressed relief and gratitude for the possibility of it. In describing their
awareness of “life-changing with surgery”, patients seemed to acknowledge a 
trade-off between survival and the aftermath of treatment, anticipating that 
achieving a cure would likely have a considerable impact on their HR-QOL. 
Fallowfield (1990) highlighted that some patients in all parts of healthcare would 
choose to sacrifice HR-QOL for the smallest chance of cure. This can be 
applied to all participants in this study, despite their individual differences and 
contexts.
There was a consistent sense from both staff and patients, that patients 
experienced the surgery as hanging over them throughout the pre-operative 
treatment process. Unlike other areas of cancer where treatment is surgical, 
these patients are required to endure months of physical and psychological 
preparation for surgery, which is unusual in oncology. However, the stress of 
long periods of preparation has been well-documented within the transplant 
literature (e.g. Kennedy, 2012). Patients in the present study described varying 
relationships to this time period, with some stating they would prefer to have 
surgery ‘tomorrow’ and others commenting that they would delay it forever if 
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possible. This illustrates that the wish to have surgery is coupled with some 
doubts. I would suggest that when faced with an operation as threatening as 
oesophagectomy, where the timescale is decided by factors beyond the 
patients’ control (such as response to chemotherapy, optimal time period post-
chemotherapy, hospital procedures and medical opinion) this would be likely to
evoke varied threat responses. As such it is understandable that some people 
would wish to run away and others to “fight” it as soon as possible (Rosenbaum 
& Rosenbaum, 2005). 
In listening to both patients and staff I thought about the stark choice between 
having no treatment leading to a likely quick progression and death within 
months, or a treatment which offers a chance of cure, but which is considered 
more harrowing than most other cancer treatments (which as a whole are some 
of the most unpleasant treatments in medicine and have been described as 
‘cutting, burning and poisoning’; Brennan, 2004, p.2). However, patient 
participants repeatedly described the decision to have surgery as a ‘no brainer’ 
and were emphatic that surgery was the correct decision for them.
4.5.1 Engagement with treatment
Staff unanimously took the view that patient ownership and engagement was bi-
directionally related to their experience of treatment and the outcome of 
surgery. This was because by adhering to changes in exercise and diet they 
could maximise the chances of effective treatment. The literature on pre-
habilitation pathways with people with O.C. further supports this, as 
engagement with the process and adherence to exercise and dietetic 
programmes is central to the efficacy of the pre-operative treatment (Viklund & 
Lagergren, 2007). This could suggest that an adjustment to the areas where 
they have no control, balanced with engagement with the areas they can control 
(such as participation in the exercise programme) is adaptive and potentially 
helpful. From a psychological perspective, this fits with the literature for 
adherence which suggests that an active style of engagement with healthcare is 
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associated with less distress and better outcomes, whereas a passive style is 
related to higher distress (Brennan, 2001).
For staff participants to so clearly express a position of unpredictability in their 
assertion that they could not predict patients’ experiences based on measurable 
characteristics seemed counter to the dominant ideas and focus in research on 
demographic factors and patients’ experiences of cancer. One participant
argued that by considering demographic factors as predictive of patients’ 
experience, our understanding of them might be limited. The view that patients’ 
experiences of this treatment cannot be predicted by one factor fits with the 
ideas of intersectionality and ecological systems theories which suggest that 
meaning is created by multiple intersecting levels of context (e.g. 
Bronfenbrenner, 1979; Cronen & Pearce, 1985). This seems compatible with 
Brennan’s (2004) critique of research which seeks to quantify psychiatric 
morbidity in cancer patients, in the process overshadowing the need to 
understand people’s distress in context and find ways of preventing as much of 
it as possible. 
The social-cognitive transition model of adjustment (Brennan, 2001) described 
in chapter one can be applied to these findings. The shocking event of being 
diagnosed with O.C. leads to feelings of being overwhelmed by threat to 
patients’ assumptions about the world and their health. The offer of potentially 
curative treatment provides hope of survival, and yet the average five year 
survival rates of 30% post-oesophagectomy creates great uncertainty and a 
much bleaker picture than for most other cancers (for example testicular 
cancer’s 98% rate of cure; CRUK, 2016). The O.C. context is highly stressful 
and patients struggle to adapt as their mental maps of self, others and the world 
attempt to accommodate the unexpected and frightening uncertainties. These 
adjustment processes will continue to take place as patients manage the 
recurrent threats of uncertainty throughout treatment. As these processes are 
influenced by context and individual meanings, it is reasonable that staff would 
struggle to predict the outcome of these processes (Brennan, 2004). The care 
pathway aims to increase certainty in a highly uncertain situation (for example 
91
helping patients to have realistic expectations while maintaining hope). On the 
other hand, my impression is that patients’ lack of description of emotion or 
struggle might link with the particular characteristics of the situation they are in. 
For example, staff proposed that they go into “survival mode”. 
Patients seemed focused on and dedicated to adhering to medical advice.
Parsons (1951) idea of sick role was highly influential across medical sociology 
until at least the 1980s (Burnham, 2014). This posits that when people become 
ill, they adopt a new role which supersedes their usual roles and that when this 
is communicated to members of the sick person’s immediate social network, 
they legitimise the sick role. This means that the person will be excused from 
their usual responsibilities, with a new responsibility of trying to become well 
enough to resume normal functioning as promptly as possible, seeking and 
adhering to the advice of professionals to aid this. When applied to this patient 
group, we see that they adhered to perceived expectations, followed medical 
advice and did not express negative emotion or ambivalence. The concept of 
sick roles has become unfashionable within the literature, critiqued for its 
determinism and focus on the patient rather than on the power of healthcare 
professionals or the systemic factors that position patients and healthcare 
professionals in particular ways (Burnham, 2014). However, it can usefully 
inform thinking about how patients might be positioned to follow medical advice, 
as part of their commitment to resuming their healthy roles as soon as possible. 
Alongside this they may also perceive an expectation that they do not express 
negative emotions. 
Patient participants often seemed to speak in pragmatic terms alluding to 
difficult emotions that might overwhelm them if they were to speak or think 
about them too much. As well as an attempt to take control and avoid 
distressing thoughts and feelings, this could also be seen as fitting with wider 
discourses that suggest cancer patients should think positively. One 
disadvantage of this, which is highlighted by Tod, Warnock and Allmark (2011), 
is that patients can feel it is unacceptable to express negative emotions and 
may even feel a sense of failure and responsibility for being insufficiently 
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positive. They may even have ideas that their lack of positivity is in some way 
responsible for progression or unsuccessful treatment.  
Patients depicted coping as consisting of practical strategies to prevent 
negative thinking from becoming overpowering.  Lazarus and Folkman’s classic 
coping theory (1984), which has been a highly influential framework in psycho-
oncology, suggests that coping entails: “constantly changing cognitive and 
behavioural efforts to manage specific external and/or internal demands that are 
appraised as taxing or exceeding the resources of the person” (Lazarus & 
Folkman, 1984: 141). Towsley et al. (2007) highlight that with cancer these 
processes are compounded by uncertainty about the impact and outcomes of 
the condition and treatment. 
4.5.2 Gender 
While being cautious not to reduce patients’ experiences to any one 
characteristic, I perceive the text to show multiple examples of the effects of 
hegemonic masculinity. This refers to the social processes which convey an 
idealised form of masculinity, which includes strength and robustness, 
suppression of needs and resistance of help-seeking (Mahalik et al. 2007). 
Courtenay (2000) suggests that men interact with and understand health and 
their bodies through this lens. Gannon, Guerro-Blanco and Abel (2010) report 
that male participants responded to the side effects of surgical treatment for 
prostate cancer using discourses associated with hegemonic masculinity.
Devisser and McDonnell (2013) argued that participants with more traditional 
gender role beliefs also had stricter ideas about the masculinity of various 
health behaviours through which they accrue ‘masculine capital’ (such as not 
attending the GP). Whilst this can act as a resource for men (Cameron & 
Bernandes, 1998), it can present challenges when faced with a health problem 
which evokes strong emotions and might require help-seeking. In
circumstances of O.C., hegemonic masculinity suggests that men would seek to 
conceal perceived weakness such as fear. For example Peter’s description of 
losing weight post-surgery, which he seemed to cushion with “…it might be 
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good for me you never know“(p.54) could be a way of continuing to appear 
‘strong’ in the face of frightening surgery. There were countless other examples 
from male participants conveying seemingly measured and coherent 
descriptions of their experiences. While female participants also spoke in 
pragmatic and certain terms, they described worries which fit with traditional 
ideas about femininity, for example about others around them. It also seemed 
notable that the two female participants became tearful during the interviews 
and none of the male participants visibly displayed distress in this way. Male 
participants described their female partners as consistent carers or as being 
upset by the man not seeking emotional support from them in the context of 
cancer. This is in line with literature from other cancers. For example Gray et al. 
(2000) found that men with prostate cancer expressed little emotion and did not 
seek emotional support which negatively impacted on their relationships.
4.5.3 Decision-making and consent
Patient participants in this study made it clear that their certainty about their 
choice to have oesophagectomy stemmed from the hope of cure and that they 
prioritised life above all other factors. There was often an accompanying 
sentiment that it would be irrational not to choose the potentially life-saving 
option. Some described declining HCPs suggestions to take time to think the 
decision over, instead wishing to proceed with treatment immediately. I was 
surprised by the lack of turmoil patient participants expressed in explaining their 
decision to have such serious surgery. My response of surprise is likely to have 
been influenced by my personal thoughts that in such a position I would likely 
need time to weigh it up (while acknowledging my belief that until we have been 
in a situation it is impossible to know how we will respond). This is also linked 
with my experiences of working in oncology and palliative care, contributing to 
ethically complicated and difficult multidisciplinary discussions about treatment 
decisions, weighing up risks and benefits often labelled in terms of HR-QOL 
(with the complexity and subjectivity this brings). I wondered whether 
participants had crossed through a process of doubt and struggle before 
arriving at their decision. However, their retrospective accounts suggested they 
were quickly certain that it would be ‘foolish’ to choose not to have surgery. 
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This led me to consider issues of decision-making, which raises complicated 
and multifactorial dilemmas across most areas of healthcare (Street, Ashcroft, 
Henderson & Campbell, 2000; Degner & Sloan, 1992). The shifts in the culture 
of oncology from expert-led, to shared decision-making and the Department of 
Health’s Expert Patient Programme has changed the landscape of decision 
making within healthcare (Martin & Lawrence et al., 2015). Charles, Gafni and 
Whelan (1997) suggest that the traditional paternalistic model of healthcare, 
where patients are passive recipients of doctors’ expert decisions is in direct 
contrast to shared decision-making models of patient care. 
In the present study, along with patients’ seeming certainty and rapid decision-
making, some staff participants described a concern that the consequences of 
oesophagectomy surgery had historically not been spoken about often enough. 
Other staff participants described how, in their experience, however much the 
risks and potential consequences were discussed with patients it seemed 
impossible for them to grasp the gravity of surgery’s implications until 
afterwards. They also suggested that for most patients uncertainty was 
concealed and infrequently acknowledged. This reflects my interpretation of the
data and reaction of feeling puzzled that patients did not express more 
emotional dilemmas or concerns.  For example, participants mostly spoke in a 
measured tone and yet used graphic terms to describe their imagined post-
oesophagectomy selves. For example, Matthew’s description of wanting “to get 
it over and done with and see what kind of a skeleton is going to be left" seems 
to allude to an acknowledgement of frightening consequences of surgery, 
although he did not state this explicitly. 
Although staff spoke about the continuing uncertainty through treatment, with 
the final decision about surgery depending on response to chemotherapy, no 
patient participants spoke about this.  I speculated that the complex uncertainty 
and fear evoked by the situation may have necessitated patients’ seeming 
certainty and trust in the medical intervention on offer. There was a consistent 
sense from patients of privilege and relief in the surgeon agreeing to offer 
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potentially life-saving surgery, with the acknowledgement that the alternative 
would be death. In reflecting on this, I wondered whether other patients might
show less confidence than participants who agreed to take part in interviews. By 
the nature of agreeing to participate in this study, I hypothesised that they may 
be likely to have a particularly confident narrative which may differ from other 
patients. 
McKneally and Martin’s (2000) Canadian paper suggests that the findings of the 
present study are reflected elsewhere. They carried out a grounded theory 
study with oesophagectomy survivors and asked them about the beliefs and 
values that informed their decision-making. They developed a model of 
‘entrustment’ and expressed surprise that patients reported not considering 
themselves to be making an ‘informed decision’. Rather, they saw the expert’s 
recommendation as consent to treatment and felt in control of the decision-
making process through their trust in the surgeon rather than because of any
analytic process. I would suggest that in the present data there was also a 
sense of patients delegating their decisions to their medical team. McKneally 
and Martin (2000) found that where doctors offered a choice between 
alternative treatments, patients reported losing confidence in their doctor’s 
competence. This suggests that they associated certainty and medically-led 
decisions with competence, which is problematic in the context of a drive 
towards shared decision-making. Patients also perceived themselves to not be 
qualified to absorb and process medical information as they did not possess the 
necessary expertise and felt stunned by anxiety and fear. The authors reported 
that patients were resigned to the risks of treatment and believed that analysing 
the risks was irrelevant as while the chances of survival were low, without 
surgery they were zero. This could be connected to the present research finding 
that patients expressed considering any option other than surgery would be 
irrational. 
Sommers and Helft (2009) examine the idea of informed consent from 
surgeons’ perspectives, highlighting the particular complexity of this with people 
with O.C. They suggest that this relates to the poor overall outcomes for O.C., 
the contested benefits of adjuvant chemotherapy, the great impact of the 
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treatment and disease on HR-QOL and varied decision-making preferences. 
They also articulated that HCPs’ ability to communicate and patients’ ability to 
process information are both central to the efficacy of explanations for 
improving patients’ understanding.  Sommers and Helft (2009) highlighted that 
there is wide variation in individual preferences for information from their doctor. 
However Jenkins, Fallowfield and Saul (2001) found that 87% of patients 
wished for full information regardless of whether it was positive or negative. 
Swenson, Buell, Zettler et al. (2004) also found that most patients (69%) valued 
shared decision-making. 
Levine and Gafni et al. (1992) described a method for supporting this 
communication process using a ‘decision board’ which is a visual tool to assist 
decision making. The assumption inherent in decision making tools is that with 
correct information patients are able to make decisions that are right for them. 
This assumption is compatible with the expert patient agenda, but the challenge 
is how clinicians assess that information has been transmitted to patients. For 
example, at times of high emotion, memory processing has been shown to be 
altered (e.g. Brewin, 2001). The present data suggests that a wish to survive 
overrides all other elements of oesophagectomy for patients.
The literature described in chapter one demonstrated that post-surgery patients 
often report a wish to have had more information (e.g. Malmstrom et al., 2013b; 
Andreassen et al., 2007; Wittmann et al., 2011). Authors such as Viklund et al. 
(2006a) emphasise the importance of detailed and honest information prior to 
surgery. However, the present study’s findings suggest that preparation for 
surgery may not be as straightforward as a thorough process of information 
exchange. Rather, multidimensional factors that might obstruct patients’ 
capacity to weigh up and make informed decisions must be considered. 
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4.5.4 Shared and unique features 
The findings of this study suggest that the experience of potentially curative 
treatment for O.C. can be seen as having characteristics both unique to this
context and shared with other cancers and treatments.
The frightening feelings of unpredictability and unfamiliarity with the system, as 
well as the “up and down”’ of uncertainty described by these participants, are 
common to many people’s cancer experiences (Rosenbaum & Rosenbaum, 
2005). Treatments are notoriously tough and unpleasant side effects are 
frequent, yet as articulated by Brennan (2004; p.27), ‘…for most people survival 
becomes the overriding concern’ and many people focus on this as the priority, 
at the expense of other areas of life. This suggests that the focus on survival for 
these participants in itself is not unique to O.C. However, the risks and impact of 
this surgery are greater than for most cancers and this, along with the long 
period of preparation for surgery, makes it a somewhat unique experience. Staff 
particularly highlighted experiences of working with people with other cancers, 
and feeling that there were qualitative differences in patients’ experiences which 
they attribute,d to the seriousness of O.C. Although surgery is always a major 
intervention, staff described that oesophagectomy is both emotionally and 
physically in a different league because of the complexity and risks. 
Many patient participants spoke about never having heard of O.C. prior to 
diagnosis. I hypothesised that the experience of being diagnosed with a form of 
cancer that one has not heard about previously would be different to being 
diagnosed with a high profile cancer that you have some familiarity with. 
Parallels can be drawn with Garau’s (2016) depiction of the qualitatively 
different experience of diagnosis of rare cancer compared with a more common 
diagnosis. The demands to then take on information about the illness and 
treatment are likely to be more difficult to process with no pre-existing 
framework, especially at this time of shock and threat.
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4.6 Implications
4.6.1 Clinical practice 
These findings have shed some light on the complexity of potentially curative 
treatment for O.C. and the great variation in patients’ experiences of this. This 
provides no easy answers other than emphasising the importance of attending 
to the great differences in meaning for people and their diverse contexts.
Some pointers for clinical practice are that, where possible, patients feeling that 
they have some degree of control is important. As part of their dedication to 
survival patients often align themselves with professionals, implementing HCP
advice such as exercise, and working towards the goal of surgery which is seen 
as symbolising hope and survival. However, while acknowledging the 
challenges of not wishing to scare patients and also the uncertainty of the 
future, HCPs must consider their responsibility in working with patients to 
temper hope with realistic expectations. The findings of this study suggest that 
providing detailed information in a traditional form may not be sufficient. Rather,
HCPs need to tailor the approach to individual patients, perhaps drawing on 
decision-making tools. As Levine et al. (1992) demonstrated, consideration of 
how to improve this transfer of information between clinicians and patients in 
clinical practice is imperative, in order to enhance patients’ preparation for 
surgery. 
Psychological theory suggests that information processing is likely to be altered
at times of trauma (Brewin, 2001) and high emotion (Kahneman, 2012) This can 
be helpfully applied to understanding that complicated psychological processes 
and multiple factors are likely to influence patients’ capacity toprocess 
information  when diagnosed with O.C.. In order to support information 
processing at these times, a multimodal approach to providing information  
should be used. This could include involving carers as much as possible to 
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provide patients with support to process information following consultations. 
Research on information needs reviewed in chapter one suggested that carers 
report feeling less well informed than patients. Carers can have multifaceted 
roles in supporting patients and it is crucial to acknowledge the strain that O.C. 
can create in those around the individual patient as well as their capacity to 
influence patients’ experiences. Joining with carers is likely to increase the 
possibility of patients grasping necessary information. There is also evidence to 
suggest that audio recording consultations is another effective way to support 
this, while also reducing decision-regret (Good et al., 2015). 
Staff data emphasised that it is not possible to predict patients’ experiences 
based on one factor. This suggests that working with this group requires 
openness and flexibility. This emphasises the importance of multidisciplinary 
care pathways with the scope to offer care tailored to the individual in the way 
that both patients and staff described as crucial here, working to not 
underestimate patients’ fears even where they appear confident. Clinical 
psychologists have a role in supporting multidisciplinary staff to achieve this.
The findings suggest that there are unique features to patients’ experience of 
this treatment, particularly related to the unusually high risks of surgery and this 
provides further evidence to suggest that HR-QOL scores cannot capture the 
whole picture and should be used with caution as a tool for conversations, 
rather than as a ‘scientific’ measure of wellbeing. 
In terms of survival, O.C. is where breast and prostate cancer were at least 30 
years ago (CRUK, 2016a). It also seems that research knowledge on decision-
making is behind other specialties and this is an area that requires urgent 
attention. From my own experience of searching for information, I found little 
clear information for patients on the risks of oesophagectomy and alternative 
treatments. On finding the National Comprehensive Cancer Network (2015) 
guidelines, which purported an intention to aid decision-making, I was 
disappointed to find little information on the disadvantages of pursuing 
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oesophagectomy. I would anticipate that unbiased accounts with information on 
prognosis and potential consequences would be available, in the spirit of truly 
informed consent. Perhaps the unavailability of such information reflects a wish 
to protect patients and their carers from the often shocking and painful details of 
this procedure and the implications of decision-making where this is the only 
potentially life-saving option. There is no easy solution in these circumstances 
and I wonder whether a collective avoidance is evoked by the extreme 
suffering, uncertainty and distress in this area. However, counter to the idea that 
shielding patients from harrowing details is protective, there is evidence to 
suggest that exposure to potentially shocking and difficult experiences can 
improve psychological outcomes in other settings. For example, family 
members witnessing resuscitation in emergency rooms has been shown to 
improve later psychological adjustment and grieving processes (Leske & Brasel, 
2010; Hanson & Strawser, 1992). Applying these findings to decision-making in 
oesophagectomy, I think it is important to develop ways of sharing the likely and 
possible implications of surgery with patients and their carers through clear and 
concrete information on the disadvantages and implications of this treatment, as 
well as the benefits. 
The overarching implication of the findings is that clinical psychologists’ have a 
multifaceted role in this context. This includes helping teams to reflect on their 
own emotional responses to the prospect of sharing more information with 
patients, perhaps considering defences against anxiety as a framework for 
understanding team processes in response to highly distressing work (Menzies-
Lyth, 1959). Psychologists can also support teams to think about decision-
making as relational, for example, it takes place in a context where patients’ 
representations of how doctors and patients relate will influence the interaction. 
In a time of the Expert Patient Agenda and emphasis on collaborative decision 
making, it is crucial to acknowledge that many patients continue to look to 
medical professionals to make decisions, as highlighted by McKneally and 
Martin’s (2000) research. This is likely to be influenced by both historical 
hierarchies between doctors and patients and a common preference at times of 
illness, fear and vulnerability to gain confidence and containment from expert 
and paternalistic figures taking decisions in our best interests. Psychologists 
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should support teams to confront the complexity of these issues and to consider 
how they would know if a patient was sufficiently prepared and if consent was 
thoroughly informed. Former patients who have undergone oesophagectomy 
could also helpfully contribute to considering these issues through drawing on 
and sharing their own experiences with pre-operative patients in order to foster 
balanced expectations. 
4.6.2 Research
In an ideal world, it would be optimal to do a prospective longitudinal study next, 
interviewing the same patients following surgery and then perhaps at yearly 
intervals post-oesophagectomy. The feasibility of such a study is likely to be 
challenging, but it would provide meaningful information to inform understanding 
beyond the current evidence base, which is mainly derived from quantitative 
measures. The numbers of patients from the original group surviving for five 
years is likely to be low and patients’ wish to take part may change. That said,
several patient participants spontaneously offered to speak again following the 
surgery “if you want to see how I got on”. I wondered whether this may have 
been influenced by their own wish to think beyond the surgery and maintain 
hope. Interviewing carers as well as staff and patients would also be of great 
value. Participants did not express expectations of psychologically changing 
post-surgery which is counter to Clarke et al.’s (2011) finding that patients post-
oesophagectomy described a sense of change in identity between pre-surgery 
and afterwards. Research exploring this prospectively would be of great value 
providing an opportunity to learn from patients whether they think anything 
further could be provided to support them. Including both carers and staff in this 
study would offer further multiperspective information. 
In particular research examining in detail how decisions are made is crucial to 
inform ethical practice and professional guidelines for HCPs working with 
patients undergoing this treatment. This could begin by using a prospective 
design to extend McKneally and Martin’s (2000) study with a UK sample,
through asking participants to describe their decision-making at key points pre-
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and post-surgery. The study could explore whether decision-regret is an issue 
for patients post-oesophagectomy. 
The inclusion of HR-QOL as a central part of the parlance and practice about 
holistic care across cancer services reflects a positive acknowledgement that 
thinking of experience as subjective and individual is central to meeting patients’ 
needs. However, it is important to pursue research which deepens 
understanding of patients’ experience in order to inform care. The use of pre-
determined measures with this population should be considered carefully, with 
the acknowledgment that relatively little research has been carried out with this 
patient group and further research is required to consider the kinds of measures 
we should be working to develop. 
4.7 Critical Evaluation 
As with all research, this study’s findings must be considered in the context of 
both strengths and limitations. A strength of this study was that all participants 
were part of the same treatment pathway at the same hospital and so some 
homogeneity of experience can be assumed, however, this also limits the 
generalisability of the findings. Another strength is that patients were speaking 
about their current experiences of pre-operative treatment, which provides 
greater proximity to their experiences than retrospective accounts. This also 
means that participants’ accounts would be likely to differ if interviewed about 
the same experiences in the future, although it is impossible to know what the 
differences would be. It is also possible that the setting of the interview will have 
influenced patients’ experiences of being interviewed. For example, patient
participants who chose to be interviewed at hospital might have been more 
likely to associate the conversation with clinical conversations they shared with 
medical professionals in the same setting. Conversations at home could be 
seen as a more intimate frame for interviews and may have encouraged 
increased openness.
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The sample size of seven interviews for the patient group and eight interviews 
for the staff group (with the relatively high homogeneity) is acceptable according 
to Guest, Bruce and Johnson (2005). However, the sample could be viewed as 
relatively small. I would have liked to have continued interviewing, but 
unfortunately within the constraints of the thesis, it was not possible. The 
process of recruiting patient interviewees was especially challenging due to 
small numbers of potential participants going through pre-operative treatment at 
any one point and patients’ busy appointment and treatment schedules, and 
frequent experiences of side effects during the pre-operative preparation period.
Patient participants were united by all undergoing pre-operative treatment for 
oesophageal cancer where oesophagectomy was anticipated. However, there 
were differences in patients’ medical pathways and stage as outlined in chapter 
one (pp. 47-48). It would have been optimal to interview patients at the same 
point in their medical treatment in order to more directly compare their 
experiences. However, as this population of patients has widely varied 
treatment needs and medical experiences, it was not possible to directly 
compare their experiences at the same time point. Future research attempting 
to do this would need to adopt a large-scale trial design. 
I would have liked to have co-produced this research with people with
experience of O.C. and hope that this will be central to future research. I am 
aware that the patient participants interviewed for this study are likely to 
represent a biased proportion of patients. Staff accounts aimed to address this 
in part through hearing their descriptions of a full range of patients, however, I 
recognise that this is no substitute for hearing directly from patients. 
The choice of research method and epistemology inevitably opens some 
possibilities and closes down others. The critical realist stance of this study 
made it possible to draw on a range of conceptual tools to explore how 
participants made sense of their experiences of this treatment. However, a 
social constructionist position would have allowed greater focus on discourse, 
perhaps revealing less of an individualised account and more about how 
participants constructed their experiences in relation to wider societal ideas. 
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Individual interviews created a private, one-to-one conversation, which has 
many strengths, particularly where the topic is as sensitive as cancer. Yet for 
future studies, I would be interested in the possibility of focus groups providing 
the opportunities to elicit data created through conversation. This would fit with 
Susan Sontag’s (1978) suggestions that experience of cancer is shaped by 
societal metaphors and discourses. 
As I conducted the interviews, I became intensely familiar and connected with 
the data which was helpful during all phases of analysis. My own emotional 
impressions at the time of the interview inevitably will have impacted on the 
analysis, although in the spirit of qualitative research I do not see this as 
negative. I have reflected on how participants might have perceived me as a 
relatively young white female and wondered how this might have influenced 
their responses. In order to encourage them to be as open as possible I 
explained that I had become interested in this topic while working in cancer 
care, emphasising confidentiality and hoping to position myself as a robust and 
non-judgmental professional, able to hear difficult or distressing experiences.  
Although my questions during interview intended to be as open and neutral as 
possible, both staff and patients are likely to have been heavily socialised by the 
culture of the care pathway which is likely to have shaped what they prioritised 
and shared in their answers as well as the position they took. 
4.7.1 Quality assessment 
The idea of quality in qualitative research is controversial, as the aims differ 
greatly from those of traditional scientific experimental methods and therefore 
do not strive for the same result. There are several frameworks for assessing 
the quality of qualitative research in psychology. I have chosen to use Elliott, 
Fischer and Rennie’s (1999) seven suggested criteria: 
1. Owning one’s perspective: This refers to the researcher attempting to 
acknowledge and be explicit about their values and assumptions and 
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how these influence the research. I have aimed to do this as much as 
possible by being clear about my epistemological stance and through 
trying to convey reflexivity throughout this thesis. I have written in the 
first person and have aimed to explain the decisions I made in both the 
analysis and discussion chapters, making links between my 
observations, interpretations and my personal beliefs and experiences. I 
have used a reflective diary and field notes throughout this research 
process as a way of making my own thoughts and interpretations 
explicit.
2. Situating the sample: This relates to providing sufficient details to put the 
participants in context. Through describing the details of the care 
pathway in chapter one and the age, gender and ethnicity of patient 
participants, and the job roles of staff participants in chapter three, I 
aimed to meet this criterion by depicting the participants in appropriate 
detail. 
3. Grounding in examples: Qualitative methods require the selection of 
appropriate examples to demonstrate the analysis. I aimed to carefully 
select examples for chapter 3 that optimally demonstrated the data 
analysis while also complying with the word limit constraints. I did this 
through a methodical process of recording all extracts relevant to each 
code during the coding process and then narrowing this with each 
revision of the report until the extracts fitted within the word limit. I tried 
to include quotes that were substantial enough to give the reader a 
sense of the data and its context. Following Braun and Clarke’s (2013) 
suggestions, I included quotes from the full breadth of participants, 
giving multiple examples to demonstrate key points. I have also provided 
varied examples of the maps involved in the analytical process in the 
appendices (Appendix R) which show the development and refinement 
of themes during the course of the analysis.
4. Providing credibility checks: This criterion refers to the importance of 
checking the credibility of the analysis. During the process of analysis I 
shared the codes, quotes and developing themes with a peer researcher 
working in psycho-oncology who reviewed the themes and I amended 
them as a result of this discussion. I later received feedback on my 
developing analysis from my field supervisor, a senior psychologist in 
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psycho-oncology, with expertise in oesophageal cancer and with my 
director of studies who has extensive psycho-oncology research 
experience. This provided assurance of the plausible standards of my 
own analysis in line with my inductive aims. 
5. Coherence: This criterion relates to the importance of a coherent 
account of the analysis in qualitative research. I aimed to balance a clear 
account of the analysis whilst depicting the nuances of the text and 
tensions. I also described both the overarching themes and where 
participants overall differed in their experiences. The process was 
iterative and involved multiple re-drafts. 
6. Accomplishing general versus specific research tasks: This relates to the 
challenge of attending to both shared, general themes and more specific 
details within the data. I attempted to achieve this balance by focusing 
on the overall themes, whilst highlighting specific details where I 
perceived them as highlighting nuances which might be of significance. 
7. Resonating with readers: The final criterion describes the standard to 
which the analysis is assessed by readers to have “clarified or expanded 
their appreciation and understanding” (Elliott et al., 1999, p. 224) of the 
phenomena. This has been my aim and the reader will assess whether I 
have achieved this. 
4.8 Reflection
The complex, systematic and creative process of this research has personally 
changed my perspective. I felt profoundly moved by meeting patients and staff, 
hearing their experiences of O.C. and immersing myself in their descriptions. I 
will continue to grapple with the complex ethical dilemmas this area presents 
and feel inspired by the staff members’ efforts to navigate these. 
Hearing the stories of patients’ suffering, their hopes and the experiences of 
staff in enduring this too, led me to question my own assumptions. For example, 
on hearing from staff the harrowing risks and consequences of the surgery and 
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knowing the low 5-year survival rates, my emotional reaction was strong. I 
initially felt shocked that this treatment is offered despite such high risks. On 
reflection, however, my view now is that the essence of quality of life is being 
able to make choices that would be inconceivable to others. The patients I met 
were emphatic that this was the optimal choice for them. However, in striving for 
shared-decision making, I believe that more must be done to understand how 
decisions are made with people with O.C., in order to guide ethical practice and 
ensure informed consent. 
I continue to feel affected by the conversations I had during the interviews and 
hold the patients I met in mind, hoping that their surgery goes well and has a 
positive outcome. I also feel curious about whether their descriptions or 
perspective would change, if we were to speak again following surgery. 
Although I would consistently have argued for the importance of HR-QOL as a 
subjective and self-defined construct, I feel that my perspective has been 
irrevocably changed by this project. It has left me with a heightened awareness 
of the challenge of facilitating decision-making that is truly responsive to 
patients’ subjective sense of quality of life, in extraordinarily difficult 
circumstances. As HCPs I believe that we have a duty to struggle with this 
complexity and yet during this project I have keenly felt the intense challenges 
this brings.
Keeping field notes throughout this research helped me to notice how I had 
been influenced by powerful assumptions about the meaning of quality of life. 
This emphasises for me the importance of time to critically reflect and hold our 
own ideas to account. When speaking with staff about these issues in the 
future, I will hold in mind my own process of becoming more conscious of how 
professional definitions of the meaning of HR-QOL can creep in, influencing 
practice which if unnoticed, could close down possibilities for truly person-
centred care. 
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8. APPENDICES
APPENDIX A: LITERATURE REVIEW TABLE 1 
Summary table of studies measuring HR-QOL post-surgery (p. 26-29) 
Authors Sample Country Measure and time points Key conclusions 
Viklund et al. 
(2006a)
282 
patients 
Sweden European Organisation for 
Research and Treatment 
of Cancer Quality of Life 
Questionnaire (EORTC)
C-30 & OES-186: 6 
months post-operatively 
HR-QOL was generally considerably 
lower for those 6 months post-
oesophagectomy than for a general 
population reference group and a 
group of mixed cancer patients. Role 
and social subscales were particularly 
reduced. They suggest that this 
reflects the magnitude of this 
treatment and its implications. 
Akkerman, 
Haverkamp, 
Rossum, van 
Hillegersberg & 
Ruurda (2015)
92 
patients
The 
Netherlands
EORTC C-30 & OES-18: 
time point varied from at 
least 1 year (with a 
median point of 36 
months; range 12-76 
months) post-
Global HR-QOL scores were similar to 
the general population reference 
group. However, patients scored 
significantly lower on physical, 
cognitive, role and social domains, 
demonstrating a continuing impact of 
                                                            
6
The most widely used measures across the literature review were the The European Organization for Research and Treatment of Cancer quality of life questionnaire (EORTC QLQ-C30 and 
QLQ-OES-18). The EORTC-QLQ is a cancer specific questionnaire that intends to measure HR-QoL. The main EORTC scale, the C-30, is a 30 item questionnaire with components for global 
health status, function and symptoms. The disease specific component for oesophageal cancer, the OES-18, has been designed to be used alongside the main scale (Lagergren et al., 2007). All 
scales are scored on a 5 point or 7 point Likert-scale. The scales have been found to have good convergent and divergent validity and multi-item correlations with Cronbachs alpha >0.7 
(Lagergren, et al. 2007).
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oesophagectomy. oesophagectomy on a range of 
functions. 
Hallas, Patel, 
Jackson, Murphy, 
Drakeley, Soorae & 
Page (2001)
37 
patients 
UK EORTC C-30 & OES-24 
and the Medical 
Outcomes Study SF-36: 5 
years post-
oesophagectomy. 
The majority of participants reported 
physical HR-QOL was lower than the 
general population group. Most 
patients experienced persisting 
symptoms including fatigue, pain, 
dysphagia and anxiety and tended to 
have lower physical functioning than 
the control group. A small proportion 
of patients reported severe physical 
symptoms. However, the majority of 
patients’ overall HR-QOL was 
reported as comparable to the general 
population group. 
Derogar, Orsini, 
Sadr-Azodi & 
Lagergren (2012)
141 
patients 
Sweden EORTC C-30 & OES-18: 
6 months, 3 years and 5 
years post-operatively 
They focused on the relationship 
between major post-operative 
complications and HR-QOL in 5-year 
survivors. They found major post-
operative complications were a 
predictor of poor HR-QOL 5 years 
post-oesophagectomy. 
Wu et al. (2015) 102 
during 
post-
oesophag
ectomy 
China M.D. Anderson Inventory 
(symptom distress), 
Hospital Anxiety and 
Depression Scale 
(HADS), the Medical 
There was found to be a negative 
relationship between symptom 
distress and quality of life. They found 
patients who were working, had more 
social support and better economic 
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chemother
apy. 
Coping Modes 
Questionnaire (MCMQ) 
and the Functional 
Assessment Cancer 
Treatment-General 
(Quality of Life) 
conditions reported less symptoms. 
Higher symptom distress was 
inversely associated with lower quality 
of life. 
Derogar & 
Lagergren (2012) 
117 
patients 
Sweden EORTC C-30 & OES-18: 
6 months, 3 years and 5 
years post-operatively.
The majority of patients reported 
similar HRQOL compared to general 
population but a limited subgroup’s 
HRQOL deteriorated over time. 
Hellstadius et al. 
(2015) 
401 at 6 
months 
and 140 
of these at 
5 years. 
Sweden EORTC C-30 emotional 
functioning scale: 6 
months and 5 years post-
operatively. 
A majority of participants reported 
problems with worry and low mood at 
6 months and this persisted in the 
majority at 5 years. They found lower 
educational experience to be 
associated with more tension and 
patients living alone were less likely to 
report worry at 6 months. Participants 
with low scores at 5 years tended to 
have low scores at 6 months, but a 
substantial minority deteriorated. 
Malmstrom et al. 
(2015)
79 
patients
Sweden EORTC C-30 & OES-18: 
before surgery, 2, 4, 6, 9 
and 12 months after 
surgery. 
During the first year post-
oesophagectomy HR-QOL scores 
were low, with the lowest point at 2 
months. The authors therefore 
recommend that additional supportive 
care input should be focused at the 2 
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APPENDIX B: LITERATURE REVIEW TABLE 2
Summary table of prospective studies on HR-QOL (p. 29-31)
Authors Sample Country Measures and time points Key conclusions
Sweed et al. 
(2002)
23 
patients 
U.S.A. EORTC (C30, OES-18): 
before chemotherapy, before 
surgery and 3 and 6 months 
post-surgery. 
Global HR-QOL declined over time but 
the change was not statistically 
significant. Physical symptoms increased 
significantly over time before surgery 
and the highest levels were immediately 
before surgery. These increased 
symptoms were associated with 
decreased HR-QOL. Overall there were 
only small changes in HR-QOL during 
this time period. 
Tatematsu et al. 
(2013)
30 Japan EORTC (C30) & objective 
measures of physical fitness 
(knee-extensor muscle 
strength and 6-min walking 
distance): diagnosis and on 
the last day in hospital post-
surgery (median time 21 
days). 
They found a significant decrease in 
physical fitness and global HR-QOL 
between the two points. All domains of 
HR-QOL reduced pre- and post-surgery 
except the emotion subscale where 
there was no significant difference. 
Chang et al. 99 Taiwan EORTC (C30, OES-18): Global HR-QOL decreased significantly 
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(2014) patients before surgery and 1month 
and 6 months after surgery. 
between baseline and 1 month post-
surgery. It gradually improved between 1 
and 6 months but by 6 months had not 
returned to the original level. 
Cavallin et al. 
(2015)
109 Italy EORTC (C-30 & OES-18): 
admission for surgery, 
discharge and 3 months after 
surgery. 
There was no significant difference in 
HR-QOL scores over time, for older and 
younger patients. 
Lagergren et al. 
(2007) 
90 
patients 
(47 who 
survived 
3 years 
post-
surgery) 
UK EORTC (C30 and OES-18): 6 
weeks before surgery, 6 
weeks, 3 months, 6 months, 9 
months, 12 months, 18 
months, 24 months and 36 
months postoperatively.  
Most aspects of HR-QOL improved 
between 6 and 12 months post-surgery. 
Even after 3 years patients reported 
persistent problems with physical 
symptoms, although emotional function 
was significantly improved between pre-
operatively and 3 years post-surgery. 
Global HR-QOL was lower at 3 years 
than pre-surgery. However, due to the 
improved emotional function, the authors 
conclude that overall patients who 
survive for more than 3 years can expect 
a good HR-QOL.
Verschuur et al. 
(2006) 
30 
patients 
The 
Netherlands 
Modified Patient’s Needs in 
Palliative Care-checklist 
(PNPC-checklist), EuroQol 
Visual Analogue Scale (VAS) 
Patients frequently reported physical and 
psychosocial problems after 
oesophagectomy. They expressed an 
expectation that professionals would 
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and semi-structured interview 
1 week following 
questionnaires: less than 1 
year post surgery.
help with physical problems but not 
psychosocial problems as they viewed 
this as the role of their social network. 
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APPENDIX C: LITERATURE REVIEW TABLE 3
Summary table 3: HR-QOL Qualitative papers (p. 31-33)
Authors Sample Country Method Key conclusions 
Malmstrom et al. 
(2013a) 
17 patients (2-5 
years after 
surgery), in 4 focus 
groups. 
Sweden Semi-structured focus 
groups: qualitative content 
analysis. 
Patients were particularly affected by 
long-term symptoms which impacted 
them emotionally and socially as well 
as physically. They described 
struggling with feelings of losing 
control of their lives and consequent 
anxiety and fear. Learning to live with 
symptoms rather than allowing them to 
constrain their lives was highlighted as 
positively influencing coping. 
Malmstrom et al. 
(2013b)
17 patients (2-5 
years after 
surgery), in 4 focus 
groups. 
Sweden Semi-structured focus 
groups, data analysed with
qualitative content analysis.
The theme ‘the need for a guiding light 
in the new life situation’ was created to 
capture patients’ descriptions of their 
experiences of supportive care. They 
expressed that support from friends 
and family and the healthcare system 
was crucial to managing the 
transitions and challenges of treatment 
and recovery. Honest information and 
clear and structured plans were 
highlighted as central to patients 
developing realistic expectations.
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Hodgson (2006) 9 patients (2-6 
years since 
surgery) and three 
partners. 
UK Qualitative and quantitative 
questionnaire: qualitative 
content analysis and 
quantitative descriptive
statistics. 
The majority of patients described 
feeling well-informed before surgery 
but stated they would have liked more 
information about post-operative 
recovery. All participants said that their 
main goal was to survive surgery, then 
gain confirmation that the cancer had 
successfully been removed and they 
could then focus on recovery. Post-
operative adjustment to reducing 
activity and accounting for persisting 
symptoms was challenging. A positive 
attitude in believing recovery is 
possible, from both participants and
healthcare professionals was viewed 
as essential. 
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APPENDIX D: LITERATURE REVIEW TABLE 4
Summary table of quantitative studies on experience of oesophagectomy (pp. 33-35)
Authors Sample Country Measures and time 
points
Key conclusions
Andreassen, Randers, 
Naslund, Stockeld &
Matthiasson (2007) 
15 patients 
16 family 
members
34 HCPs
Sweden Study specific 
questionnaire: 2-3 weeks 
since diagnosis.
HCPs believe patient and family 
members’ needs for information to 
be lower than patients and family 
members themselves.
Wittmann, Beaton, Lewis,
Hopper, Zamawi, Jackson,
Dave, Bowen, Willacombe,
Blackshaw, Crosby (2011)
100 patients 
and 100 
doctors 
UK Socio-economic 
deprivation scores (Welsh 
Index of Multiple 
Deprivation) 
Junior doctors’ perceptions of 
information needs were reported 
as lower than patients’ wishes for 
information which participants 
rated as very high. Low 
socioeconomic rating was 
associated with poor access to 
internet information. 
Dempster et al. (2011) 317 patient-
partner dyads 
UK Illness Perception 
Questionnaire-Revised, the 
Cancer Coping 
Questionnaire, the Hospital 
Anxiety and Depression 
Scale. 
Patients’ illness perceptions were 
found to explain the majority of 
variance in anxiety and 
depression. They found positive-
focus coping strategies were 
associated with better 
psychological wellbeing. Carer 
illness perceptions were found to 
mediate the relationship between 
patients’ perceptions and 
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psychological distress. 
Dempster et al. (2010) 189 patients UK The Hospital Anxiety and 
Depression Scale, The 
Cancer Coping 
Questionnaire, Illness 
Perception Questionnaire-
Revised: a median of 48 
months post diagnosis, 
repeated one year later. 
They found that changes in 
psychological wellbeing are related 
to changes in illness perceptions. 
They report that participants’ levels 
of anxiety and depression were 
similar to those reported for people 
with head and neck cancers but 
higher than for breast, prostate, 
bronchial and gastrointestinal 
cancers. They hypothesise this 
relates to the social implications of 
head and neck and oesophageal 
cancers. They found rates of 
anxiety and depression increased 
during the 12 months of the study. 
Wikman et al. (2015) 1615 Sweden National health registries’ 
information on psychiatric 
diagnoses from 2 years 
pre-surgery until 2 years 
post-surgery. 
Patients without  a history of 
accessing psychiatric care were 
found to have accessed   
psychiatric inpatient care within 2 
years post-operatively at a rate of 
2.5%, psychiatric out-patient care 
at 4.2%, and
treatment with psychotropic drugs 
at 32.3%. The authors conclude 
that this shows the importance of 
identifying psychiatric difficulties in 
oesophageal cancer patients. 
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Appendix E: LITERATURE REVIEW TABLE 5
Summary table of qualitative studies on experience of oesophagectomy (pp. 35-40) 
Authors Sample Count
ry 
Design Conclusions 
Clarke, McCorry & 
Dempster (2011) 
Five patients who 
had undergone 
oesophagectomy
(3-17 years since 
diagnosis) 
Northe
rn 
Ireland
, UK
Semi-structured 
interviews: 
Interpretative 
Phenomenological 
Analysis. 
The theme of identity became central as 
participants tried to make sense of their 
experiences of O.C. and find meaning.  Changed 
relationships with food, family and societal roles 
and the biomedical aspects of O.C. threatened 
their self-concept.  The authors suggest that 
identity is a helpful framework for considering the 
impact of O.C. and its treatment. Social networks 
that nurture a positive sense of self should be 
encouraged and healthcare professionals must 
recognise the range of challenges to identity. 
Surviving patients may be able to help with 
adjusting patient expectations. 
Wainwright, Donovan, 
Vas Kavadas et al. 
(2007) 
11 patients (at 
least 3 months 
post-surgery) 
UK Qualitative 
interviews: 
thematic analysis
The study found that physical difficulties 
encountered by oesophagectomy 
survivors influenced their psychosocial 
wellbeing and a long period of adjustment 
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is likely to be required. The authors 
concluded that the magnitude of learning 
to eat again should not be 
underestimated and intensive 
professional support would enhance 
patients’ experiences and adaptation. 
Jaromahum and 
Fowler (2010)
Seven patients 
(between first and 
third meals post-
oesophagectomy)
U.S.A. Interviews: 
phenomenological 
analysis 
This study aimed to explore patients’ lived 
experiences of initial eating following 
oesophagectomy. Both physical and 
psychological problems were found to 
influence patients’ experiences of eating. 
The authors reported that eating for the 
first time post-surgery was an emotional 
experience for all patients and healthcare 
professionals should recognise this. 
Participants expressed determination and 
that they would do whatever was required 
to improve. 
McCorry et al. (2009) 12 
oesophagectomy 
survivors (7 
months to 17 
years since 
surgery) and 10 
carers. 
Northe
rn
Ireland
, UK
Focus groups: 
thematic analysis
They found three key themes for patients 
of ‘coping with a death sentence’, 
‘adjusting to and accepting an altered 
self’ and ‘unique benefits of peer support’
and for carers ‘carer as buffer’, 
‘representations of recovery and 
recurrence’ and ‘normalising experiences 
through peer support’. The authors 
emphasise a holistic approach to support 
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in this context of threat to social, 
emotional and physical wellbeing, as well 
as the value of peer support. 
Andreassen et al. 
(2006) 
13 patients post-
oesophagectomy 
Swede
n
Qualitative 
interviews: 
qualitative content 
analysis
Four themes were reported: experiences 
of becoming a patient diagnosed with 
oesophageal cancer, experiences of 
undergoing investigations and treatment, 
experiences of intrusions in daily life, 
managing a life-threatening illness. The 
authors found that participants were 
unprepared for receiving the diagnosis of 
oesophageal cancer and that their 
everyday lives were particularly affected 
by dysphagia, fatigue and uncertainty. 
Seeking information was a strategy used 
by participants for managing the illness, 
with healthcare professionals viewed as 
the main source of knowledge. Patients 
believed their partners to be struggling 
emotionally more than they themselves.
Henselmans et al. 
(2011) 
20 patients, at 
least 3 months 
post-
oesophagectomy. 
The 
Netherl
ands
Semi-structured 
interviews: 
qualitative content 
analysis.
Patients’ reported needing information in 
order to anticipate the future and reduce 
uncertainty. They authors described that 
factors influencing communication 
included: patient characteristics (e.g. a 
belief in their right to have information, 
experience with similar conversations), 
healthcare professional characteristics 
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(patients believing they will not be able to 
give an answer, or topics are not part of 
the staff members’ jobs, or that they 
appear unfriendly hinder communication) 
and interaction characteristics (such as 
time and duration of knowing the 
physician). For patients, support of 
companions or pre-meeting preparation 
also reportedly made a difference. Many
patients thought that facilitating 
interventions would be helpful (such as a 
written question prompt sheet, website or 
preparatory conversation a nurse prior to 
consultations with a doctor). Some 
patients also talked about appreciating 
example questions. They felt that these 
would show the type of questions 
appropriate to ask, reflecting the worry 
that their concerns may not fit the doctors’ 
remit.
Mills and Sullivan 
(2000) 
Seven patients: 
within 18-months 
since 
oesophagectomy. 
Northe
rn 
Ireland
, UK
Semi-structured 
interviews: 
qualitative content 
analysis.  
Patients described a wish for more 
information pre- and post-operatively. 
They emphasised expecting honest 
information from staff and valued staff 
who took time to speak with them, 
conveying interest and concern. Where 
staff were perceived as inaccessible this 
created barriers to communication. The 
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authors also identified that written 
information could be improved though 
being updated and that a staff education 
programme could improve delivery of 
information. 
144
APPENDIX F: NRES COMMITTEE ETHICAL APPROVAL
NRES Committee London - London Bridge
Skipton House
80 London Road
London
SE1 6LH
Telephone: 020 7972 2491
21 September 2015
Ms. Kirsten Stewart-Knight
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Water Lane, Stratford E15 4LZ
Dear Ms. Stewart-Knight 
Study title: The psychological impact of pre-operative chemotherapy treatment 
for oesophageal cancer: a mixed methods study.
REC reference: 15/LO/1356
IRAS project ID: 180740
Thank you for your letter of 15 September 2015, responding to the Committee’s request for further 
information on the above research and submitting revised documentation.
The further information has been considered on behalf of the Committee by the Chair.
We plan to publish your research summary wording for the above study on the HRA website, together 
with your contact details. Publication will be no earlier than three months from the date of this opinion 
letter. Should you wish to provide a substitute contact point, require further information, or wish to make 
a request to postpone publication, please contact the REC Manager, Miss Kirstie Shearman on 
nrescommittee.london-londonbridge@nhs.net.
Confirmation of ethical opinion
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion for the above research 
on the basis described in the application form, protocol and supporting documentation as revised, subject 
to the conditions specified below.
Conditions of the favourable opinion
The favourable opinion is subject to the following conditions being met prior to the start of the study.
Management permission or approval must be obtained from each host organisation prior to the start of the 
study at the site concerned.
Management permission ("R&D approval") should be sought from all NHS organisations involved in the 
study in accordance with NHS research governance arrangements.
Guidance on applying for NHS permission for research is available in the Integrated Research Application 
System or at http://www.rdforum.nhs.uk.  
Where a NHS organisation’s role in the study is limited to identifying and referring potential participants to 
research sites ("participant identification centre"), guidance should be sought from the R&D office on the 
information it requires to give permission for this activity.
For non-NHS sites, site management permission should be obtained in accordance with the procedures of 
the relevant host organisation. 
Sponsors are not required to notify the Committee of approvals from host organisations
Registration of Clinical Trials
145
All clinical trials (defined as the first four categories on the IRAS filter page) must be registered on a 
publically accessible database within 6 weeks of recruitment of the first participant (for medical device 
studies, within the timeline determined by the current registration and publication trees). 
There is no requirement to separately notify the REC but you should do so at the earliest opportunity e.g 
when submitting an amendment. We will audit the registration details as part of the annual progress 
reporting process.
To ensure transparency in research, we strongly recommend that all research is registered but for non 
clinical trials this is not currently mandatory.
If a sponsor wishes to contest the need for registration they should contact Catherine Blewett 
(catherineblewett@nhs.net), the HRA does not, however, expect exceptions to be made. Guidance on 
where to register is provided within IRAS.
It is the responsibility of the sponsor to ensure that all the conditions are complied with before the 
start of the study or its initiation at a particular site (as applicable).
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NHS sites
The favourable opinion applies to all NHS sites taking part in the study, subject to management permission 
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After ethical review
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Proposed amendment Rationale
Additional interviews with staff members of 
the NHS multidisciplinary team, who are 
working with patients we have ethical 
approval to interview (NHS and University of 
East London approvals). 
In order to gain knowledge of staff members’ 
valuable perspective on what patients say 
influences their experiences. This will also 
aid recruitment. 
Please tick YES NO
Is your supervisor aware of your proposed amendment(s) and 
agree to them?
YES
Student’s signature (please type your name): K Stewart-Knight
Date: 4th January 2015
TO BE COMPLETED BY REVIEWER
Amendment(s) approved YES
Comments
Reviewer: M Finn
Date: 4/01/15
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153
APPENDIX I: PATIENT INFORMATION SHEET AND CONSENT FORM
Research Study Information Sheet
UNIVERSITY OF EAST LONDON
School of Psychology
Stratford Campus
Water Lane
London E15 4LZ
Project Title
The psychological impact of pre-operative chemotherapy treatment for people with 
Oesophageal Cancer.
Principal researcher
My name is Kirsten Stewart-Knight and I am a Trainee Clinical Psychologist at the 
University of East London. This study is being conducted as part of my Doctorate in 
Clinical Psychology.  
Introduction
I am doing a research study about people’s experiences of chemotherapy treatment 
before surgery for Oesophageal Cancer. This information sheet is the first part of the 
informed consent forms for patients. We are inviting you to take part and the purpose 
of this information sheet is to explain what the study involves so that you can decide 
whether to participate. 
Once you have read the information sheet, if you are interested in taking part let the 
member of staff who gave this to you know and I will contact you to arrange a time to 
meet. After reading this information sheet and taking time to think about whether you 
are interested in taking part in the study (and discussing this with another person you 
feel comfortable with if you wish to), we can arrange to meet and you will have an 
opportunity to ask any questions you have. If you are still interested in taking part in 
the study, you will be asked to read and sign a consent form. If you choose to 
participate, you will be given a copy of the full information sheet and consent form. 
You can ask questions at any time. 
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If you change your mind about taking part in the study you can withdraw at any time 
without giving a reason. It is your choice about whether you wish to participate or not. 
If you choose not to participate, all of the healthcare services you received will 
continue and nothing will change. 
Purpose of research
The project aims to understand the experiences and psychological wellbeing of 
patients currently having chemotherapy treatment for oesophageal cancer, where it is 
expected that they will later have surgery. There is currently little research that asks 
patients having this treatment about their experiences and psychological wellbeing. 
We are inviting patients who are having this treatment for Oesophageal Cancer at xxx
NHS to take part in an interview. We believe that this might help us to better 
understand what patients who are having this treatment say about their experiences 
and what they think influences their psychological wellbeing during these experiences. 
We hope that this can help us to think about whether the way patients are currently 
supported could be improved.
Why have I been asked to participate?
You have been selected to participate in this study because you are currently receiving 
chemotherapy treatment for Oesophageal Cancer and are expecting to have surgery at 
xxx NHS Trust. We are selecting patients at xxx NHS Trust who are having this 
particular treatment for Oesophageal Cancer. 
What is involved?
If you decide you are interested in taking part we will arrange to meet for an interview 
at a time and place convenient to you (this could be at your home or at a hospital). 
During this meeting, if after reading all of the information sheet and asking any 
questions you think you would like to take part, you will be asked to sign a consent 
form If you give your consent to go ahead with the study we will begin the interview. 
You can change your mind and withdraw from the study at any time without giving a 
reason. This will not affect your medical care in any way. 
Risks of the study
We are asking you to share with us some personal and confidential information, and 
you may feel uncomfortable or distressed talking about some of the topics. You do not 
have to answer any question or take part in the interview if you don't wish to do so, 
and that is also fine. You do not have to give us any reason for not responding to any 
question, or for refusing to take part in the interview.
If during the interview you would like to take a break or to end the interview early, you 
can do so at any time without having to give a reason. This would not affect your care 
in any way. We will write to your Clinical Nurse Specialist to let them know that you 
are taking part in the study and if you would like us to also notify your GP we can do so 
(you will be asked about this on the consent form). If during or after the interview you 
would like to talk further about your experiences of the interview, I will be happy to do 
so.
Benefits of taking part 
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There will be no direct benefit to you, but your participation is likely to help us find out 
more about how to give better care and whether we should support people who are 
having this treatment differently in the future. Taking part in the study will provide an 
opportunity to talk about your experiences of this type of cancer and treatment and 
how you have coped with this, with the possibility of improving our understanding of 
the impact of this type of cancer treatment.
Will my input remain confidential?
Yes. This study will follow strict ethical guidelines and legal practice to ensure that all 
of the information that you provide will remain anonymous. To ensure anonymity, 
identification numbers will be used for participant identification instead of names. 
Only the researcher (Kirsten Stewart-Knight) will know what your number is and we 
will lock that information up with a lock and key. It will not be shared with or given to 
anyone.
Electronic data will be stored on a password protected database and hard copies of 
recorded data will be kept in a locked filing cabinet. Once the study is finished 
identification numbers will be deleted and only anonymized transcripts will be kept. If 
you change your mind you can withdraw from the study at any time. If you do, up until 
the point of transcription, any information that you have given will not be used and 
this will not affect your care in any way. 
Please note, it may be the case that some direct quotes will be included within the 
final report. However, all personal details that could be used to identify any one 
participant will be removed. Moreover, although it is not expected that the interview 
will reveal any information concerning harm to yourself or others, you should be 
aware that if such information should be disclosed, the researcher is duty bound to 
report this to the relevant professionals. We will routinely write to your Clinical Nurse 
Specialist to let them know that you are taking part in the study and your GP on your 
request.  
Arranging an interview 
The interview will last less than one hour.  You can choose for the interview to take 
place at a location of your choice which could be at a hospital or at your home. 
The interview will be with Kirsten Stewart-Knight. I have an enhanced Criminal Record 
Check and am currently employed by the NHS with experience of working with people 
with cancer. During the interview, I will sit down with you in a comfortable and private
place at the hospital or at your home. No one else but the interviewer will be present 
unless you would like someone else to be there. If you do not wish to answer any of 
the questions during the interview, you may say so and the interviewer will move on to 
the next question. 
The format of the interview will be semi-structured, meaning that I will ask you some 
questions about your experiences of cancer and treatment and how you have coped 
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with this, but you are free to talk about the topics you wish to in relation to these 
general areas. 
The whole interview will be tape recorded but only I (Kirsten Stewart-Knight) will 
access the information documented during your interview. No-one will be identified by 
name on the tape and the tape will be kept in a locked cabinet and on a password 
protected computer. The tapes will be destroyed after the words have been 
transcribed (this will be within a maximum 4 weeks of the interview). 
If you are interested in taking part, when I contact you I will ask you about your 
preferences and will be happy to answer any questions you have. 
Reimbursement
If you travel to the hospital solely to meet for the interview, if you get a receipt for the 
specific journey we will be able to reimburse your travel expenses.
Sharing the Results
At the end of the study (May 2016), I will be happy to send you a summary of the 
results. If you would like a copy of this please send a request to Kirsten Stewart-Knight 
using the contact details below. You will also be welcome to ask any questions you 
have at any point in the study. Following this, we aim that the research findings will be 
shared more broadly through a research journal and conferences.
Do I have to take part?
You do not have to take part in this research if you do not wish to do so, and choosing 
to 
participate will not affect your medical care or the services you receive any way. You 
may stop participating in the interview] at any time that you wish without any 
disadvantage to you. I will give you an opportunity at the end of the interview to 
review your remarks, and you can ask to modify or remove portions of those. 
Who to Contact
My contact details are: Kirsten Stewart-Knight, 0780 44 99 125, u1331817@uel.ac.uk -
please feel free to ask me any questions. 
If you have any questions or concerns about how the study has been conducted, 
please contact the study’s supervisor: Dr. Kenneth Gannon at School of Psychology, 
University of East London, Water Lane, London E15 4LZ. Telephone: 020 8223 4174 or 
Email address: K.N.Gannon@uel.ac.uk
or 
Chair of the School of Psychology Research Ethics Sub-committee: Dr. Mark Finn, 
School of Psychology, University of East London, Water Lane, London E15 4LZ.
(Tel: 020 8223 4493. Email: m.finn@uel.ac.uk)
This proposal has been reviewed and approved by the University of East London Ethics 
committee and by the London National Research Ethics Service (London Bridge) which 
is a committee whose task it is to make sure that NHS research participants are 
protected from harm. 
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Please retain this information sheet for reference.
YOUR DECISION ABOUT WHETHER TO TAKE PART IN THIS STUDY WILL NOT EFFECT 
YOUR CARE IN ANY WAY
Thank you in anticipation.
Yours sincerely,
Kirsten Stewart-Knight
(Trainee Clinical Psychologist, Study’s Chief Investigator
UNIVERSITY OF EAST LONDON
Consent to participate in a research study:
The psychological impact of pre-operative chemotherapy treatment 
for people with Oesophageal Cancer
I have the read the information sheet relating to the above research study and have 
been given a copy to keep. The nature and purposes of the research and the 
processes in which I will be involved have been explained to me. I have had the 
opportunity to discuss the details and ask questions about this information and any 
questions that have been asked have been answered to my satisfaction. 
I have been told that my involvement in this study, and data from this research, will 
remain strictly confidential. Only the researcher involved in the study will have access 
to identifying data. It has been explained to me what will happen once the research 
study has been completed. I have been told that the researcher will write to my Clinical 
Nurse Specialist to inform them that I am participating in this study.
I hereby freely and fully consent to participate in the study which has been fully 
explained to me. Having given this consent I understand that I have the right to 
withdraw from the study at any time without disadvantage to myself and without 
being obliged to give any reason. I also understand that should I withdraw following 
the transcription of the interview, the researcher reserves the right to use my 
anonymous data in the write-up of the study and in any further analysis that may be 
conducted by the researcher.
I consent voluntarily to be a participant in this study: 
Participant’s Name (BLOCK CAPITALS) …………………………………….
Signature of Participant ………………………………………………………..
Date ……………………………..
In addition to my Clinical Nurse Specialist, I would like you to write to my GP to let 
them know that I am participating in the study: 
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Participant’s Name (BLOCK CAPITALS) 
……………………………………………………………………………………….
Participant’s Signature 
…………………………………………………………………….. Date ……………………
GP name and 
address……………………………………………………………………………………………
……………………………………………………………………………………………………
….
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APPENDIX J: STAFF INFORMATION SHEET AND CONSENT FORM
Research Study Information Sheet
UNIVERSITY OF EAST LONDON
School of Psychology
Stratford Campus
Water Lane
London E15 4LZ
Project Title
The psychological impact of pre-operative chemotherapy treatment for people with 
Oesophageal Cancer.
Principal researcher
My name is Kirsten Stewart-Knight and I am a Trainee Clinical Psychologist at the 
University of East London. This study is being conducted as part of my Doctorate in 
Clinical Psychology.  
Introduction
I am doing a research study about people’s experiences of chemotherapy treatment 
before surgery for Oesophageal Cancer. This information sheet is the first part of the 
informed consent forms for patients at xxx NHS Trust. We are inviting you to take part 
and the purpose of this information sheet is to explain what the study involves so that 
you can decide whether to participate. 
Once you have read the information sheet, if you are interested in taking part please 
respond to this email and I will contact you to arrange a time to meet. After reading 
this information sheet and taking time to think about whether you are interested in 
taking part in the study (and discussing this with another person you feel comfortable 
with if you wish to), we can arrange to meet and you will have an opportunity to ask 
any questions you have. If you are still interested in taking part in the study, you will be 
asked to read and sign a consent form. If you choose to participate, you will be given a 
copy of the full information sheet and consent form. You can ask questions at any 
time. 
If you change your mind about taking part in the study you can withdraw at any time 
without giving a reason. It is your choice about whether you wish to participate or not. 
If you choose not to participate, all of the healthcare services you received will 
continue and nothing will change. 
Purpose of research
The project aims to understand the experiences and psychological wellbeing of 
patients currently having chemotherapy treatment for oesophageal cancer, where it is 
expected that they will later have surgery. There is currently little research that asks 
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patients having this treatment about their experiences and psychological wellbeing. 
We are inviting patients and staff to take part in an interview. We believe that this 
might help us to better understand what patients who are having this treatment say 
about their experiences and what they think influences their psychological wellbeing 
during these experiences. We hope that this can help us to think about whether the 
way patients are currently supported could be improved.
Why have I been asked to participate?
You have been selected to participate in this study because you are a member of the 
Upper GI team working on the treatment pathway we are studying. We are inviting all 
members of the team to participate. 
What is involved?
If you decide you are interested in taking part we will arrange to meet for an interview 
at a time and place convenient to you (this could be at any of the hospital sites). 
During this meeting, if after reading all of the information sheet and asking any 
questions you think you would like to take part, you will be asked to sign a consent 
form If you give your consent to go ahead with the study we will begin the interview. 
You can change your mind and withdraw from the study at any time without giving a 
reason. This will not affect your employment in any way. 
Risks of the study
We are asking you to share with us some personal and confidential information, and 
you may feel uncomfortable or distressed talking about some of the topics. You do not 
have to answer any question or take part in the interview if you don't wish to do so, 
and that is also fine. You do not have to give us any reason for not responding to any 
question, or for refusing to take part in the interview.
If during the interview you would like to take a break or to end the interview early, you 
can do so at any time without having to give a reason. If during or after the interview 
you would like to talk further about your experiences of the interview, I will be happy 
to do so.
Benefits of taking part 
There will be no direct benefit to you, but your participation is likely to help us find out 
more about how to give better care and whether we should support people who are 
having this treatment differently in the future. Taking part in the study will provide an 
opportunity to talk about your experiences of this type of cancer and treatment and 
how you have coped with this, with the possibility of improving our understanding of 
the impact of this type of cancer treatment.
Will my input remain confidential?
Yes. This study will follow strict ethical guidelines and legal practice to ensure that all 
of the information that you provide will remain anonymous. To ensure anonymity, 
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identification numbers will be used for participant identification instead of names. 
Only the researcher (Kirsten Stewart-Knight) will know what your number is and we 
will lock that information up with a lock and key. It will not be shared with or given to 
anyone.
Electronic data will be stored on a password protected database and hard copies of 
recorded data will be kept in a locked filing cabinet. Once the study is finished 
identification numbers will be deleted and only anonymized transcripts will be kept. If 
you change your mind you can withdraw from the study at any time. If you do, up until 
the point of transcription, any information that you have given will not be used and 
this will not affect your care in any way. 
Please note, it may be the case that some direct quotes will be included within the 
final report. However, all personal details that could be used to identify any one 
participant will be removed. Moreover, although it is not expected that the interview 
will reveal any information concerning harm to yourself or others, you should be 
aware that if such information should be disclosed, the researcher is duty bound to 
report this to relevant professionals. 
Arranging an interview 
The interview will last less than one hour.  You can choose for the interview to take 
place at a location of your choice.
The interview will be with Kirsten Stewart-Knight. I have an enhanced Criminal Record 
Check and am currently employed by the NHS with experience of working with people 
with cancer. During the interview, I will sit down with you in a comfortable and private 
place at the hospital or at your home. No one else but the interviewer will be present 
unless you would like someone else to be there. If you do not wish to answer any of 
the questions during the interview, you may say so and the interviewer will move on to 
the next question. 
The format of the interview will be semi-structured, meaning that I will ask you some 
questions about your experiences of cancer and treatment and how you have coped 
with this, but you are free to talk about the topics you wish to in relation to these 
general areas. 
The whole interview will be tape recorded but only I (Kirsten Stewart-Knight) will 
access the information documented during your interview. No-one will be identified by 
name on the tape and the tape will be kept in a locked cabinet and on a password 
protected computer. The tapes will be destroyed after the words have been 
transcribed (this will be within a maximum 4 weeks of the interview). 
If you are interested in taking part, when I contact you I will ask you about your 
preferences and will be happy to answer any questions you have. 
Sharing the Results
At the end of the study (May 2016), I will be happy to send you a summary of the 
results. If you would like a copy of this please send a request to Kirsten Stewart-Knight 
using the contact details below. You will also be welcome to ask any questions you 
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have at any point in the study. Following this, we aim that the research findings will be 
shared more broadly through a research journal and conferences.
Do I have to take part?
You do not have to take part in this research if you do not wish to do so, and choosing 
to 
participate will not affect your medical care or the services you receive any way. You 
may stop participating in the interview] at any time that you wish without any 
disadvantage to you. I will give you an opportunity at the end of the interview to 
review your remarks, and you can ask to modify or remove portions of those. 
Who to Contact
My contact details are: Kirsten Stewart-Knight, 0780 44 99 125, u1331817@uel.ac.uk -
please feel free to ask me any questions. 
If you have any questions or concerns about how the study has been conducted, 
please contact the study’s supervisor: Dr. Kenneth Gannon at School of Psychology, 
University of East London, Water Lane, London E15 4LZ. Telephone: 020 8223 4174 or 
Email address: K.N.Gannon@uel.ac.uk
or 
Chair of the School of Psychology Research Ethics Sub-committee: Dr. Mark Finn, 
School of Psychology, University of East London, Water Lane, London E15 4LZ.
(Tel: 020 8223 4493. Email: m.finn@uel.ac.uk)
This proposal has been reviewed and approved by the University of East London Ethics 
committee and by the London National Research Ethics Service (London Bridge) which 
is a committee whose task it is to make sure that NHS research participants are 
protected from harm. 
Please retain this information sheet for reference.
YOUR DECISION ABOUT WHETHER TO TAKE PART IN THIS STUDY WILL NOT EFFECT 
YOUR EMPLOYMENT IN ANY WAY
Thank you in anticipation.
Yours sincerely,
Kirsten Stewart-Knight
(Trainee Clinical Psychologist, Study’s Chief Investigator)
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UNIVERSITY OF EAST LONDON
Consent to participate in a research study:
The psychological impact of pre-operative chemotherapy treatment 
for people with Oesophageal Cancer
I have the read the information sheet relating to the above research study and have 
been given a copy to keep. The nature and purposes of the research and the 
processes in which I will be involved have been explained to me. I have had the 
opportunity to discuss the details and ask questions about this information and any 
questions that have been asked have been answered to my satisfaction. 
I have been told that my involvement in this study, and data from this research, will 
remain strictly confidential. Only the researcher involved in the study will have access 
to identifying data. It has been explained to me what will happen once the research 
study has been completed. 
I hereby freely and fully consent to participate in the study which has been fully 
explained to me. Having given this consent I understand that I have the right to 
withdraw from the study at any time without disadvantage to myself and without 
being obliged to give any reason. I also understand that should I withdraw following 
the transcription of the interview, the researcher reserves the right to use my 
anonymous data in the write-up of the study and in any further analysis that may be 
conducted by the researcher.
I consent voluntarily to be a participant in this study: 
Participant’s Name (BLOCK CAPITALS) …………………………………….
Signature of Participant ………………………………………………………..
Date ……………………………..
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APPENDIX K: PATIENT INTERVIEW SCHEDULE
Patient interview schedule
As the interviews will be semi-structured the following will guide the areas to be 
discussed. 
Introduction
Explain consent, confidentiality and that the participant may withdraw at any 
time. Agree approximate length of interview and answer any questions or 
concerns participant wishes to discuss. Once consent process is complete, 
begin audiorecording. 
Areas for questions 
1. Can you tell me how you found out you had oesophageal cancer? 
2. What has the experience of receiving treatment in preparation for the 
operation been like for you?  
3. During these experiences, what have been the things you have found 
most difficult? 
4. What have been the things that have been helpful in getting through this? 
Prompts: What do you mean? What was that like for you? How does that make 
you feel? How do you think about that? Can you give me an example? 
Debriefing:
 How do you feel about the conversation we have had today?
 Is there anything that bothered you about the interview? 
 Is there anything that you’d like me to leave out of the transcript? 
 Is there anything you would have wanted to say but didn’t get to? 
 Do you have any questions? 
 You can contact me if you have any questions and here are some 
contact details for support organisations if you feel you’d like to talk to 
someone later on.
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APPENDIX L: STAFF INTERVIEW SCHEDULE
Staff interview schedule
As the interviews will be semi-structured the following will guide the areas to be 
discussed. 
Introduction
Explain purpose, consent, confidentiality and that the participant may withdraw 
at any time. Agree approximate length of interview and answer any questions or 
concerns participant wishes to discuss. Once consent process is complete, 
begin audiorecording. 
Areas for questions 
1. Can you explain to me your role in the team? How long have you been 
working with patients with potentially curable oesophageal cancer? 
2. From your experience, what is the process leading up to surgery like for 
patients having chemotherapy? Can you give examples?
3. What do you think the biggest challenges are for patients? Can you give 
examples?
4. What do patients say is most helpful? Can you give examples?  
5. Do you have a sense of what makes a difference to patients’ 
experiences? (Demographic and individual differences?) 
6. Within your role what makes a difference to whether you feel you are 
effective are not? What are the skills, environmental factors, experiences 
or attitudes patients might have that make a difference to how effective 
your role is? 
7. Anything I have not asked you about that you think is important to 
understand about the experiences of patients having this treatment? 
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Prompts: What do you mean? How do you understand that? Why do you think 
that is? How do you think about that? Can you give me an example? 
Debriefing:
 How do you feel about the conversation we have had today?
 Is there anything that bothered you about the interview? 
 Is there anything that you’d like me to leave out of the transcript? 
 Is there anything you would have wanted to say but didn’t get to? 
 Do you have any questions? 
 You can contact me if you have any questions and here are some 
contact details for support organisations if you feel you’d like to talk to 
someone later on.
APPENDIX M: TRANSCRIPTION KEY, PARKER (2005) 
( )     Indicates pause in speech
[unclear] Indicates speech was unclear
[ ] Indicates when a comment has been added by the author
< > Indicates interruption
/  Indicates overlapping speech
- Indicates unfinished word
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APPENDIX N: EXAMPLE OF TRANSCRIPT WITH INITIAL OBSERVATIONS 
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APPENDIX O: INITIAL PATIENT CODEBOOK 
1. My responsibility/my part
2. Continuing uncertainty through chemotherapy
3. Preparation now will have an impact on surgery
4. Doctor's expertise and power
5. Prioritising work over health
6. Regrets not presenting earlier
7. Current circumstances pushed to do things would usually avoid
8. Response typical of me
9. Impact on everyday life
10. Difficult life experiences at the same time as beginning to notice symptoms
11. Symptoms worsening and worry increasing
12. Family experiences of cancer
13. Symptoms seeming insignificant until later
14. Trying not think about it
15. Not looking like someone with cancer (linked with not being defined as someone 
with cancer)
16. Never heard of oesophageal cancer
17. Risks and responsibility for smoking/drinking/weight
18. It's about luck
19. Loss of eating (food everywhere, feeling excluded)
20. Worries about the gravity of this operation and aftermath
21. Advocating for self/navigating the healthcare system
22. Stopping cancer taking over
23. Others not always getting it right but their efforts help
24. Waiting for next step in treatment
25. Not knowing what to expect from chemo
26. Process of getting familiar
27. Staff help
28. Determination
29. Prayer helps
30. Not being alone for operation
31. Varied experience of chemo
32. Taking your mind off it
33. Change in speed once at cancer centre
34. Being in professionals hands  - giving over control.
35. Whole team thinking about and explaining
36. Surgery - best chance
37. Seeing results from chemo encouraging
38. Other patients are worse off than me
39. Constantly thinking about next step
40. Practical concerns
41. Explaining properly and knowing what to expect
42. Family support helpful
43. You need a point of contact in the team
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44. Surprised myself by not being frightened
45. Get on with it attitude
46. Risk of death
47. Still the same me
48. NHS admin system
49. Worry about loved ones
50. How do others less confident/intelligent/more anxious cope
51. People assuming you know
52. Life changes after surgery
53. Not feeling ill pre-op
54. Surgery offers hope/cure
55. Turning worries into positives
56. Pushing myself to follow advice
57. Work as  important
58. Feeling stupid
59. Support of friends
60. Being open about cancer
61. Life happens
62. Others' responses
63. Hope and disappointment
64. Staying positive
65. Focusing on what needs to be done
66. Physically feeling well
67. Decision to have treatment no brainer
68. Seeing results from chemotherapy
69. Making sense of it
70. Choosing happiness
71. Treated like an individual
72. Building up fitness
73. Wanting to get the operation over
74. Wanting to delay the operation
75. Cancer diagnosis
76. Relying on yourself
77. Recovery taking time
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APPENDIX P: INITIAL CODEBOOK, STAFF
1. Uncertainty: curative plan, changing to palliative.
2. Surgery offering cure
3. Massive journey to get to surgery
4. Diverse responses to the long journey
5. Ideas about chemotherapy
6. Completely different experiences of chemo
7. Anxiety at the beginning, likely to struggle with treatment
8. Unpredictable how patients will experience treatment
9. Some who struggle at the start surprise the team
10. Family pressure leads patients to comply and be more engaged.
11. Patients without a family network more likely to struggle
12. A lot of information to take in
13. Patients who have been active more likely to engage in preparing for surgery.
14. Support from other patients
15. Engagement predicts experience
16. Different context to healthcare in previous times, expectation patients influence care  
17. Team offering a personalised approach - likely to be different from previous 
experiences of healthcare
18. Masculinity influencing experience
19. Initially patients not reporting difficulties
20. Seeing a whole team not just 1 member of staff
21. Staff delivering on promises makes patients more confident
22. Small proportion of older patients fit for surgery
23. Physiological insult of surgery
24. Implications not talked about
25. Not wanting to dissuade people from treatment
26. Influence of home environment on experience
27. Nutritional impact of surgery
28. Patients don't understand implications
29. Everyone trying to be positive in contrast to awful ideas about cancer in the past
30. Oesophageal cancer worst procedure
31. Differences in expectation and outcome
32. Central role of family
33. Some patients frustrated by so many appointments and tests
34. Need to move quickly with this cancer
35. Some patients frustrated that system can't be flexible around them.
36. Younger patients tend to be more anxious
37. Higher social class more anxious
38. Older patients often more resigned
39. Demographics make a difference to experience
40. Supportive family as advocates
41. Anxiety can lead to demanding things that can't be done
42. Consumerist approach of some patients trying to get the process to move quicker than 
it can
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43. Decisions about how much information to share
44. Passive role of patient - often want to be told what to do
45. Patients wishes often different from patient centric fashion
46. Oesophageal cancer less possible to be positive
47. Human support makes a difference
48. Structured pathway fits for some and not others
49. willingness to engage with structured pathway relates to class (active and passive 
related to class)
50. Key nutritional challenges
51. Pre surgical health predicts outcome of surgery
52. Uncertainty about whether surgery can go ahead
53. Wide variety of pre-op symptoms
54. Process of coming to terms with diagnosis
55. Best case scenario - early cancer
56. Worst case scenario - very rapid
57. More difference between patients in OC than other cancers
58. Social support makes more of a difference in OC than other cancers
59. Family support has a role in food preparation
60. Central role of food in this cancer
61. Carers need perserverance
62. Seriousness of O.C.
63. Patients knowing they are close to not making it
64. Motivated by goal
65. Different from other cancers
66. Hope and risks
67. Chemo seen as something that will move them closer to the goal
68. Ethnicity seems less influential than other areas
69. Education higher anxiety
70. Patient ownership influences experience
71. Structure and clarity of care pathway leads to more ownership
72. Social support and survival
73. Optimising pre-op through exercise aiming to prevent weight loss
74. Push patients hard in exercise pre-op
75. Pre-op exercise the one thing patients can control
76. Patients' support needs vary
77. Working to maintain activity through chemotherapy
78. Optimising pre-op is counterintuitive and educating patients about this
79. Supporting patients to no be fearful of the fatigue
80. Control is the key thing
81. Post chemotherapy tough
82. Exercise and maintaining fitness leading to feeling in control
83. Having understanding of what's happening in body helps
84. Small breakthroughs
85. Patients' psychology makes a difference
86. Not having social support, more difficult
87. Normalising helps
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88. Other patients, unique shared experience
89. Social support and adherence
90. Carers - someone else to take the pressure off
91. Social support = reasons to get better (MOTIVATION)
92. Loss of control
93. Knowing history helps to make sense of behaviour
94. Past experiences influence experience of OC
95. Pre-op phase a fragile stage
96. Respecting patients' time
97. Class or intelligence makes a difference
98. Adherence and mental health
99. Patients more likely to tell non-medical staff things
100. O.C. toll physically and psychologically
101. Particular characteristics of this cancer relating to demographics
102. Risks with this surgery
103. Psychological preparation for surgery
104. Information helps patients to prepare for surgery
105. Motivation linked with feeling ill
106. Information , motivation and psychological preparation
107. Engagement
108. Exercise improving mood
109. Knowing whole team is looking after me helps
110. Reciprocal efforts
111. Variations in engagement with treatment
112. Tailoring staff approach to individual patient
113. Family support mediates language barriers
114. Patient factors influence how successful care can be
115. Some patients wish it could be removed straight away
116. Seeing results of chemo psychologically helps
117. Why can't you just do the surgery now?
118. If the patient understands why they cope better
119. Not spending too long at ‘why me’ helps patient cope better
120. Physical effects don't predict psychological
121. Social support isn't the full story of who copes better
122. People who know the most more anxious
123. Making a decision 'this is not going to consume me
124. Having someone makes a difference
125. Believing in something you can rely on helps
126. Huge loss of eating
127. Aim to be holistic
128. Chemo can give time to adjust
129. Trying to get into the best possible position
130. Different patients want different levels of information
131. Between the devil and the deep blue sea
132. A cohesive support structure makes a difference
133. Thinking about the whole person makes a difference
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134. Demographics don't predict, it's more complicated than one factor
135. Reasons to live for
136. Seeing beyond diagnosis
137. Person to person
138. adjusting to being 're-plumbed'
139. Survival mode
140. Surgery offering hope
141. Some feeling unwell when they present, chemotherapy makes it worse.
142. Focus moves from getting through chemotherapy to surgery
143. Uncertainty (hidden)
144. The treatment plan gives hope
145. Worry about chemotherapy (media representations)
146. Side effects of chemo
147. Wanting the cancer to be cut out
148. Uncertainty post-surgery
149. Realistic expectations and reducing uncertainty
150. Other patients, reducing fear
151. Controlling what they can
152. Individual differences
153. Trying to get into the best possible position
154. Pre-surgery scary to know what's ahead
155. Difficult to process feelings pre-op
156. Hard to get your head round the information pre-op
175
APPENDIX Q: EXTRACT FROM CODING TABLES
Code Example Extracts 
PATIENTS: 
Taking your mind off it
Audrey: "I was a bit shocked to be truthful, and walking it home, 
walking to the bus stop I’m thinking about it, on the bus I’m 
thinking about it and my mind said ‘look, stop thinking about it 
you’re just going to wear yourself down thinking about it all the 
time’. So sometimes I think about it, sometimes I don’t think 
about it, I try to take it off my brains because otherwise it’s just 
going to put me down and make me feel sad and miserable and 
(laughter) I don’t want to feel like that."
Audrey: "It has been working for me [not thinking about it]....It’s 
like if you have a problem and you think about it like a problem 
with your boyfriend and you have an argument and you think 
about it constantly you won’t concentrate on you’re doing at work 
and so forth, so you have to cast it off your mind."
Abdul: "My children say to me you have to be positive and brave, 
they always tell me don’t think about too much, just stay positive. 
It helps me."
Carole: "I’m trying not to think too much about the next bit 
because it’s quite a big bit, just the way I’m trying to 
compartmentalise things at the moment and keep them in little 
blocks."
Joe: "...if you’re still above that line there’s a good chance you’re 
not going to die from it and so you should bloody well treat it as 
though you’re not going to die and be as positive as you can and 
do as much as you can. Just assume and act as though you are 
about to not die...so when he said treatable and curable, I think 
my head kicked into that." 
STAFF:
Hope and risks 
Emma: "It is partly the chemotherapy () and being so focused on 
surgery and getting the chemotherapy to work .  They often have 
such hopefulness that the tumour will shrink but they understand 
if it can’t shrink it won’t be taken out." 
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Olivia "...I think sometimes and I tend to use this with 
patients you get the impression that they feel they’re stuck 
between the devil and the deep blue sea, on the one hand 
they desperately don’t want to have the surgery and they’re 
terrified of it and the impact it will have and the way it will 
interfere with their life as they know it, but on the other 
hand they know that it’s the only key to life and living and so 
it’s that huge unknown . Nobody would ever want to be in
that position."
Josh: "We don’t want to dissuade people from having a 
potentially curative operation or scare them but it is rather 
brushed over historically and so not often covered. And so 
inevitably erm () this often results in people losing aspects of 
their independence and requiring additional support from 
family and so forth () and whether that is something that’s 
attainable depends on the family set up, the network, the 
home….and you know that I think is a huge impact for the 
people."  
Sarah: "If we’re just talking about the neoadjuvant it doesn’t 
always turn out that way, meaning they don’t always end up 
having the surgery and with that group of patients it’s more 
challenging. Because they start off with this goal and if the 
goal shifts a little bit I think that’s where things get more 
challenging for patients and for medical staff too for some 
degree because if you’re scanning them to prepare them for 
surgery, then all of a sudden they have liver bone mets and 
they can’t go onto have that treatment because intent of 
their surgery switches from neoadjuvant to palliative now, it 
can be a little bit challenging." 
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APPENDIX R: EXAMPLES OF PROGRESSING THEMATIC MAPS 
Early patient thematic map
POWER AND CONTROL
Doing my part
Preparations now will impact on surgery.
Prioritising work over health.
Regret not going to GP sooner.
Risks and responsibility (drinking, smoking, weight).
Relying on myself.
Advocating for myself.
Navigating the healthcare system.
Pushing myself to follow advice.
Building up fitness.
Choosing to be open.
LOSS OF CONTROL
Being in professionals’
hands.
Pushed to do things
would usually avoid.
It’s about luck.
Waiting for next step.
Doctors’ expertise and
power.
Continuing uncertainty.
NEW, UNPREDICTABLE AND
UNKNOWN
Never heard of O.C.
Not knowing what to expect from
chemotherapy.
People assuming you know.
Confusing systems.
Feeling stupid.
Process of getting familiar/used to it.
NOT LETTING CANCER TAKE
OVER
Trying not to think about it
Not looking like someone with
cancer
Still the same me
Taking your mind off it
Stopping cancer taking over
Choosing happiness.
Work
Prayer
THINKING POSITIVE
Other patients are worse off than
me.
Staying positive
Turning worries into positives
GET ON WITH IT ATTITUDE
Get on with it attitude
CANCER TAKING OVER
Interrupting every day.
Impact on relationships.
Loss of eating.
Feel. ing excluded.
Constantly thinking about next
steps.
Practical worries.
Side effects of chemo
Worry about loved ones.
Identity
Typical of me.
Determination.
Surprised myself by not being scared.
Making sense of it.
How do others (less privileged) people
cope?
TREATMENT OFFERS
HOPE
Surgery – best chance of
cure.
Seeing results from
chemotherapy
encouraging.
Decision to have
treatment a ‘no-brainer’
LIFE CHANGES WITH SURGERY
Feeling scared.
Risk of death.
Would like surgery not to happen.
Worries about the seriousness of surgery.
Worries about the aftermath.
Life changes after surgery.
Feeling physically well pre-op.
Recovery will take time.
Wanting to get the operation over /
wanting to operation to be delayed.
CANCER ITSELF
Family experiences.
Long lead up to
diagnosis –
symptoms
worsened, worry
increased.
Difficult life
experiences.
Symptoms seemed
insignificant until
later – regret.
OTHERS MAKE A DIFFERENCE
Treated as an individual not a
number.
Support of friends and family
helps.
Having two points of contact in the
team makes a difference.
Knowing the whole team is
thinking about you helps.
UP AND DOWN
Hope and
disappointment.
Bad news and good
news.
Continuing uncertainty.
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Intermediate provisional patient themes 
TAKING POWER AND CONTROL
Doing my part
Preparations now will impact on surgery.
Prioritising work over health.
Regret not going to GP sooner.
Risks and responsibility (drinking, smoking, weight).
Relying on myself.
Advocating for myself. Navigating the healthcare
system.
Pushing myself to follow advice.
Building up fitness.
Choosing to be open.
NOT LETTING CANCER TAKE OVER
Trying not to think about it
Not looking like someone with cancer
Still the same me
Taking your mind off it
Stopping cancer taking over
Choosing happiness.
Work
Prayer
THINKING POSITIVE
Other patients are worse off than me.
Staying positive.
Turning worries into positives.
GET ON WITH IT ATTITUDE
Getting on with it
Focusing on what needs to be done
CANCER TAKING OVER
Interrupting every day.
Impact on relationships.
Loss of eating.
Feeling excluded.
Constantly thinking about next
steps
Practical worries.
Side effects of chemo.
Worry about loved ones.
Theme 1: 
POWER
LOSS OF CONTROL
Being in professionals’ hands.
Pushed to do things would usually avoid.
It’s about luck.
Waiting for next step.
Doctors’ expertise and power.
Continuing uncertainty.
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NEW, UNPREDICTABLE AND UNKNOWN*
 Never heard of O.C. 
 Not knowing what to expect 
from chemotherapy.
 People assuming you know.
 Confusing systems. 
 Feeling stupid.
 Process of getting 
familiar/used to it. 
TREATMENT 
OFFERS HOPE
 Surgery – best 
chance of cure. 
 Seeing results from 
chemotherapy 
encouraging. 
 Decision to have 
treatment a ‘no-
brainer’
CANCER ITSELF*
 Family experiences. 
 Long lead up to diagnosis –
symptoms worsened, worry 
increased.
 Difficult life experiences. 
 Symptoms seemed 
insignificant until later –
regret. 
Theme 2: 
CHALLENGES 
OF 
TREATMENT 
UP AND DOWN
 Hope and disappointment. 
 Bad news and good news.
 Continuing uncertainty. 
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Identity
 Typical of me.
 Determination.
 Surprised myself by not being 
scared. 
 Making sense of it.
 How do others (less 
privileged) people cope? 
OTHERS MAKE A DIFFERENCE
 Treated as an individual not a number.
 Support of friends and family helps. 
 Having two points of contact in the team 
makes a difference. 
 Knowing the whole team is thinking about 
you helps. 
 Staff explaining everything –helps to know 
what to expect. 
Theme 3 
EFFECTS ON 
SELF AND 
OTHERS
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Early staff thematic map 
UNCERTAINTY
Curative plan changing to palliative
Uncertainty often hidden
What will it feel like after surgery?
SURGERY OFFERS CURE
Surgery offers cure
Patients working towards the big goal
Chemotherapy seen as moving them closer towards the goal.
Massive journey to get to surgery
Some patients wish it could be removed quicker.
Surgery offers hope
Scary
Big risks (may not be talked about)
Patients know they are close to not making it
DIFFERENCES IN PHYSICAL EFFECTS
Diverse experiences of chemotherapy (varied side effects)
At point of diagnosis range from no symptoms to highly symptomatic.
Physiological insult of surgery
UNPREDICTABLE HOW PATIENTS WILL EXPERIENCE TREATMENT
Physical effects alone do no predict experience.
Social support makes a difference – family as advocates/motivators.
Class might make a difference (more educated = more anxious?/more
adherence?)
Home environment – suitable.
Masculinity – many patients unlikely to share feelings.
More complicated than one factor
Patients without family network may struggle
PATIENT OWNERSHIP PREDICTS EXPERIENCE
Reasons to live increase motivation (e.g. family and
friends).
Social support increases adherence
Less side effects = more motivation
Pushed hard to exercise pre-operatively.
Family pressure = adherence
Patients who have been more active in the past more likely
to engage in prep for surgery.
LONG JOURNEY
Diverse responses –
unpredictable.
Media representations of
chemotherapy as horrible.
Some  who struggle at
first, cope surprisingly
well.
A lot of info to take in.
Seeing patients who have
got to the other side
reassuring.
CONTROL
Exercise one thing they can control.
Information and understanding related to coping.
Realistic expectations reduces uncertainty.
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Intermediate staff themes
LONG JOURNEY
Massive journey to get to surgery, diverse responses –unpredictable.
Uncertainty (hidden) – whether surgery can go ahead
Worry about chemotherapy (media representations)
May be keen to have cancer cut out ASAP – why can’t you just do the
surgery now?
A lot of info to take in.
Seeing patients who have got to the other side reassuring.
CONTROLLING what they you can – control key
Exercise, information and understanding related to coping.
Realistic expectations reduces uncertainty.
Hard to get your head around the information pre-op.
In survival mode/difficult to process feelings.
Scary to know what’s ahead
Focus moves from getting through chemotherapy to surgery
Some feeling unwell when they present, chemotherapy makes it worse.
Some patients frustrated by appointments and tests.
Chemotherapy seen as something that will move them closer to the
goal.
Chemotherapy can allow time to come to terms with situation.
treatment plan gives hope. seeing results of chemo encouraging.
Between the devil and the deep blue sea
Central role of food and loss for patients who cannot eat.
If patients understand what is happening, they cope better.
Patients want different levels of information.
THE GOAL OF SURGERY
Surgery offers cure
Motivating to work towards this goal.
Chemotherapy seen as moving them closer towards the goal.
Some patients wish it could be removed quicker.
Surgery offers hope
Scary
PATIENT OWNERSHIP
PREDICTS EXPERIENCE
Reasons to live increase motivation
(e.g. family and friends).
Social support increases adherence
Less side effects = more motivation
Pushed hard to exercise pre-
operatively.
Family pressure = adherence
Patients who have been more
active in the past more likely to
engage in prep for surgery.
Variations in engagement with
treatment
UNPREDICTABLE HOW PATIENTS WILL EXPERIENCE TREATMENT
Physical effects alone do no predict experience.
Social support makes a difference – family as advocates/motivators/ reasons to live for but not
the full story of who copes better.
Class might make a difference (more educated = more anxious? / more adherence?)
Home environment – suitable.
Masculinity – many patients unlikely to share feelings.
More complicated than one factor
Patients without family network may struggle
DIFFERENCES IN PHYSICAL EFFECTS
Diverse experiences of chemotherapy (varied side effects
At point of diagnosis range from no symptoms to highly symptomatic.
More differences between patients experiences in this cancer than others – role of food?
Decision – this will not consume me, not spending too long thinking ‘why me’
RISKS OF SURGERY
Biggest procedure possible – huge physiological insult.
Implications difficult to talk about because of tension of not
wanting to dissuade people from life-saving treatment –
dilemmas about how much  information to share.
Big risks (may not be talked about)
Patients know they are close to not making it: seriousness of
O.C. changes experience and motivation.
Impossible for patients to understand the implications –
differences in expectation.
CARE PATHWAY AS A BUFFER
Different context to paternalistic healthcare in
previous times – expectation that patients
influence care.
Team offering a personalised approach - likely
to be different from previous experiences of
healthcare
Seeing a whole team loking after them, not just
1 member of staff
Staff delivering on promises makes patients
more confident
Need to move quickly with this cancer
Pre surgical health predicts outcome of surgery
Seeing beyond the diagnosis to the person.
Person to person relationships.
A cohesive support structure makes a difference
Thinking about the whole person makes a
difference
Trying to get into the best possible position
Aim to be holistic
Structure and clarity of care pathway leads to
more ownership
Realistic expectations and parameters reduce
uncertainty
Reciprocal efforts (team and patient)
Working to maintain activity through
chemotherapy
Optimising pre-op is counterintuitive and
educating patients about this
Supporting patients to no be fearful of the
fatigue
Exercise therapy – small breakthroughs – push
patients hard during pre-op phase.
Exercise improves mood
Tailoring approach to individual patient
Normalising
Information about what they need to do part of
psychological preparation for surgery
Information , motivation and psychological
preparation
Patient factors influence how successful care
can be ( like nucleus)
“Between the devil and the deep blue sea”
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